ASSET PURCHASE AGREEMENT BY AND AMONG SCIENZA LABS, INC. AND ROMARK GLOBAL PHARMA, LLC August 13, 2018
Exhibit
2.1
BY AND
AMONG
SCIENZA LABS, INC.
AND
ROMARK
GLOBAL PHARMA, LLC
August 13,
2018
TABLE OF CONTENTS
Page
ARTICLE I ASSET
PURCHASE; PURCHASE PRICE
|
|
1
|
1.1 Purchase
and Sale of Assets
|
|
1
|
1.2 Purchase
Price
|
|
4
|
1.3 Closing
|
|
4
|
1.4 Closing
Actions and Deliveries
|
|
4
|
1.5 Allocation
of Purchase Price
|
|
5
|
ARTICLE II REPRESENTATIONS
AND WARRANTIES OF SELLER
|
|
6
|
2.1 Organization
and Qualification
|
|
6
|
2.2 Authority
and Enforceability
|
|
6
|
2.3 Consents
and Approvals; No Violations
|
|
6
|
2.4 Litigation
|
|
7
|
2.5 Compliance
with Laws
|
|
7
|
2.6 Brokers
|
|
7
|
2.7 Personal
Property
|
|
7
|
2.8 Taxes
|
|
7
|
2.9 Solvency
|
|
8
|
2.10 Compliance
with Assigned Contracts
|
|
8
|
2.11 Environmental
Laws
|
|
8
|
2.12 Disclosure
Schedules
|
|
8
|
2.13 No
Other Representations and Warranties
|
|
8
|
ARTICLE III REPRESENTATIONS
AND WARRANTIES OF BUYER
|
|
8
|
3.1 Organization
|
|
8
|
3.2 Authority
|
|
8
|
3.3 Consents
and Approvals; No Violations
|
|
9
|
3.4 Brokers
|
|
9
|
3.5 Litigation
|
|
9
|
3.6 Sufficiency
of Funds
|
|
9
|
3.7 Solvency
|
|
9
|
3.8 Acknowledgement
by Buyer
|
|
10
|
ARTICLE
IV COVENANTS
|
|
10
|
4.1 Taxes
|
|
10
|
4.2 Further
Assurances
|
|
10
|
4.3 Public
Announcements; Confidentiality Agreement
|
|
10
|
4.4 Seller
Employees Seller Employees
|
|
11
|
4.5 Reasonable
Efforts; Further Assurances; Cooperation
|
|
11
|
4.6 Laboratory
Permits
|
|
11
|
4.7 No
Use of Names
|
|
11
|
4.8 Post-Closing
|
|
11
|
4.9 Non-Solicitation
|
|
11
|
ARTICLE V CLOSING
CONDITIONS
|
|
12
|
5.1 Conditions
to Obligation of Buyer
|
|
12
|
5.2 Conditions
to Obligation of Seller
|
|
12
|
ARTICLE VI INDEMNIFICATION
|
|
13
|
6.1 Survival
|
|
13
|
6.2 Indemnification
|
|
13
|
6.3 Procedures
|
|
13
|
6.4 Indemnification
as Sole Remedy
|
|
14
|
ARTICLE VII TERMINATION
|
|
14
|
7.1 Termination
|
|
14
|
7.2 Effect
of Termination
|
|
14
|
ARTICLE VIII MISCELLANEOUS
|
|
14
|
8.1 Definitions
|
|
14
|
8.2 Expenses
|
|
19
|
8.3 Entire
Agreement; Amendment; Waiver; Assignment
|
|
19
|
8.4 Notices
|
|
19
|
8.5 Governing
Law
|
|
21
|
8.6 Dispute
Resolution
|
|
21
|
8.7 Exhibits
and Schedules
|
|
21
|
8.8 Construction;
Interpretation
|
|
22
|
8.9 Parties
in Interest
|
|
22
|
8.10 Severability
|
|
22
|
8.11 AS
IS CONDITION; DISCLAIMER OF WARRANTIES; EXCLUSIVITY OF
REPRESENTATIONS AND WARRANTIES
|
|
22
|
8.12 Counterparts
|
|
23
|
8.13 Waiver
of Jury Trial
|
|
23
|
8.14 Non-Recourse
|
|
24
|
8.15 Time
of Essence
|
|
24
|
Exhibits:
Schedule
1.1(a)(i):
Furniture &
Equipment
Schedule
1.1(a)(iv):
Assigned
Contracts
Schedule
1.1(a)(v):
Transferred
Software
Schedule
1.1(a)(vii):
Inventory
Exhibit
A:
Form of Escrow
Agreement
Exhibit
B:
Form of Xxxx of
Sale
Exhibit
C:
Form of Assignment
and Assumption Agreement
Exhibit
D:
Form of Promissory
Note
Exhibit
E:
Form of Security
Agreement
Exhibit
F:
Form of Guaranty
Agreement
Exhibit
G:
Process of
Obtaining FDA Establishment Identifier Number
Exhibit
H:
Form of Sublease
Agreement
THIS
ASSET PURCHASE AGREEMENT
(this “Agreement”), dated as of
August 13, 2018, is made by and among Scienza Labs, Inc., a
corporation organized under the laws of the Commonwealth of Puerto
Rico (“Seller”), and Romark
Global Pharma, LLC, a limited liability company organized under the
laws of the Commonwealth of Puerto Rico (“Buyer”). Seller and Buyer
shall be referred to herein from time to time collectively as the
“Parties” and individually as a “Party.”
Definitions of certain terms are set forth in Section 8.1.
WHEREAS, Seller desires to sell to Buyer
and Buyer desires to purchase from Seller, substantially all of the
assets of Seller used in its Laboratory Business in exchange for
the Purchase Price.
NOW, THEREFORE, in consideration of the
premises and the mutual promises contained herein, and for other
good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Parties hereby agree as
follows:
ARTICLE I
ASSET PURCHASE; PURCHASE PRICE
1.1 Purchase
and Sale of Assets
(a) Sale
of Assets. Subject to the terms and conditions set forth
herein, at the Closing, Seller shall sell, assign, transfer, convey
and deliver to Buyer, and Buyer shall purchase, acquire and accept
from Seller, all of Seller’s right, title and interest in, to
and under the following assets, property and rights of Seller, that
are used or held for use solely in Seller’s Laboratory
Business (collectively, the “Assets”):
(i) all
tangible personal property used or held for use in the operation of
the Laboratory Business, including, without limitation, all
equipment, appliances, tooling, parts, counter space, fixtures,
spare parts, maintenance equipment, cleaning equipment and
supplies, telephones, printers, and computer hardware including,
without limitation, those assets listed in Schedule 1.1(a)(i)
(collectively, the “Furniture &
Equipment”);
(ii) all
quality manuals, general procedures, quality systems, standard
operating procedures and technical procedures used in connection
with the Laboratory Business, including electronic copies thereof,
if any (collectively, the “Transferred
IP”);
(iii) any
Improvements (only to the extent of Seller’s interest
therein) located on or attached to the Laboratory Premises, and all
rights arising out of the ownership thereof;
(iv) any
Contract entered into in the Ordinary Course of Business that is
used in the operation of the Laboratory Business and listed on
Schedule 1.1(a)(iv)
(the “Assigned
Contracts”);
(v) the
software and related licenses used in the operation of the
Laboratory Business listed on Schedule 1.1(a)(v) (the
“Transferred
Software”);
(vi) all
third party guarantees, warranties and other similar agreements
(collectively, the “Guarantees”) primarily
related to the Assets or the Assumed Liabilities; and
(vii) all
Inventory, including Inventory listed on Schedule 1.1(a)(vii) attached
hereto.
1
All of
the Assets shall be sold, assigned, transferred, conveyed and
delivered to Buyer free and clear of all Liens (other than
Permitted Liens).
(b) Excluded
Assets. Buyer expressly understands and agrees that it is
not purchasing or acquiring, and Seller is not selling,
transferring or assigning, any other assets or properties of Seller
other than the Assets, and all such other assets and properties
shall be excluded from the Assets (such other assets and
properties, the “Excluded Assets”).
Without limitation of the foregoing, the Excluded Assets shall
include the following assets and properties of Seller:
(i) all
assets of Pharma-Bio Serv, Inc. and Pharma-Bio Serv PR, Inc.
(collectively, the “Affiliate Entities”) held
by such Affiliate Entity and used in the Laboratory
Business;
(ii) all
assets and rights of the Affiliate Entities and their Affiliates
other than the Assets;
(iii) any
signs or personal property which contain the name (or trade
derivative thereof) or logo of Seller, including all uniforms
supplied to Seller’s employees, if any;
(iv) accounts
receivable of Seller or the Affiliate Entities relating to the
Laboratory Business or its operation thereof, refunds of insurance
premiums, and credit and debit card receivables (collectively, the
“Accounts
Receivable”), including but not limited to any
accounts receivable or other amounts owed by Buyer or its
Affiliates to Seller or its Affiliates, which such amounts shall
remain due and payable and not be affected by the transactions
contemplated; hereby;
(v) all
files, documents, instruments, papers, computer files and records
and all other books and records of Seller in any form or
media;
(vi) any
Permits relating to the Laboratory Business which are not permitted
to be transferred or assigned under applicable Law;
(vii) all
Deposits and Prepaid Expenses;
(viii) other
than the Transferred IP, all Intellectual Property owned by or
licensed to Seller (except pursuant to any Assigned Contract),
including all rights in the name “Scienza”, the
websites and web addresses of Seller, its trademarks, service
marks, trade names, and similar intangibles including any right to
use, or interest in, any of the name of Seller or any Affiliate
thereof, or any similar name or intangible registered or licensed
to any of the foregoing, or any trade names used by Seller or any
Affiliate thereof (except pursuant to any Contract that is an
Asset) and all goodwill of Seller and its Affiliates;
(ix) claims,
rebates, refunds and other general intangibles arising from the
operation of the Laboratory Business prior to the Effective
Time;
(x) all
refunds and credits of Taxes attributable to the Laboratory
Business or the Assets for any Pre-Closing Tax Period, including
any personal property taxes and municipal license tax paid in
advance by Seller;
(xi) all
casualty insurance, title insurance, liability insurance and other
insurance policies of Seller and its Affiliates and claims or
proceeds thereunder;
2
(xii) other
than the Transferred Software, any and all rights to any software
used in any computer equipment;
(xiii) the
books and business records of Seller primarily relating to assets
and liabilities of Seller other than the Assets or the Assumed
Liabilities and the books and business records of Seller or the
Affiliate Entities relating to (A) employees, independent
contractors and other personnel of Seller, including employee
manuals, employee handbooks and employee personnel records, and
instructional, promotional and educational materials, or (B)
corporate, chain-wide or division-level operations, policies, or
plans, including the following: policy, compliance and procedures
manuals; internal audit reports and any information, books, records
or files (whether in writing or electronic format) concerning the
financial performance, strategic plans, budgets, forecasts,
projections, or competitive or capital spending analysis of
excluded operations;
(xiv) all
cash and cash equivalents, bank accounts and securities of
Seller;
(xv) all
Contracts of Seller that are not Assigned Contracts;
(xvi) the
rights which accrue or will accrue to Seller under the Transaction
Documents;
(xvii) all
trucks, vans, and automobiles;
(xviii) all
customers, customer relationships, customer lists, customer data
and information;
(xix) all
property which, upon installation thereof, under Seller’s
current lease agreement becomes the property of the landlord
thereunder;
(xx) all
Benefit Plans, and all funding vehicles and assets attributable
thereto;
(xxi) all
rights to occupy the Laboratory Premises under lease except to the
extent subleased to Buyer as provided herein;
(xxii) all
rights to, or obligations under, any Legal Proceeding of any nature
available to or being pursued by Seller, whether arising by way of
counterclaim or otherwise; and
(xxiii) all
equity or other ownership interests in any entity.
(c) Assumption
of Certain Liabilities. On and subject to the terms and
conditions of this Agreement, at the Closing, Buyer shall assume
and agree to pay, perform and discharge when due any and all of the
following Liabilities (other than the Retained Liabilities)
(collectively, the “Assumed
Liabilities”):
(i) all
Liabilities under the Assigned Contracts arising, and based upon
facts occurring, after the Effective Time;
3
(ii) all
Liabilities (other than with respect to Taxes, it being understood
that the Assumed Liabilities with respect to Taxes are set forth in
Section
1.1(c)(iii)) arising, and based upon facts occurring, after
the Effective Time, with respect to the ownership of the Assets;
and
(iii) all
Liabilities for Taxes relating to the Assets for any Post-Closing
Tax Period.
(d) Retained
Liabilities. Notwithstanding anything to the contrary in
this Agreement or in any other Transaction Document, Buyer shall
not assume, and shall not be obligated to assume or pay, perform or
discharge, and Seller shall retain, pay, perform and discharge, any
Liabilities of Seller that are not Assumed Liabilities (such
retained Liabilities, collectively, the “Retained
Liabilities”).
1.2 Purchase
Price. The aggregate consideration (collectively, the
“Purchase
Price”) to be paid by Buyer for the Assets, in
addition to the assumption of the Assumed Liabilities, shall be
Five Million Dollars ($5,000,000.00), payable in accordance with
Section 1.4(b)(i).
On the date hereof, Seller and Buyer have entered into an escrow
agreement in the form of Exhibit A hereto (the
“Escrow
Agreement”) pursuant to which (1) Buyer has deposited
One Million Seven Hundred Fifty Thousand Dollars ($1,750,000.00)
(the “Escrow
Amount”) and (2) each of Buyer, Seller, and Guarantor
(as hereinafter defined), as applicable, have delivered undated
original executed copies of the Escrow Closing Documents with the
escrow agent thereto. The Escrow Amount shall be released to Seller
and the Escrow Closing Documents shall be released to the
respective parties identified in the Escrow Agreement upon
Seller’s written certification that Seller has satisfied the
conditions to Buyer’s obligations to consummate the
transactions set forth in Section 5.1 (other than those
conditions that by their nature are to be satisfied at Closing, but
subject to the fulfillment or waiver of those conditions). The
Escrow Amount shall be released to Buyer in accordance with the
terms of the Escrow Agreement upon the termination of this
Agreement in accordance with ARTICLE VII.
1.3 Closing.
The consummation of the purchase of the Assets (the
“Closing”) will occur when
the Parties have complied with their respective obligations under
ARTICLE V. The date
on which the Closing occurs is referred to herein as the
“Closing
Date.” The Closing shall be effective as of 12:01 AM
EST time (the “Effective Time”) on the
Closing Date. The Closing shall be deemed to occur upon the
delivery of the Escrow Amount and Escrow Closing Documents by the
escrow agent in accordance with the Escrow Agreement.
1.4 Closing
Actions and Deliveries.
(a) On
the Closing Date (other than item (iii) which shall be delivered on
the date hereof), Seller shall deliver to Buyer (provided that
delivery by the escrow agent shall be deemed delivery by
Seller):
(i) a
xxxx of sale in the form of Exhibit B hereto (the
“Xxxx of
Sale”), duly executed by Seller, transferring the
tangible personal property included in the Assets to
Buyer;
(ii) an
assignment and assumption agreement in the form of Exhibit C hereto (the
“Assignment and
Assumption Agreement”), duly executed by Seller,
effecting the assignment to, and assumption by, Buyer of all of the
Assets and the Assumed Liabilities;
(iii) a
certificate of the secretary or manager of Seller certifying to (A)
Seller’s articles of incorporation and bylaws, if any, (or
similar governing documents), (B) the adoption of resolutions of
Seller approving the transactions contemplated hereby and by each
of the other Transaction Documents to which Seller is a party, (C)
the incumbency of the officers signing this Agreement and other
Transaction Documents to which Seller is a party on behalf of
Seller (together with their specimen signatures), and (D) attaching
a good standing certificate (or similar document) issued by the
secretary of state certifying that Seller is existing and in good
standing under the laws of the Commonwealth of Puerto Rico;
and
4
(iv) such
other documents, instruments or certificates as shall be reasonably
requested by Buyer or its counsel.
(b) On
the Closing Date (other than items (iv) and (v) which shall be
delivered on the date hereof), Buyer shall deliver to Seller
(provided that delivery by the escrow agent shall be deemed
delivery by Buyer):
(i) the
Purchase Price in the following manner: (A) the Escrow Amount will
be released to Seller, (B) delivery of a promissory note in the
form attached hereto as Exhibit D in the principal
amount of Three Million Dollars (the “Promissory Note”), and
(C) application of a credit to Buyer for Two Hundred Fifty Thousand
Dollars ($250,000.00) in respect of the Buyer Deposit;
(ii) the
Xxxx of Sale and the Assignment and Assumption Agreement, each duly
executed by Buyer;
(iii) a
security agreement in the form attached hereto as Exhibit E (the
“Security
Agreement”), granting Seller a secured interest on the
Assets;
(iv) a
guaranty agreement in the form attached hereto as Exhibit F (the
“Guaranty
Agreement”) duly executed by Romark Laboratories L.C.,
a Florida limited liability company (the “Guarantor”), providing
for Guarantor’s limited guaranty of Three Million Dollars
($3,000,000.00) of the Purchase Price;
(v) a
certificate of the secretary or manager of Buyer certifying to (A)
Buyer’s articles of organization and limited liability
company agreement (or similar governing documents), (B) the
adoption of resolutions of Buyer approving the transactions
contemplated hereby and by each of the other Transaction Documents
to which Buyer is a party, (C) the incumbency of the officers
signing this Agreement and other Transaction Documents to which
Buyer is a party on behalf of Buyer (together with their specimen
signatures), and (D) attaching a good standing certificate (or
similar document) issued by the secretary of state certifying that
Seller is existing and in good standing under the laws of the
Commonwealth of Puerto Rico;
(vi) a
certificate of the secretary or manager of Guarantor certifying to
(A) Guarantor’s articles of organization and limited
liability company agreement (or similar governing documents), (B)
the adoption of resolutions of Guarantor approving the transactions
contemplated by the Guaranty Agreement to which Guarantor is a
party, (C) the incumbency of the officers signing the Guaranty
Agreement to which Guarantor is a party on behalf of Guarantor
(together with their specimen signatures), and (D) attaching a good
standing certificate (or similar document) issued by the secretary
of state certifying that Guarantor is existing and in good standing
under the laws of Florida; and
(vii) such
other documents, instruments or certificates as shall be reasonably
requested by Seller or its counsel.
1.5 Allocation
of Purchase Price. Buyer and Seller shall agree on the
allocation of the Purchase Price among the Assets within sixty (60)
days after the Closing Date; provided, however, that a minimum of Two Million
Dollars ($2,000,000.00) of the Purchase Price will be allocated to
the equipment included in the Assets. The Parties agree to file (or
cause to be filed) all Tax Returns (including amended Tax Returns
and claims for refund) in a manner consistent with such allocation
of the Purchase Price described herein. The Parties agree to
refrain from taking any position that is inconsistent with such
allocation, and to use their commercially reasonable efforts to
sustain such allocation in any subsequent Tax audit or Tax dispute.
Notwithstanding any of the foregoing, the agreed upon allocation
shall also comply with the rules and regulations promulgated under
the 2011 Puerto Rico Internal Revenue Code, as
amended.
5
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF SELLER
Except
as set forth in the Disclosure Schedule, Seller hereby represents
and warrants to Buyer as follows:
2.1 Organization
and Qualification.
(a) Seller
is a corporation duly organized, validly existing and in good
standing under the laws of the Commonwealth of Puerto Rico and is
qualified to do business in each jurisdiction in which the Assets
are located. Seller has the requisite power and authority to own,
lease and operate its properties and to carry on its Laboratory
Business as presently conducted.
(b) Seller
is duly qualified or licensed to do business and is in good
standing (or the equivalent thereof) in each jurisdiction in which
the property owned, leased or operated by it, or the nature of the
Laboratory Business conducted by it, makes such qualification or
licensing necessary, except in such jurisdictions where the failure
to be so duly qualified or licensed and in good standing would not
reasonably be expected to have a material adverse effect on
Seller.
2.2
Authority and
Enforceability. Seller has all requisite corporate power and
authority to execute and deliver this Agreement and each other
Transaction Document to which it is a party, and to consummate the
transactions contemplated hereby and thereby. The execution and
delivery of this Agreement and the consummation of the transactions
contemplated hereby and by each of the other Transaction Documents
have been duly authorized by all necessary action on the part of
Seller. This Agreement and the other Transaction Documents to which
Seller is a party have been duly and validly executed and delivered
by Seller, and, each Transaction Document constitutes, or will
constitute, as the case may be, a valid, legal and binding
agreement of Seller, enforceable against Seller in accordance with
its terms, subject to applicable bankruptcy, insolvency,
reorganization, moratorium and similar Laws affecting
creditors’ rights and remedies generally and subject, as to
enforceability, to general principles of equity (regardless of
whether enforcement is sought in a proceeding at Law or in
equity).
2.3 Consents
and Approvals; No Violations.
(a) Except
(i) as set forth in Section 2.3(a) of the
Disclosure Schedule, and (ii) as may be necessary as a result of
any facts or circumstances relating solely to Buyer or any of its
Affiliates, no material filing with or material notice to, and no
authorization, Consent or approval of, or material Order of, any
Governmental Entity or any other Person is necessary for the
execution and delivery by Seller or any of its Affiliates of this
Agreement or any of the other Transaction Documents to which it is
a party or the consummation by Seller of the transactions
contemplated hereby or thereby.
(b) Neither
the execution, delivery and performance of this Agreement or any of
the other Transaction Documents to which Seller is a party by
Seller nor the consummation by Seller of the transactions
contemplated hereby or by any of the other Transaction Documents to
which Seller is a party will conflict with, or result in any breach
or violation of, or default (with or without notice or lapse of
time, or both) under, or give rise to a right of, or result in,
termination, right of first refusal, amendment, revocation,
cancellation or acceleration of any obligation or to the loss of a
benefit under, or result in the creation of any Lien upon any of
the Assets (other than Permitted Liens) under, (i) the articles of
incorporation or bylaws (or similar governing documents) of Seller,
(ii) except as set forth in Section 2.3(b) of the
Disclosure Schedule, any of the terms, conditions or provisions of
any material note, bond, mortgage, indenture, lease, license,
Contract, agreement or other instrument or obligation to which
Seller is a party or by which Seller or any of its properties or
assets may be bound, or (iii) any Order or Law applicable to Seller
or any of its Affiliates or any of their respective properties or
assets.
6
2.4 Litigation.
Except as set forth in Section 2.4 of the Disclosure
Schedule, there is no Legal Proceeding pending or, to
Seller’s knowledge, threatened against Seller or any of its
Affiliates related to the Assets or the Laboratory Business, or
that challenges the validity or enforceability of any Transaction
Document or seeks to enjoin or prohibit consummation of the
transactions contemplated thereby. Neither Seller nor any of its
Affiliates is subject to any outstanding Order related to the
Assets or the Laboratory Business or that would otherwise prevent
or materially delay Seller’s ability to consummate the
transactions contemplated by any Transaction Document or perform in
any material respect its obligations thereunder.
2.5 Compliance
with Laws. Seller is in compliance, in all material
respects, with all applicable Laws and Orders which apply to the
Laboratory Business and its conduct thereof.
2.6 Brokers.
No broker, finder or investment banker or other Person is entitled
to any broker’s, finder’s or investment banker’s
fee or commission or other similar compensation or payments in
connection with the transactions contemplated by this Agreement or
by any of the other Transaction Documents based upon arrangements
made by and on behalf of Seller. Seller shall be responsible for
the payment of any commission or fee payable to any broker engaged
by Seller.
2.7 Personal
Property.
(a) As
of the date hereof, Seller owns, or holds under valid leases, all
material tangible personal property necessary for the operation of
the Laboratory Business, subject to no Liens or encumbrances except
for Liens identified in Section 2.7(a) of the
Disclosure Schedule, and (i) Liens for Taxes that are not yet due
and payable, (ii) statutory Liens of landlords and Liens of
carriers, warehousemen, incurred in the Ordinary Course of Business
for sums not yet paid; (iii) Liens on the Laboratory Premises real
property, and (iv) Liens which do not materially impair the value
of any material portion of the Assets as a whole
(“Permitted
Liens”).
(b) Seller
owns, or holds under valid leases, all of the assets, properties
and rights described in Section 1.1(a)(i)-(vii). Seller
has the power and right to sell, assign and transfer to Buyer, and
upon consummation of the transactions contemplated by the
Transaction Documents, Buyer will acquire good and marketable title
to, all of such assets, properties and rights, free and clear of
all Liens (other than Permitted Liens).
2.8 Taxes.
Seller has timely filed with the appropriate taxing authorities all
Tax Returns with respect to the Assets that it has been required to
file and all such Tax Returns are true, correct, and complete in
all material respects. All Taxes owed by Seller with respect to the
Assets, including any Taxes with respect to the Laboratory Business
to the extent required to be paid by Seller, (whether or not shown
or required to be shown on any Tax Return) have been timely paid.
There are no Liens (other than Permitted Liens) on any of the
Assets that arose in connection with any failure (or alleged
failure) to pay any Tax. Seller and/or its Affiliates have not
received any claims in writing concerning any material Tax
Liability of Seller with respect to the Laboratory Business, Assets
or Laboratory Premises and there are no pending or threatened
assessments for Taxes with respect to any of the Assets or the
Laboratory Premises.
2.9 Solvency.
Assuming the (i) accuracy in all material respects of the
representations and warranties of Buyer set forth in this Agreement
and/or the Transaction Documents and (ii) performance in all
material respects by Buyer of its obligations under the Transaction
Documents, immediately after giving effect to the transactions
contemplated by this Agreement and the other Transaction Documents,
Seller shall be solvent and shall: (a) be able to pay its debts as
they become due; (b) own property that has a fair saleable value
greater than the amounts required to pay its debts (including a
reasonable estimate of the amount of all contingent liabilities);
and (c) have adequate capital to carry on its business. No transfer
of property is being made and no obligation is being incurred in
connection with the transactions contemplated hereby with the
intent to hinder, delay or defraud either present or future
creditors of Seller. In connection with the transactions
contemplated hereby, neither Seller nor its Affiliates have
incurred, nor plan to incur, debts beyond their ability to pay as
they become absolute and matured.
7
2.10 Compliance
with Assigned Contracts. Seller has complied with its
obligations in all material respects under the Assigned
Contracts.
2.11 Environmental
Laws. To the best of Seller’s knowledge, there are no
Environmental Liabilities pending or threatened.
2.12 Disclosure
Schedules. The Disclosure Schedule is complete and accurate
in all material respects and is incorporated herein by
reference.
2.13 No
Other Representations and Warranties. Except for the
representations and warranties contained in this Agreement
(including the related portions of the Disclosure Schedule) or in
any other Transaction Document, neither Seller nor any other Person
has made or makes any other express or implied representation or
warranty, either written or oral, on behalf of Seller, including
any representation or warranty as to the accuracy or completeness
of any information regarding the Laboratory Business and the Assets
furnished or made available to Buyer and its representatives
(including any information, documents or material made available to
Buyer in any electronic data room, management presentations or in
any other form in expectation of the transactions contemplated
hereby or by any of the other Transaction Documents) or as to the
future revenue, profitability or success of the Laboratory
Business, or any representation or warranty arising from statute or
otherwise in Law.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF BUYER
Buyer
hereby represents and warrants to Seller as follows:
3.1 Organization.
Buyer is duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization. Buyer has
the requisite power and authority carry on its business as
presently conducted.
3.2 Authority.
Buyer has all necessary power and authority to execute and deliver
this Agreement and each other Transaction Document to which it is a
party, and to consummate the transactions contemplated hereby and
thereby. The execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby and by each of
the other Transaction Documents to which Buyer is a party have been
duly authorized by all necessary action on the part of Buyer and no
other proceeding (including by its direct or indirect equity
holders) on the part of Buyer is necessary to authorize this
Agreement or any of the other Transaction Documents to which it is
a party, or to consummate the transactions contemplated hereby and
thereby. This Agreement and the other Transaction Documents to
which Buyer is a party have been duly and validly executed and
delivered by Buyer, except for such Transaction Documents that are
required by the terms hereof to be executed and delivered by Buyer
after the date hereof, in which case such Transaction Documents
will be duly executed and delivered by Buyer at or prior to the
Closing, and each Transaction Document constitutes, or will
constitute, as the case may be, a valid, legal and binding
agreement of Buyer, enforceable against Buyer in accordance with
its terms, subject to applicable bankruptcy, insolvency,
reorganization, moratorium and similar Laws affecting
creditors’ rights and remedies generally and subject, as to
enforceability, to general principles of equity (regardless of
whether enforcement is sought in a proceeding at Law or in
equity).
8
3.3 Consents
and Approvals; No Violations. No material filing with or
material notice to, and no material Permit, authorization, Consent
or approval of, or material Order of, any Governmental Entity is
necessary for the execution and delivery by Buyer or any of its
Affiliates of this Agreement or any of the other Transaction
Documents to which it is a party or the consummation by Buyer of
the transactions contemplated hereby or thereby, except where the
failure to obtain such permits, authorizations, consents or
approvals or to make such filings or give such notice would not,
individually or in the aggregate, be reasonably expected to prevent
or materially delay the consummation of the transactions
contemplated hereby and thereby. Neither the execution, delivery
and performance by Buyer of this Agreement or any of the other
Transaction Documents to which Buyer is a party, nor the
consummation by Buyer of the transactions contemplated hereby or by
any of the other Transaction Documents to which Buyer is a party
will conflict with, or result in any breach or violation of, or
default (with or without notice or lapse of time, or both) under,
or give rise to a right of, or result in, termination, right of
first refusal, amendment, revocation, cancellation or acceleration
of any obligation or to the loss of a benefit under, or result in
the creation of any Lien under, (a) the certificate or articles of
formation or bylaws (or similar governing documents) of Buyer or
its Affiliates, (b) any of the terms, conditions or provisions of
any note, bond, mortgage, indenture, lease, license, Contract,
agreement or other instrument or obligation to which Buyer or its
Affiliates are a party to or by which Buyer or its Affiliates or
any of its properties or assets may be bound or (c) any Law or
Order applicable to Buyer or any of Buyer’s Affiliates or any
of their respective properties or assets.
3.4 Brokers.
No broker, finder or investment banker or other Person is entitled
to any broker’s, finder’s or investment banker’s
fee or commission or other similar compensation or payments in
connection with the transactions contemplated hereby or by any of
the other Transaction Documents based upon arrangements made by and
on behalf of Buyer.
3.5 Litigation.
Neither Buyer nor any of its Affiliates is a party to any
litigation or threatened litigation which would reasonably be
expected to affect or prohibit the consummation of the transactions
contemplated hereby.
3.6 Sufficiency
of Funds. Buyer has and will have at Closing sufficient cash
on hand or other sources of immediately available funds to enable
it to pay the Purchase Price and consummate the transactions
contemplated by this Agreement.
3.7 Solvency.
Assuming the (i) accuracy in all material respects of the
representations and warranties of Seller set forth in this
Agreement and/or the Transaction Documents and (ii) performance in
all material respects by Seller of its obligations under the
Transaction Documents, immediately after giving effect to the
transactions contemplated by this Agreement and the other
Transaction Documents, Buyer and its Affiliates shall be solvent
and shall: (a) be able to pay its debts as they become due; (b) own
property that has a fair saleable value greater than the amounts
required to pay its debts (including a reasonable estimate of the
amount of all contingent liabilities); and (c) have adequate
capital to carry on its business. No transfer of property is being
made and no obligation is being incurred in connection with the
transactions contemplated hereby with the intent to hinder, delay
or defraud either present or future creditors of Buyer and its
Affiliates or Seller. In connection with the transactions
contemplated hereby, neither Seller nor its Affiliates have
incurred, nor plan to incur, debts beyond their ability to pay as
they become absolute and matured.
3.8 Acknowledgement
by Buyer. Buyer acknowledges and agrees that it has
conducted its own independent review and analysis of the Laboratory
Business, including the Assets to be acquired. In entering into
this Agreement, Buyer has relied solely upon its own investigation
and analysis and the representations and warranties of Seller set
forth in this Agreement and in the other Transaction
Documents.
9
ARTICLE IV
COVENANTS
4.1 Taxes.
(a) All
transfer, sales and use, value added, registration, documentary,
stamp and similar Taxes (including any penalties, interest,
additions to Tax and costs and expenses, if any, relating to such
Taxes, but excluding any transfer gains Taxes or Taxes in the
nature of an income Tax, municipal license tax, franchise Tax or
excise Tax), whether for real or personal property (collectively,
“Transfer
Taxes”), in connection with the transactions
contemplated under this Agreement shall be borne fifty percent
(50%) by Buyer and fifty percent (50%) by Seller. The Party that is
required by applicable Law to file any Tax Returns in connection
with any such Taxes shall timely prepare and file all Tax returns
and other filings with respect thereto. Buyer and Seller will
cooperate with each other in the preparation of any such Tax
Returns or other filings and shall cooperate in good faith to
minimize, to the fullest extent possible under such Laws, the
amount of any such Transfer Taxes.
(b) Buyer
and Seller shall furnish or cause to be furnished to each other, as
promptly as reasonably practicable, such information and assistance
relating to the Assets and Laboratory Business as is reasonably
necessary for (i) the preparation and filing of any Tax Return,
(ii) the preparation for and proof of facts during any Tax audit,
(iii) the preparation for any Tax protest, (iv) the prosecution or
defense of any Legal Proceeding relating to Tax matters and (v) the
answer of any governmental or regulatory inquiry relating to Tax
matters.
4.2 Further
Assurances. If any further action is necessary or desirable
to carry out the purposes of this Agreement, each of the Parties
will take such further action (including the execution and delivery
of such further instruments and documents) as any other Party
reasonably may request.
4.3 Public
Announcements; Confidentiality Agreement.
(a) If
any Party or any of its Affiliates proposes to make any
announcement or other disclosure relating to the existence or
subject matter of this Agreement, the disclosing Party shall give
the other Party prior notice of, and an opportunity to comment on,
the proposed announcement or disclosure, except if and to the
extent that such Party is required to make any public disclosure or
filing (i) by applicable Law, (ii) pursuant to any rules or
regulations of any securities exchange of which the securities of
such party or any of its Affiliates are listed or traded or (iii)
in connection with enforcing its rights under this
Agreement.
(b) Each
Party acknowledges and agrees that the Confidentiality Agreement
remains in full force and effect and, in addition, Buyer covenants
and agrees to keep confidential, in accordance with and subject to
the provisions of such Confidentiality Agreement (to the extent
such provisions are not in conflict or inconsistent with the
provisions of this Agreement, including Section 4.3(a)), information
provided to Buyer pursuant to this Agreement. If this Agreement is,
for any reason, terminated prior to the Closing, the
Confidentiality Agreement and the provisions of this Section 4.3(b) shall
nonetheless continue in full force and effect.
4.4 Seller
Employees Seller Employees. Buyer will use its reasonable
best efforts to offer post-Closing employment to any of
Seller’s employees that are terminated by Seller in
connection with the transactions contemplated hereby and as to
which Seller submits reasonable evidence that such employees have
been terminated. With respect to employees, Seller shall be
responsible for all compensation, benefits and indemnification,
either contractual or required by law, arising prior to the Closing
(in accordance with Seller’s employment terms), and Buyer
shall be responsible for all compensation, benefits and
indemnification, either contractual or required by law, arising
after the Closing (in accordance with Buyer’s employment
terms) for each such employee who accepts Buyer’s offer of
employment, if any. Seller will indemnify and hold harmless Buyer
from any employee claim for services rendered to Seller or its
Affiliates prior to the Closing and based on facts occurring prior
to the Closing. The limitations of Article VI will not be
applicable to claims against Seller pursuant to this Section 4.4.
10
4.5 Reasonable
Efforts; Further Assurances; Cooperation. Subject to the
other provisions hereof, each Party shall use its commercially
reasonable efforts to perform its obligations hereunder and to
take, or cause to be taken, and do, or cause to be done, all things
necessary, proper or advisable under applicable Law to obtain all
required authorizations, Consents or approvals over the
transactions contemplated hereby, including but not limited to
those described in in Section 2.3(a) of the
Disclosure Schedule and by the other Transaction Documents,
including using commercially reasonable efforts to give all notices
to, and obtain all Consents from, all third parties that are
described in Section
2.3(b) of the Disclosure Schedules; provided, however, that Seller shall not be
obligated to pay any consideration therefor to any third party from
whom Consent or approval is requested.
4.6 Laboratory
Permits. Buyer acknowledges and agrees that Buyer shall be
solely responsible in obtaining any required accreditations,
registrations, Permits, or similar documentation which is not an
Acquired Permit and that may be required to be obtained by Buyer in
order to properly operate the Laboratory Business following the
Closing; provided,
however, that at
Buyer’s request, Seller will reasonably support any efforts
of Buyer to transfer its Federal Drug Administration Establishment
Identifier Number to Buyer. Without limiting the generality of the
foregoing, Seller acknowledges that, in order for Buyer to request
or obtain certain permits, Seller may be required to file certain
notices and/or forms with Governmental Entities and Seller agrees
that it shall undertake all commercially reasonable actions
(without undue burden or out-of-pocket expenses to Seller) required
for timely delivering or filing such notices or forms. Seller shall
also cooperate with, and provide to Buyer such information related
to the Assets (without undue burden or out-of-pocket expenses to
Seller) as may be reasonably required from Seller or the Laboratory
Business in order for Buyer to obtain such accreditations, Permits
or registrations. Attached hereto as Exhibit G is an illustrative
example on the process involved in obtaining a Federal Drug
Administration Establishment Identifier Number.
4.7 No
Use of Names. Buyer agrees that it shall not use the names
or logos of Seller or any of its Affiliates or any similar name or
logos. As soon as reasonably practical following Closing, but
before commencing general operations of the Laboratory Business,
Buyer shall remove the other names and logos of Seller appearing on
the Assets, at Buyer’s expense.
4.8 Post-Closing.
Buyer and Seller hereby agree to cooperate to ensure the orderly
transfer of the Laboratory Premises and the Assets upon
Closing.
4.9 Non-Solicitation.
In order to ensure that the Parties will respectively realize the
benefits of transactions contemplated hereby, Seller and Buyer
hereby agree that each shall not, and shall each cause its
respective Affiliates not to, during the period commencing on the
Closing Date and ending two (2) years after the Closing Date,
directly or indirectly, (i) employ or permit any company or
business directly or indirectly controlled by it to employ any
person who is or was employed by the other Party or its Affiliates
or within the six (6) months prior to such time, or (ii) in any
manner seek to induce any such person to leave his or her
employment or to not seek employment with the other Party, except
that the preceding clauses (i) and (ii) shall not
prohibit:
(a)
either Party from any general solicitation for employment
(including newspapers or magazines, over the internet or by any
search or employment agency) if not specifically directed towards
any person; or
(b) Buyer
from offering post-Closing employment to any of Seller’s
employees that were terminated in connection with the transactions
contemplated hereby.
11
ARTICLE V
CLOSING CONDITIONS
5.1 Conditions
to Obligation of Buyer. The obligation of Buyer to
consummate the transactions contemplated by this Agreement is
subject to the fulfillment on or prior to the Closing of each of
the following conditions, any one or more of which (to the extent
permitted by applicable Law) may be waived by Buyer in its sole
discretion.
(a) Each
of the representations and warranties of Seller contained in this
Agreement shall be true in all respects when made and as of the
Closing Date, with the same effect as though such representations
and warranties had been made on and of the Closing Date, except for
such failures to be true that would not be reasonably likely to
have, individually or in the aggregate, a material adverse
effect.
(b) Seller
shall have performed or complied in all material respects with its
obligations and covenants required by this Agreement to be
performed or complied with by Seller at or prior to the Closing
Date, except for such failures to be true that would not be
reasonably likely to have, individually or in the aggregate, a
material adverse effect.
(c) No
temporary restraining Order, Law, preliminary or permanent
injunction, cease and desist Order, or other Order issued by any
Governmental Entity, shall be in effect prohibiting or preventing
the transactions contemplated by this Agreement or any other
Transaction Document.
(d) Seller
shall have made the deliveries to Buyer required under Section 1.4(a).
(e) Buyer
shall have obtained a sublease for the Laboratory Premises in the
form attached hereto as Exhibit H (the
“Sublease”).
(f) Seller
shall have vacated the Laboratory Premises.
5.2 Conditions
to Obligation of Seller. The obligation of Seller to
consummate the transactions contemplated by this Agreement is
subject to the fulfillment on or prior to the Closing of each of
the following conditions, any one or more of which (to the extent
permitted by applicable Law) may be waived by Seller in its sole
discretion:
(a) Buyer
shall have performed or complied in all material respects with its
other obligations and covenants required by this Agreement to be
performed or complied with by Buyer at or prior to the
Closing.
(b) No
temporary restraining Order, Law, preliminary, or permanent
injunction, cease and desist Order or other order issued by any
Governmental Entity shall be in effect prohibiting or preventing
the transactions contemplated by this Agreement or any other
Transaction Document.
(c) Buyer
shall have made the deliveries to Seller required under
Section
1.4(b).
ARTICLE VI
INDEMNIFICATION
6.1 Survival.
Subject to the limitations and other provisions of this Agreement,
the representations and warranties contained herein shall survive
the Closing and shall remain in full force and effect until the
date that is two (2) years from the Closing Date, except that
representations and warranties under Section 2.1, Section 2.2, Section 2.6, and Section 2.7 shall survive the
Closing for a period of three (3) years and those relating to
Liabilities for Taxes shall survive until the latest date permitted
by applicable Law (provided that any claim brought prior to such
time bar shall survive until resolution of such claim). The
covenants and other agreements contained in this Agreement shall
survive the Closing Date in accordance with their
terms.
12
6.2 Indemnification.
(a) From
and after Closing, Seller shall defend, indemnify and hold harmless
Buyer from and against any and all losses, costs, damages,
liabilities or expenses, including reasonable attorneys’ fees
and expenses and expenses of enforcing this indemnity (collectively
“Damages”) incurred by
Buyer arising out of, relating to or resulting from: (i) the breach
or default of any representation or warranty of Seller under this
Agreement; (ii) the breach or default of any covenant or agreement
of Seller under this Agreement; (iii) the Retained Liabilities;
(iv) the Excluded Assets; and (v) Seller’s noncompliance of
any bulk sale requirements under the Commonwealth of Puerto
Rico’s Act 60 of April 27, 1931, sec.1, as amended;
provided, however, Seller shall not, absent
fraud, be liable under Section 6.2(a)(i) for any
indemnification claims: (A) unless and until the Damages incurred
by Buyer exceed Twenty Five Thousand Dollars ($25,000.00) in the
aggregate, at which point Seller shall be liable for all such
Damages that have been incurred by Buyer; and (B) for any Damages
that exceed, in the aggregate, Three Million Dollars
($3,000,000.00).
(b) From
and after Closing, Buyer shall defend, indemnify and hold harmless
Seller from and against any and all Damages incurred by Seller
arising out of or resulting from: (i) the breach or default of any
representation or warranty of Buyer under this Agreement, (ii) the
breach or default of any covenant or agreement of Buyer under this
Agreement, and (iii) the Assumed Liabilities; provided, however, that Buyer, absent fraud,
shall not be liable under Section 6.2(b)(i) for any
indemnification claims: (A) unless and until the Damages incurred
by Buyer exceed Twenty Five Thousand Dollars ($25,000.00) in the
aggregate, at which point Buyer shall be liable for all such
Damages that have been incurred by Seller; and (B) for any Damages
that exceed, in the aggregate, Three Million Dollars
($3,000,000.00).
6.3 Procedures.
(a) The
indemnified party shall give prompt written notice to the
indemnifying party of any demand, suit, claim or assertion of
liability by a third party that is subject to indemnification
hereunder (a “Claim”), but a failure to
give such notice or delaying such notice shall not affect the
indemnified party’s rights or the indemnifying party’s
obligations, except to the extent the indemnifying party’s
ability to remedy, contest, defend or settle with respect to such
Claim is thereby prejudiced.
(b) The
indemnifying party shall have the right to undertake the defense or
opposition to such Claim with counsel reasonably satisfactory to
the parties. In the event that the indemnifying party does not
undertake such defense or opposition within fifteen (15) days of
notice of Claim (or such shorter period as applicable in the
circumstances in the event earlier action or response is necessary
or appropriate), then the indemnified party may undertake the
defense, opposition, compromise or settlement of such Claim with
counsel selected by it at the indemnifying party’s cost.
Notwithstanding any provision herein to the contrary, the
indemnifying party shall not have the right to assume control of
such defense and shall pay the reasonable fees and expenses of
counsel retained by the indemnified party, if the claim for which
the indemnifying party seeks to assume control: seeks non-monetary
relief or involves criminal allegations (other than
misdemeanors).
(c) Notwithstanding
anything herein to the contrary: (i) the indemnified party shall
have the right, at its own cost and expense, to participate in the
defense, opposition, compromise or settlement of any Claim, and
shall have the right to consult with the indemnifying party and its
counsel concerning any Claim, and the indemnifying party and the
indemnified party shall cooperate in good faith with respect to any
Claim; and (ii) the indemnifying party shall not, without the
indemnified party’s written consent, settle or compromise any
Claim or consent to entry of any judgment which does not include a
release of the indemnified party from all liability in respect of
such Claim.
13
6.4 Indemnification
as Sole Remedy. The Parties acknowledge and agree that their
sole and exclusive remedy with respect to any and all claims for
any breach of any representation, warranty, covenant, agreement or
obligation set forth herein, shall be pursuant to the
indemnification provisions set forth in this ARTICLE VI. Notwithstanding the
foregoing or anything else in this Agreement to the contrary, (a)
in the case of intentional fraud, the indemnified party shall have
all remedies available under this Agreement or otherwise without
giving effect to any of the limitations or waivers contained
herein, and (b) nothing herein shall limit any Party’s right
to seek and obtain equitable remedies with respect to any covenant
in this Agreement.
ARTICLE VII
TERMINATION
7.1 Termination.
This Agreement may be terminated at any time prior to the Closing
by either Buyer or Seller, by providing written notice to the other
Party and the escrow agent, if the Closing shall not have been
consummated within sixty (60) days of the date hereof (the
“Optional End
Date”); provided, however, that the Optional End Date
shall be extended by (i) the number of days Seller is impacted by a
Force Majeure Event plus
(ii) the number of days Seller is impacted by a Third-Party Audit
Event.
7.2 Effect
of Termination. In the event of the termination of this
Agreement as provided in Section 7.2, this Agreement and
each of the Transaction Documents shall forthwith become void and
there shall be no liability on the part of any Party.
ARTICLE VIII
MISCELLANEOUS
8.1 Definitions.
(a) For
purposes of this Agreement, the terms set forth below have the
following meanings:
“Affiliate” of any
particular Person means any other Person controlling, controlled by
or under common control with such particular Person, where
“control” means the possession, directly or indirectly,
of the power to direct the management and policies of a Person
whether through the ownership of voting securities or
otherwise.
“Benefit Plan” means any
pension, benefit, retirement, compensation, employment, consulting,
profit-sharing, deferred compensation, incentive, bonus,
performance award, phantom equity, stock or stock-based, change in
control, retention, severance, vacation, paid time off, welfare,
health, fringe-benefit and other similar agreement, plan, policy,
program or arrangement (and any amendments, supplements or
modifications thereto), in each case whether or not in writing,
including each “employee benefit plan” within the
meaning of Section 3(3) of ERISA, whether or not tax-qualified and
whether or not subject to ERISA, which is or has been maintained,
sponsored, contributed to, or required to be contributed to by
Seller or Seller’s Affiliates for the benefit of any current
or former employee, officer, director, retiree, independent
contractor or consultant of Seller’s or its Affiliates’
respective businesses or any spouse or dependent of such
individual, or under which Seller or any of its Affiliates has or
may have any Liability.
“Business Day” means any
day of the year on which national banking institutions in Puerto
Rico are open to the public for conducting business and are not
required or authorized to close.
14
“Buyer Deposit” means an
amount equal to $250,000 paid by Buyer on or about April 4,
2018.
“Code” means the Internal
Revenue Code of 1986, as amended from time to time and the
regulations promulgated and rulings issued thereunder.
“Confidentiality
Agreement” means that certain Mutual Confidentiality
Agreement, dated January 10, 2018, by and among Pharma-Bio Serv PR,
Inc., Seller and Buyer.
“Consent” means any
consent, approval, authorization, Permit of, filing with, or
notification to, any Person.
“Contract” shall mean any
agreement, contract, instrument, commitment, lease, guaranty,
indenture, license, or other arrangement or understanding (and all
amendments, side letters, modifications and supplements thereto)
between parties or by one party in favor of another party, whether
written or oral.
“Deposits” means, all
utility deposits, security, vendor and other deposits actually
being held directly or indirectly by a third party related
primarily to the Assets or the Assumed Liabilities.
“Disclosure Schedule”
means the disclosure schedule dated the date hereof regarding this
Agreement that has been provided by Seller to Buyer.
“Environmental Laws” means
all laws, rules, regulations, resolutions, codes, ordinances,
orders, decrees, judgments, injunctions, notices or binding
agreements issued, promulgated or entered into by any Governmental
Entity, relating in any way to pollution, contamination or
protection of the environment or similar health or safety matters,
or natural resources, including, without limitation, those relating
to the uses, handling, transportation, treatment, storage,
disposal, release or discharge of hazardous materials, substances
or wastes.
“Environmental
Liabilities” means any and all allegations, demands,
claims, liabilities, losses, obligations, causes of actions,
damages, fines, penalties, costs, and expenses, including
reasonable attorneys’ fees, consultants’ fees,
remediation costs, court costs, and other costs of suit arising out
of or relating to Environmental Laws, but only to the extent such
liabilities and obligations arise from Seller’s: (i) use,
operation, tenure or control of the Assets, the Laboratory Business
or the Laboratory Premises; (ii) Seller’s violation or
noncompliance with any Environmental Law, a Permit or Permit
condition; or (iii) any environmental condition of the Laboratory
Premises or coming from the Laboratory Premises (including above or
below ground) caused by or related to (i) or (ii)
above.
“ERISA” means the Employee
Retirement Income Security Act of 1974, as amended from time to
time, and the regulations promulgated and rulings issued
thereunder.
“Escrow Closing Documents”
means the Xxxx of Sale, the Assignment and Assumption Agreement,
the Promissory Note, the Security Agreement, the Guaranty
Agreement, and the Sublease Agreement required to be delivered to
the escrow agent on the date hereof.
“Force Majeure Event”
means a delay caused by or resulting from acts beyond
Seller’s reasonable control, including the following Force
Majeure Events: (a) acts of God; (b) flood, fire, earthquake or
explosion; (c) war, invasion, hostilities (whether war is declared
or not), terrorist threats or acts, riot or other civil unrest; (d)
government order or law; (e) actions, embargoes or blockades in
effect on or after the date of this Agreement; (f) action by any
Governmental Entity; (g) national or regional emergency; (h)
strikes, labor stoppages or slowdowns or other industrial
disturbances; and (i) shortage of adequate power or transportation
facilities.
15
“GAAP” means United States
generally accepted accounting principles, consistently
applied.
“Governmental Entity”
means any United States federal, state, local, municipal, foreign
(including for the avoidance of doubt, the Commonwealth of Puerto
Rico) or supranational governmental department, any political
subdivision thereof or any court, commission, board, bureau,
legislative or administrative body, instrumentality or
agency.
“Improvements” means the
buildings, fixtures, lighting, electrical, mechanical, plumbing and
heating, ventilation and air conditioning systems and improvements
located on or attached to the Laboratory Premises, to the extent
owned by Seller and which upon installation or expiration of the
relevant Laboratory Premises lease agreement do not become the
property of the landlord thereunder, if any.
“Intellectual Property”
means: (i) all inventions (whether patentable or unpatentable and
whether or not reduced to practice), all improvements thereto, and
all patents, patent applications, and patent disclosures, together
with all reissuances, continuations, continuations-in-part,
revisions, extensions, and reexaminations thereof; (ii) all
trademarks, service marks, trade dress, logos, trade names, and
corporate names, together with all translations, adaptations,
derivations, and combinations thereof and including all goodwill
associated therewith, and all applications, registrations and
renewals in connection therewith; (iii) all copyrightable works,
all copyrights, and all applications, registrations and renewals in
connection therewith; (iv) all trade secrets and confidential
information (including ideas, research and development, know-how,
formulas, compositions, manufacturing and production processes and
techniques, technical data, designs, drawings, specifications,
customer and supplier lists, pricing and cost information, and
business and marketing plans and proposals); (v) all computer
software (including data and related documentation); and (vi) all
copies and tangible embodiments thereof (in whatever form or
medium).
“Inventory” means all raw
materials used in the Laboratory Business, and general supplies,
containers, labels, packaging material, maintenance supplies and
other similar items, whether in broken or unbroken units, which are
located at the Laboratory Premises.
“Laboratory Business”
means the business conducted by Seller at the Laboratory
Premises.
“Laboratory Premises”
means the laboratory operated by Seller located at 6 Road 696,
Dorado, Puerto Rico and, unless the context otherwise requires, and
Improvements relating thereto.
“Law” means any federal,
state, local, common law or foreign law (including, for the
avoidance of doubt, U.S. or the Commonwealth of Puerto Rico law,
statute, code, ordinance, rule, regulation, resolution, order,
permit, conventions, restrictions, treaties, ordinances, approvals,
directives, judgments, injunctions, stipulations, writs, awards and
decrees of, or other requirement or rule of law of, or issued by,
any Governmental Entity.
“Legal Proceeding” means
any judicial, administrative or arbitral actions, suits,
proceedings (public or private), claims, hearings, investigations,
charges, complaints, demands, petitions, mediations, audits,
inquiries, examinations, arbitrations or governmental or other
legal proceedings, whether at law or in equity.
“Liability” means any
debt, liability, obligation or commitment of any nature whatsoever
(whether known or unknown, whether asserted or unasserted, whether
absolute or contingent, whether accrued or unaccrued, whether
liquidated or unliquidated, whether determined or determinable, and
whether due or to become due, or otherwise), including any
liability for Taxes.
16
“Lien” or
“lien”
means any mortgage, pledge, lien, charge, security interest,
option, right of first refusal, right of first offer, servitude,
sublease, easement, hypothecation, restrictive covenant,
encroachment, security agreement, equitable interest, earn-out,
conditional sale or other title retention device or arrangement,
deed of trust, or other similar encumbrance or restriction of any
kind, in each case whether contingent, fixed or otherwise or
whether relating to any property or right or the income or profits
therefrom.
“Order” means any order,
injunction, judgment, decree, ruling, writ, assessment, verdict or
award or any arbitration award.
“Ordinary Course of
Business” means the ordinary course of business,
consistent with past practice.
“Permit” means any
authorization, approval, Order, consent, license, certificate,
permit, registration or qualification required to be obtained from
a Governmental Entity.
“Person” means an
individual, partnership, corporation, limited liability company,
joint stock company, unincorporated organization or association,
trust, joint venture, association or other organization, whether or
not a legal entity, or a Governmental Entity.
“Post-Closing Tax Period”
means any Tax period beginning any time after the Closing
Date.
“Pre-Closing Tax Period”
means any Tax period ending on or before the Closing
Date.
“Prepaid Expenses” means
and all prepaid rent and other prepaid charges and expenses related
primarily to the Assets or the Assumed Liabilities, if
any.
“Tax” or
“Taxes”
means (a) all United States federal, state, local and non-United
States (including the Commonwealth of Puerto Rico) and other taxes
including: (i) taxes or other charges on or with respect to income,
franchises, windfall or other profits, gross receipts, sales, use,
capital stock, payroll, employment, social security, disability,
workers’ compensation, unemployment compensation, intangible,
real property, personal property, alternative or add on minimum,
net worth, ad valorem, customs duty, stamp, documentary, license,
transfer, value added, escheat or gains taxes; (ii) taxes or other
charges in the nature of excise, or collected through withholding;
and (iii) any interest, additions to tax, or penalties applicable,
or costs and expenses relating, to the items in clauses (i) and
(ii) and (b) any Liability for any items described in clause (a)
payable by reason of transferee, successor or secondary liability,
contract, assumption, operation of law (including Treasury
Regulations Section 1.1502-6) or otherwise.
“Tax Return” means any
return, report, declaration, form, filing, claim for refund or
information return or statement relating to Taxes, including any
schedule or attachment thereto, and including any amendment
thereof.
“Third-Party Audit Event”
means a delay caused by or resulting from a third-party audit or
investigation conducted on Seller, the Laboratory Business, and/or
the Laboratory Premises.
“Transaction Document”
means this Agreement, the Xxxx of Sale, the Assignment and
Assumption Agreement, the Promissory Note, the Security Agreement
and the other agreements, instruments and documents required to be
delivered at or prior to the Closing.
17
(b) Each
of the following terms is defined in the Section set forth opposite
such term:
Term
|
|
Section
|
AAA
|
|
Section 8.6
|
Accounts Receivable
|
|
Section 1.1(b)(iv)
|
Affiliate Entities
|
|
Section 1.1(b)(i)
|
Agreement
|
|
Preamble
|
Asset
|
|
Section 1.1(a)
|
Assigned Contracts
|
|
Section 1.1(a)(iv)
|
Assignment and Assumption Agreement
|
|
Section 1.4(a)(ii)
|
Assumed Liabilities
|
|
Section 1.1(c)
|
Xxxx of Sale
|
|
Section 1.4(a)(i)
|
Board of Arbitration
|
|
Section 8.7
|
Buyer
|
|
Preamble
|
Claim
|
|
Section 6.3(a)
|
Closing
|
|
Section 1.3
|
Closing Date
|
|
Section 1.3
|
Damages
|
|
Section 6.2(a)
|
Effective Time
|
|
Section 1.3
|
Escrow Agreement
|
|
Section 1.2
|
Escrow Amount
|
|
Section 1.2
|
Excluded Asset
|
|
Section 1.1(b)
|
Guaranty Agreement
|
|
Section 1.4(b)(iv)
|
Retained Liability
|
|
Section 1.1(d)
|
Furniture
& Equipment
|
|
Section 1.1(a)(i)
|
Guarantees
|
|
Section 1.1(a)(v)
|
Non-Party Affiliates
|
|
Section 8.14
|
Optional End Date
|
|
Section 7.1
|
Party
|
|
Preamble
|
Permitted Liens
|
|
Section 2.7(a)
|
Promissory Note
|
|
Section 1.4(b)(i)(B)
|
Purchase Price
|
|
Section 1.2(a)
|
Rules
|
|
Section 8.6
|
Seller
|
|
Preamble
|
Security Agreement
|
|
Section 1.4(b)(iii)
|
Sublease
|
|
Section 5.1(e)
|
Transfer Taxes
|
|
Section 4.1(a)
|
Transferred IP
|
|
Section 1.1(a)(ii)
|
Transferred Software
|
|
Section 1.1(a)(v)
|
18
8.2 Expenses.
Except as otherwise provided in this Agreement or in any other
Transaction Document, all fees and expenses incurred in connection
with this Agreement and other Transaction Documents and the
transactions contemplated hereby and thereby, including the fees
and disbursements of counsel, financial advisors and accountants,
shall be paid by the Party incurring such fees or
expenses.
8.3 Entire
Agreement; Amendment; Waiver; Assignment. This Agreement
(including all Schedules and Exhibits hereto) constitutes the
entire agreement among the Parties with respect to the subject
matter hereof and supersedes all other prior agreements and
understandings, both written and oral, among the Parties with
respect to the subject matter hereof. Any provision hereof can be
amended, supplemented, changed, or waived, only by written
instrument making specific reference to this Agreement and signed,
in the case of an amendment, supplement or modification, by Buyer
and Seller, or in the case of a waiver, by the Party against whom
the waiver is to be effective. No failure or delay by any Party in
exercising any right, power or privilege hereunder shall operate as
a waiver thereof nor shall any single or partial exercise thereof
preclude any other or further exercise thereof or the exercise of
any other right, power or privilege. Any rights or obligations
hereunder shall not be assigned by any Party (whether by operation
of Law or otherwise) without the prior written consent of the other
Party. Any attempt to assign this Agreement in violation of the
foregoing shall be void and of no effect.
8.4 Notices.
All notices, requests, claims, demands and other communications
hereunder shall be deemed to have been duly given and made if in
writing and if given by personal delivery upon the Person for whom
it is intended, nationally recognized overnight courier or
certified mail at the following addresses, return receipt
requested, or if sent by facsimile or email, provided that the
facsimile or email is promptly followed by a confirmation copy
delivered by certified mail or by a nationally recognized overnight
courier to the Person at the address set forth below (or to such
other address as a Party may have specified by notice given to the
other Party pursuant to this provision):
To
Buyer:
Romark
Global Pharma, LLC
c/o
Romark Laboratories, L.C.
0000
Xxxxxxx Xxxxx Xxxxx 000
Xxxxx,
XX 00000
Attn: Chief Executive Officer
Fax:
(000) 000-0000
Email:
xxxx.xxxxx@xxxxxx.xxx
|
19
with a
copy (which shall not constitute notice to Buyer) to:
X’Xxxxx & Xxxxxx
000 Xxxxx Xxxxxx Xxxxxx, Xxxxx 000
Xxx Xxxx, XX 00000
Attn: Xxxx X. Xxxxx
Fax: (000) 000-0000
Email:
xxxx.xxxxx@xxxxxxxxxxxx.xxx
and
Xxxxx
& Lardner LLP
000
Xxxxx Xxxxx Xx. Xxxxx 0000
Xxxxx
XX 00000
Attn:
Xxxxx Xxxxx
Fax:
(000) 000-0000
Email:
xxxxxx@xxxxx.xxx
|
|
To
Seller:
Scienza
Labs, Inc.
0 Xxxx 000
Xxxxxx, XX
Attn: Chairman
Fax: (000) 000-0000
Email:
xxxxxx@xxxxxxxxxxxxx.xxx
xxxxxxxx@xxxxxxxxxxxxx.xxx
|
|
With a
copy (which shall not constitute notice Seller) to:
Akerman
LLP
Three
Brickell City Centre
00
Xxxxxxxxx Xxxxxxx Xxxxxx, Xxxxx 0000
Xxxxx,
Xxxxxxx 00000
Attn:
Xxxxx X. Xxxxxxxxx
Fax:
(000) 000-0000
Email:
xxxxx.xxxxxxxxx@xxxxxxx.xxx
|
Any
such notice or communication shall be deemed to have been received
(i) when delivered, if personally delivered, (ii) on the next
Business Day after dispatch, if sent postage pre-paid by nationally
recognized, overnight courier guaranteeing next Business Day
delivery, (iii) the Business Day received, if sent by facsimile or
email, provided that any notice received by facsimile transmission
or otherwise at the addressee’s location on any non-Business
Day or any Business Day after 5:00 p.m. (addressee’s local
time) shall be deemed to have been received at 9:00 a.m.
(addressee’s local time) on the next Business Day, and (iv)
on the 5th Business Day following the date on which the piece of
mail containing such communication is posted, if sent by certified
mail, postage prepaid, return receipt requested. Rejection or other
refusal to accept or the inability to deliver because of changed
address of which no notice was given shall be deemed to be receipt
of the notice as of the date of such rejection, refusal or
inability to deliver.
20
8.5 Governing
Law. This Agreement and any claim or controversy arising out
of or relating to this Agreement, shall be governed by and
construed in accordance with the internal laws of the Commonwealth
of Puerto Rico without giving effect to any choice or conflict of
law provision or rule that would cause the application of the Laws
of any jurisdiction other than Puerto Rico.
8.6 Dispute
Resolution.
(a) Any
controversy or claim arising out of or relating to this Agreement
or the other Transaction Documents, or a breach thereof, shall be
settled by final and binding arbitration administered in the
Commonwealth of Puerto Rico in accordance with the then existing
rules (“Rules”) of the American
Arbitration Association (“AAA”), and judgment upon
the award rendered by the arbitrators may be entered in any court
having jurisdiction thereof; provided, however, that the law applicable to any
controversy shall be the law of the Commonwealth of Puerto Rico in
accordance with Section
8.5 hereof.
(b) In
any arbitration pursuant to this Agreement, (i) discovery shall be
allowed and governed by the Rules, and the award or decision shall
be rendered by a majority of the members of a board of arbitration
(the “Board of
Arbitration”) consisting of three (3) members, one (1)
of whom shall be appointed by each of the respective Parties and a
third (3rd) of whom shall be
appointed by mutual agreement of said two (2) Party-appointed
arbitrators. In the event of failure of said two (2) arbitrators to
agree within thirty (30) days after the commencement of the
arbitration proceeding upon the appointment of the third
(3rd)
arbitrator, the third (3rd) arbitrator shall
be appointed by the AAA in accordance with the Rules. Nothing set
forth above shall be interpreted to prevent the Parties from
agreeing in writing to submit any dispute to a single arbitrator in
lieu of a three (3) member Board of Arbitration.
(c) Notwithstanding
the foregoing, the request by either Party for preliminary or
permanent injunctive relief, whether prohibitive or mandatory,
shall not be subject to arbitration and may be adjudicated only by
the courts of the Commonwealth of Puerto Rico or such Federal Court
of the United States of America, sitting in the Commonwealth of
Puerto Rico.
8.7 Exhibits
and Schedules. If and to the extent any information required
to be furnished in any Section of the Disclosure Schedule is
contained in this Agreement or in any other Section of the
Disclosure Schedule, such information shall be deemed to be
included in all Sections of the Disclosure Schedule in which the
information would otherwise be required to be included to the
extent that the disclosure is reasonably apparent on its face to be
applicable to such other Sections of the Disclosure Schedule.
Disclosure of any fact or item in any Section of the Disclosure
Schedule shall not be considered an admission by Seller that such
item or fact (or any non-disclosed item or information of
comparable or greater significance) represents a material exception
or fact, event or circumstance and shall not be construed as an
admission by Seller of any non-compliance with, or violation of,
any third party rights (including to any intellectual property
rights) or any applicable Law of any Governmental Entity, such
disclosures having been made solely for the purposes of creating
exceptions to the representations made herein or of disclosing any
information required to be disclosed under the
Agreement.
8.8 Construction;
Interpretation. When a reference is made in this Agreement
to an article, section, paragraph, clause, schedule or exhibit,
such reference shall be deemed to be to this Agreement unless
otherwise indicated. The text of all Schedules and Exhibits is
incorporated herein by reference. Whenever the words
“include,” “includes” or
“including” are used in this Agreement, they shall be
deemed to be followed by the words “without
limitation.” Words used in this Agreement in the singular
shall have a comparable meaning when used in the plural, and vice
versa. Whenever the context may require, any pronouns used herein
shall include the corresponding masculine, feminine or neuter
forms, and the singular form of names and pronouns shall include
the plural and vice versa. As used in this Agreement: (a) the terms
“hereof,” “herein,” and
“herewith” and words of similar import will, unless
otherwise stated, be construed to refer to this Agreement as a
whole and not to any particular provision of this Agreement, (b)
the word “if” and other words of similar import shall
be deemed, in each case, to be followed by the phrase “and
only if”, (c) any reference herein to “Dollars”
or “$” shall mean United States dollars, (d) the use of
“or” herein is not intended to be exclusive, (e)
references herein to a Person are also to its successors and
permitted assigns, and any reference herein to a Governmental
Entity shall be deemed to include reference to any successor
thereto, (f) the words “asset” and
“property” shall be construed as having the same
meaning and effect and to refer to any and all assets and
properties, real and personal, tangible and intangible, and (g) an
accounting term not otherwise defined has the meaning assigned to
it in accordance with GAAP. Unless otherwise expressly indicated,
any agreement, instrument or Law defined or referred to herein or
in any agreement or instrument that is referred to herein means
such agreement, instrument or Law as from time to time amended,
modified or supplemented, including (in the case of agreements or
instruments) by waiver or consent and (in the case of Laws) by
succession of comparable successor Laws and references to all
attachments thereto and instruments incorporated
therein.
21
8.9 Parties
in Interest. This Agreement shall be binding upon and inure
solely to the benefit of each Party and its successors and
permitted assigns and nothing in this Agreement, express or
implied, is intended to or shall confer upon any other Person any
rights, benefits or remedies of any nature whatsoever under or by
reason of this Agreement.
8.10 Severability.
If any term or other provision of this Agreement is invalid,
illegal or unenforceable, all other provisions of this Agreement
shall remain in full force and effect so long as the economic or
legal substance of the transactions contemplated hereby is not
affected in any manner materially adverse to any Party. Upon such
determination that any term or other provision is invalid, illegal
or incapable of being enforced, the Parties shall negotiate in good
faith to modify this Agreement so as to effect the original intent
of the Parties as closely as possible in a mutually acceptable
manner in order that the transactions contemplated by this
Agreement be consummated as originally contemplated to the fullest
extent possible.
8.11 AS
IS CONDITION; DISCLAIMER OF WARRANTIES; EXCLUSIVITY OF
REPRESENTATIONS AND WARRANTIES.
(a) EXCEPT
AS OTHERWISE EXPRESSLY SET FORTH IN THIS AGREEMENT, BUYER WILL BE
ACQUIRING THE ASSETS ON THE CLOSING DATE IN THEIR THEN EXISTING
CONDITION “AS IS”, “WHERE IS”, SUBJECT TO
ALL LEGAL REQUIREMENTS, ANY STATE OF FACTS WHICH AN ACCURATE SURVEY
OR PHYSICAL INSPECTION OF THE ASSETS MIGHT REVEAL, WITHOUT
WARRANTIES, EITHER EXPRESS OR IMPLIED, “WITH ALL
FAULTS” INCLUDING BOTH LATENT AND PATENT DEFECTS, AND THE
EXISTENCE OF HAZARDOUS MATERIALS, IF ANY.
(b) EXCEPT
AS OTHERWISE EXPRESSLY SET FORTH IN THIS AGREEMENT, NO WARRANTIES
OR REPRESENTATIONS HAVE BEEN MADE OR ARE MADE, AND NO
RESPONSIBILITY HAS BEEN OR IS HEREBY ASSUMED BY ANY PARTY, AND EACH
PARTY EXPRESSLY DISCLAIMS, AND HEREBY WAIVES, ALL SUCH OTHER
WARRANTIES AND REPRESENTATIONS WHATSOEVER, EXPRESS OR
IMPLIED.
(c) WITHOUT
LIMITING THE FOREGOING, EXCEPT TO THE EXTENT THAT THE SAME MAY BE
OTHERWISE EXPRESSLY SET FORTH IN THIS AGREEMENT, NO WARRANTIES OR
REPRESENTATIONS HAVE BEEN MADE OR ARE MADE, AND NO RESPONSIBILITY
HAS BEEN OR IS HEREBY ASSUMED, BY SELLER (AND SELLER EXPRESSLY
DISCLAIMS, AND BUYER HEREBY WAIVES ALL SUCH OTHER WARRANTIES AND
REPRESENTATIONS WHATSOEVER, EXPRESS OR IMPLIED), AS TO THE
ENVIRONMENTAL CONDITION OF THE ASSETS INCLUDING THE PRESENCE OF
HAZARDOUS MATERIALS, IF ANY, WHETHER LOCATED ABOVE OR BELOW GROUND,
OR ON OR OFF THE LABORATORY PREMISES. TO THE EXTENT THAT SELLER
PROVIDES TO BUYER ANY INFORMATION REGARDING ANY OF THE FOREGOING OR
THE RESULTS OF ANY INSPECTION OR ANY ENGINEERING OR ENVIRONMENTAL
REPORTS, EXCEPT AS SET FORTH IN ANY TRANSACTION DOCUMENT, SELLER
MAKES NO WARRANTIES OR REPRESENTATIONS WITH RESPECT TO THE CONTENT,
ACCURACY, COMPLETENESS, METHODOLOGY OR ANY OTHER MATTER CONCERNING
SUCH REPORTS.
(d) BUYER
ACKNOWLEDGES AND AGREES THAT THE PROVISIONS OF THIS SECTION 8.11 WERE NEGOTIATED
AND AGREED TO BY BUYER AND SELLER AND WERE A MATERIAL FACTOR IN THE
DETERMINATION OF THE AMOUNT OF THE PURCHASE PRICE OF THE
ASSETS.
22
(e) In
particular, and without limiting the generality of the foregoing,
each Party acknowledges and agrees that, in making its decision to
enter into this Agreement and consummate the transactions
contemplated hereby, it is not relying on any information or
materials, oral, written or in electronic format, distributed or
made available prior to the date hereof, in each case, other than
matters set forth in this Agreement, including the Disclosure
Schedule. With respect to any projection, forecast or business plan
delivered by or on behalf of Seller or any of its Affiliates to
Buyer, Buyer acknowledges that (i) there are uncertainties inherent
in attempting to make such projections, forecasts and plans, (ii)
it is responsible for making its own evaluation of the adequacy and
accuracy of all such projections, forecasts and plans so furnished
to it, and (iii) except in the case of fraud, it shall have no
claim of any kind whatsoever against any Person with respect
thereto.
(f) TO
THE EXTENT REQUIRED TO BE OPERATIVE, THE DISCLAIMERS OF WARRANTIES
CONTAINED HEREIN ARE “CONSPICUOUS” DISCLAIMERS FOR
PURPOSES OF ANY APPLICABLE LAW.
8.12 Counterparts.
This Agreement may be executed in one or more counterparts, each of
which shall be deemed an original but all of which together shall
constitute one and the same agreement. Delivery of an executed
counterpart of a signature page to this Agreement by facsimile,
portable document format or other electronic means shall be
effective as delivery of a manually executed counterpart to this
Agreement.
8.13 Waiver
of Jury Trial. EACH OF THE PARTIES HEREBY IRREVOCABLY AND
UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY
RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, LEGAL
PROCEEDING OR CAUSE OF ACTION (I) DIRECTLY OR INDIRECTLY ARISING
UNDER THIS AGREEMENT OR (II) IN ANY WAY CONNECTED WITH OR RELATED
OR INCIDENTAL TO THE DEALINGS OF THE PARTIES IN RESPECT OF THIS
AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH CASE
WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT,
TORT, EQUITY, OR OTHERWISE. THE PARTIES EACH HEREBY AGREES AND
CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION
SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES
MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH
ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES TO THE
WAIVER OF THEIR RIGHT TO TRIAL BY JURY.
8.14 Non-Recourse.
All claims or causes of action (whether in contract or in tort, in
law or in equity, by statute or otherwise) that may be based upon,
arise out of or relate in any manner to this Agreement or the other
Transaction Documents, or the negotiation, execution or performance
of this Agreement or the other Transaction Documents (including any
representation or warranty made in or in connection with this
Agreement or the other Transaction Documents or as an inducement to
enter into this Agreement or the other Transaction Documents), may
be made only against (and are expressly limited to) the Persons
that are expressly identified as parties hereto and thereto. No
Person who is not a named party to this Agreement or the other
Transaction Documents, including any past, present or future
director, officer, employee, incorporator, member, partner,
stockholder, equity holder, controlling person, Affiliate, agent,
attorney or representative of any named party to this Agreement or
the other Transaction Documents (the “Non-Party Affiliates”),
shall have any liability (whether in contract or in tort, in law or
in equity, by statute or otherwise, or based upon any theory that
seeks to impose liability of an entity party against its owners or
Affiliates, including by or through theories of equity, agency,
control, instrumentality, single business enterprise, piercing the
veil or undercapitalization) for any obligations or liabilities
arising under, in connection with or related to this Agreement or
the other Transaction Documents (as the case may be) or for any
claim based on, in respect of, or by reason of this Agreement or
the other Transaction Documents (as the case may be) or the
negotiation or execution hereof or thereof; and each Party waives
and releases all such liabilities, claims and obligations against
any such Non-Party Affiliates. The Parties acknowledge and agree
that the Non-Party Affiliates are intended third-party
beneficiaries of this Section 8.14.
8.15 Time
of Essence. With regard to all dates and time periods set
forth or referred to in this Agreement, time is of the
essence.
* * * *
*
23
IN WITNESS WHEREOF, each of the Parties
has caused this Asset Purchase Agreement to be duly executed on its
behalf as of the day and year first above written.
|
ROMARK GLOBAL
PHARMA, LLC
a
Puerto Rico limited liability company
|
|
|
|
|
|
|
|
By:
|
/s/ Xxxxxxx Xxxxxx
Xxxxxx
|
|
|
|
Name: Xxxxxxx
Xxxxxx Xxxxxx, attorney-at-law
|
|
|
|
Title: Authorized
Representative
|
|
|
|
|
|
|
SCIENZA LABS, INC.,
a corporation organized under the laws of the Commonwealth of
Puerto Rico
|
|
|
|
|
|
|
|
By:
|
/s/
Xxxxx
Xxxxxxx
|
|
|
|
Name: Xxxxx
Xxxxxxx
|
|
|
|
Title: Chief
Financial Officer
|
|
|
|
|
|
24
EXHIBIT A
FORM OF
ESCROW AGREEMENT
ESCROW AGREEMENT
This
ESCROW AGREEMENT (the
“Agreement”) is
executed this 13th day of August, 2018, by and between, SCIENZA
LABS, INC., a corporation organized under the laws of Puerto Rico
(the “Seller”);
ROMARK GLOBAL PHARMA, LLC a limited liability company organized
under the laws of Puerto Rico (the “Buyer”), and COMPLIANCE RESOURCES
GROUP, INC., a corporation organized under the laws of Puerto Rico
(the “Escrow
Agent”). Seller, Buyer and Escrow Agent are from time
to time collectively referred herein to as the “Parties” and individually as a
“Party.” All
capitalized terms used but not defined herein shall have the
meaning ascribed to such terms in the Asset Purchase Agreement (as
hereinafter defined).
W I T N E SS E T H:
WHEREAS, on the date hereof, Seller and
Buyer have executed and entered into that certain Asset Purchase
Agreement (the “Asset
Purchase Agreement”) pursuant to which Seller has
agreed to sell, assign and transfer to Buyer, and Buyer has agreed
to purchase, acquire and accept from Seller, all of Seller’s
rights, title and interest in, to and under the Assets, for the
aggregate purchase price of Five
Million Dollars ($5,000,000.00);
WHEREAS, pursuant to Section 1.2 of the Asset
Purchase Agreement, (1) Buyer has agreed to deposit One Million Seven Hundred Fifty Thousand
Dollars ($1,750,000.00) (the “Escrow Amount”) and (2) each of
Buyer, Seller, and Guarantor have agreed to deliver undated
original executed copies of the Escrow Closing Documents with the
Escrow Agent, to be released in accordance with Section 6 hereof;
WHEREAS, the Buyer and Seller desire to
enter into this Agreement pursuant to which Buyer will deposit the
Escrow Amount with the Escrow Agent and each of Buyer, Seller, and
Guarantor will deliver undated executed copies of the Escrow
Closing Documents to the Escrow Agent;
WHEREAS, the Escrow Amount shall be held
by the Escrow Agent to be disbursed to Seller, or returned to
Buyer, as may be applicable, in accordance with the terms of this
Agreement and the Asset Purchase Agreement;
WHEREAS, the Escrow Closing Documents
shall be held by the Escrow Agent to be released to Buyer or
Seller, as may be applicable, in accordance with the terms of this
Agreement and the Asset Purchase Agreement;
NOW THEREFORE, in consideration of the
mutual covenants and agreements hereinafter set forth, the Parties
hereto enter into this Agreement, under the following terms and
conditions:
1. Appointment
of Escrow Agent.
(a) Escrow
Agent. Seller and Buyer hereby jointly appoint Escrow Agent
to serve as escrow agent hereunder. Escrow Agent hereby accepts
such appointment, upon receipt shall acknowledge receipt of the
Escrow Amount and the Escrow Closing Documents (collectively, the
“Escrow
Property”) and agrees to hold the Escrow Property,
subject to the terms and conditions of this Agreement. The Escrow
Agent shall not distribute or release the Escrow Property except in
accordance with the terms and conditions of this
Agreement.
(b) Escrow
Agent Representative. The Parties hereto agree that Mrs.
Liza Ru’z, Vice-President of Escrow Agent, shall be the
authorized representative to act on behalf and in representation of
the Escrow Agent for all matters arising under this Agreement, and
she shall remain the authorized representative of the Escrow Agent
until a successor authorized representative shall be chosen by the
Escrow Agent, whose name shall be notified in writing to Seller and
Buyer.
A-1
2. The
Escrow and Scope of Services Provided.
(a) The
Escrow Amount. On the date hereof, Buyer will pay, or cause
to be paid, an amount in cash equal to the Escrow Amount to the
Escrow Agent by wire transfer of immediately available funds to
Escrow Agent’s bank account listed below, to be held by the
Escrow Agent in accordance with the terms and provisions of this
Agreement.
Escrow
Agent’s Bank Information:
Bank:
Scotiabank of Puerto Rico
ABA:
Acct.
No.:
(b) The
Escrow Closing Documents. On the date hereof, Buyer, Seller,
and Guarantor will deliver, or cause to be delivered, the Escrow
Closing Documents to the Escrow Agent by personal delivery or
nationally recognized overnight courier, to Escrow Agent’s
address listed in Section
9(b) below, to be held by Escrow Agent in accordance with
the terms and provisions of this Agreement.
(c) Scope
of Responsibility. Notwithstanding any provision of this
Escrow Agreement to the contrary, the Escrow Agent is obligated
only to perform the duties specifically set forth in this Escrow
Agreement (or required by applicable law), which the Parties agree
are purely ministerial in nature.
3. Compensation
for Services. In consideration for the
services to be performed by Escrow Agent hereunder, Buyer and
Seller shall pay to Escrow Agent the sum of (a) One Hundred Dollars
($100) for administration fees plus (b) One Thousand Eight Hundred
Ninety Dollars ($1,890.00) as reimbursement for the cost incurred
by Escrow Agent to acquire the insurance policy with the coverage
requested by Buyer and Seller, for the total aggregate sum of One
Thousand Nine Hundred Ninety Dollars ($1,990.00) (the “Escrow
Fees”). Each of Buyer, on the one hand, and Seller, on the
other hand, shall pay one-half of the Escrow Fees for the services
to be rendered by the Escrow Agent pursuant to this
Agreement.
4. No
Investment. The Parties to this Agreement agree that
the Escrow Amount shall not be invested or used for any purpose,
other than to be held by the Escrow Agent in a separate designated
account to be opened by the Escrow Agent in a financial institution
in Puerto Rico until and when the Escrow Amount is to be disbursed
to Seller or returned to Buyer in accordance with and the pursuant
to the terms of this Agreement.
5. Release
of Escrow Amount and Escrow Closing Documents. Upon
Seller’s delivery of the written certification to Escrow
Agent in the form attached hereto as Exhibit A (the
“Certification”), the
Escrow Agent shall:
(a) wire
to Seller the Escrow Amount in accordance with Seller’s wire
instructions set forth in Exhibit B attached
hereto;
(b) date
each Escrow Closing Document as of the date of the
Certification;
(c) deliver
to Buyer the original (A) Xxxx of Sale, (B) Assignment and
Assumption Agreement, and (C) Landlord Consent and
Estoppel;
A-2
(d) deliver
to Seller the original (A) Promissory Note, (B) Security Agreement,
and (C) Guaranty Agreement; and
(e) deliver
to each of Buyer and Seller an original Sublease
Agreement.
6. Return
of Escrow Amount. In the event Buyer and
Seller deliver a joint written notice to Escrow Agent that the
Asset Purchase Agreement has been terminated, the Escrow Agent
shall (a) deliver to Buyer the Escrow Amount in accordance with
Buyer’s wire instructions set forth in Exhibit B attached hereto, and
(b) destroy the Escrow Closing Documents.
7. Termination.
This Agreement shall terminate upon the earlier of (a) the
disbursement of all of the Escrow Property pursuant to Section 5 or (b) the return of
the Escrow Amount and destruction of the Escrow Closing Documents
pursuant to Section
6. Upon termination of this Agreement, Escrow Agent shall
thereafter be relieved and released from any liability or
obligation under this Agreement.
8. Liability
of Escrow Agent and Indemnification.
(a) Duties.
Escrow Agent’s sole duties and responsibilities shall be to
hold and disburse the Escrow Property in accordance with this
Agreement. Escrow Agent undertakes to perform only such duties as
are expressly set forth in this Agreement. Escrow Agent shall not
be deemed to have any implied duties or obligations under or
related to this Agreement.
(b) Reliance.
Escrow Agent may (i) act in reliance upon any writing or instrument
or signature from Xxxxxxxxx Plaza or Xxxxx Xxxxxxx (each, a
“Seller Authorized
Representative”) which it, in good faith believes to
be genuine; (ii) assume validity and accuracy of any statement or
assertion contained in such a writing or instrument; and (iii)
assume that any Seller Authorized Representative purporting to give
any writing, notice, advice or instructions in connection with the
provisions of this Agreement has been duly authorized to do so.
Escrow Agent shall not be liable in any manner for the sufficiency
or correctness as to form, manner of execution, or validity of any
instrument deposited in escrow, nor as to the identity, authority,
or right of any Person executing any instrument.
(c) Indemnification.
Buyer and Seller shall jointly and severally indemnify and hold the
Escrow Agent harmless from and against any liability, loss, damage
or expense (including, without limitation, reasonable and
documented attorneys’ fees) that the Escrow Agent may incur
in connection with this Agreement and its performance hereunder or
in connection herewith, except to the extent such liability, loss,
damage or expense arises from its willful misconduct or gross
negligence. The indemnification provided under this Section 9(c) shall be allocated
and paid in the same manner as the Escrow Fees under Section 3 above. For the
avoidance of doubt, the Escrow Fees set forth in Section 3 are the only
compensation Escrow Agent shall receive in connection with the work
performed under this Agreement and the indemnification provided
under this Section
8(c) applies in the case of a future controversy between the
Parties.
9. Miscellaneous.
(a) Entire
Agreement; Amendment; Waiver; Assignment. This Agreement
constitutes the entire agreement among the Parties with respect to
the subject matter hereof and supersedes all other prior agreements
and understandings, both written and oral, among the Parties with
respect to the subject matter hereof. Any provision hereof can be
amended, supplemented, changed, or waived, only by written
instrument making specific reference to this Agreement and signed,
in the case of an amendment, supplement or modification, by Buyer,
Seller and Escrow Agent, or in the case of a waiver, by the Party
against whom the waiver is to be effective. No failure or delay by
any Party in exercising any right, power or privilege hereunder
shall operate as a waiver thereof nor shall any single or partial
exercise thereof preclude any other or further exercise thereof or
the exercise of any other right, power or privilege. Any rights or
obligations hereunder shall not be assigned by any Party (whether
by operation of Law or otherwise) without the prior written consent
of the other Parties hereto. Any attempt to assign this Agreement
in violation of the foregoing shall be void and of no
effect.
A-3
(b) Notice.
All notices, requests, claims, demands and other communications
hereunder shall be deemed to have been duly given and made if in
writing and if given by personal delivery upon the Person for whom
it is intended, nationally recognized overnight courier or
certified mail at the following addresses, return receipt
requested, or if sent by email, provided that the email is promptly
followed by a confirmation copy delivered by certified mail or by a
nationally recognized overnight courier to the Person at the
address set forth below (or to such other address as a Party may
have specified by notice given to the other Party pursuant to this
provision):
If to
Seller:
Scienza
Labs, Inc.
0 Xxxx
000
Xxxxxx,
XX
Attn:
Chairman
Email:
xxxxxx@xxxxxxxxxxxxx.xxx
xxxxxxxx@xxxxxxxxxxxxx.xxx
|
With a
copy (which shall not constitute notice to Seller) to:
Akerman
LLP
Three
Brickell City Centre
00
Xxxxxxxxx Xxxxxxx Xxxxxx, Xxxxx 0000
Xxxxx,
Xxxxxxx 00000
Attn:
Xxxxx X. Xxxxxxxxx
Email:
xxxxx.xxxxxxxxx@xxxxxxx.xxx
and
Xxxxx
Brau Xxxxxxxx Xxxxx Xxxxx
Xxxxx
000 Xxxx., Xxxxx 000
Xxx
Xxxx, XX 00000
Attn:
Xxxxxxx Xxxxx
|
|
If to Buyer:
Romark
Global Pharma, LLC
c/o
Romark Laboratories, L.C.
0000
Xxxxxxx Xxxxx Xxxxx 000
Xxxxx,
XX 00000
Attn:
Chief Executive Officer
Email:
xxxx.xxxxx@xxxxxx.xxx
|
With a
copy (which shall not constitute notice to Buyer) to:
X’Xxxxx
& Xxxxxx
000
Xxxxx Xxxxxx Xxxxxx, Xxxxx 000
Xxx
Xxxx, XX 00000
Attn:
Xxxx X. Xxxxx
Email:
xxxx.xxxxx@xxxxxxxxxxxx.xxx
and
Xxxxx
& Lardner LLP
000
Xxxxx Xxxxx Xx. Xxxxx 0000
Xxxxx
XX 00000
Attn:
Xxxxx Xxxxx
Email:
xxxxxx@xxxxx.xxx
|
A-4
If to the Escrow Agent:
Compliance
Resources Group, Inc.
273
Xxxxx de Xxxx Xxxxxx
Xxxxx
000, Xxxxx 000
Xxx
Xxxx, XX 00000
Attn:
Liza Ru’z
Email:
xxxx.xxxx@xxx-xx.xxx
|
(c) Governing
Law. This Agreement shall be governed by and construed in
accordance with the internal laws of the Commonwealth of Puerto
Rico.
(d) Severability.
If any term or provision of this Agreement is invalid, illegal or
unenforceable in any jurisdiction, such invalidity, illegality or
unenforceability shall not affect any other term or provision of
this Agreement or invalidate or render unenforceable such term or
provision in any other jurisdiction. Upon such determination that
any term or other provision is invalid, illegal or unenforceable,
the Parties hereto shall negotiate in good faith to modify this
Agreement so as to effect the original intent of the Parties as
closely as possible in a mutually acceptable manner in order that
the transactions contemplated hereby be consummated as originally
contemplated to the greatest extent possible.
(e) Headings.
The headings in this Agreement are for reference only and shall not
affect the interpretation of this Agreement.
(f) No
Third-Party Beneficiaries. This Agreement is for the sole
benefit of the Parties hereto and their respective successors and
permitted assigns and nothing herein, express or implied, is
intended to or shall confer upon any other Person any legal or
equitable right, benefit or remedy of any nature whatsoever under
or by reason of this Agreement.
(g) Counterparts.
This Agreement may be executed in counterparts, each of which shall
be deemed an original, but all of which together shall be deemed to
be one and the same agreement. A signed copy of this Agreement
delivered by facsimile, email or other means of electronic
transmission shall be deemed to have the same legal effect as
delivery of an original signed copy of this Agreement.
[Signature
Page Follows]
A-5
IN WITNESS WHEREOF, each of the Parties has caused this
Agreement to be executed in its name and delivered by a duly
authorized officer, on the date first written above.
Escrow
Agent:
Compliance Resources Group, Inc.
________________________________
Name:
Xxxx Xxxx
Title:
Vice-President
Seller:
Scienza Labs, Inc.
________________________________
Name:
Xxxxx Xxxxxxx
Title:
Chief Financial Officer
Buyer:
Romark Global Pharma, LLC
________________________________
Name:
Xxxxxxx Xxxxxx Xxxxxx, attorney-at-law
Title:
Authorized Representative
A-6
EXHIBIT A
CERTIFICATION
Date:_________________________
This
Certification is being delivered on behalf of Scienza Labs, Inc., a
corporation organized under the laws of the Commonwealth of Puerto
Rico (“Seller”) pursuant to
Section 1.2 of that
certain Asset Purchase Agreement (the “Asset Purchase
Agreement”), dated as of August 13, 2018, by and among
Seller and Romark Global Pharma, LLC, a limited liability company
organized under the laws of the Commonwealth of Puerto Rico
(“Buyer”), and pursuant to
Section 5 of that
certain Escrow Agreement, dated August 13, 2018, by and among
Seller and Buyer. Capitalized terms used and not defined herein
shall have the meaning ascribed to such term in the Asset Purchase
Agreement.
I,
____________________________, being the duly appointed, qualified
and acting ___________________ of Seller, solely in my capacity as
an officer of Seller, and not in my individual capacity and without
personal liability, do hereby certify that Seller has satisfied the
conditions to Buyer’s obligations to consummate the
transaction set forth in Section 5.1 of the Asset
Purchase Agreement (other than those conditions that by their
nature are to be satisfied at Closing).
|
|
By:
Name:
Title:
|
|
|
|
A-7
EXHIBIT B
WIRE
INSTRUCTIONS
Scienza Labs, Inc.
Bank:
BPPR
Account
Name: Scienza Labs, Inc.
ABA:
Acct.
No.:
Romark Global Pharma, LLC
Bank:
Banco Popular
Account
Name: Romark Global Pharma
ABA:
Acct:
No.:
A-8
EXECUTION VERSION
EXHIBIT B
FORM OF
XXXX OF SALE
XXXX OF SALE
THIS
XXXX OF SALE is dated as of
_______________________, 2018 (this “Xxxx of Sale”), by and
among Scienza Labs, Inc., a corporation organized under the laws of
the Commonwealth of Puerto Rico (“Seller”) and Romark
Global Pharma, LLC, a limited liability company organized under the
laws of the Commonwealth of Puerto Rico (“Buyer”). Capitalized
terms used but not defined herein shall have the meaning ascribed
to such terms in the Asset Purchase Agreement (as defined
hereafter).
Recitals
WHEREAS, pursuant to the terms of that
certain Asset Purchase Agreement, dated as August 13, 2018 (the
“Asset Purchase
Agreement”), by and among Seller and Buyer, the
Sellers are selling, assigning, transferring, conveying and
delivering to Buyer, and the Buyer is acquiring and accepting from
Seller, all of the right, title and interest of the Seller in and
to the Assets upon the terms and subject to the conditions of the
Asset Purchase Agreement;
WHEREAS, the Assets conveyed to Buyer
include all of the assets set forth in the Asset Purchase Agreement
(including the Schedules thereto), which Assets are listed in
Exhibit A attached
hereto; and
WHEREAS, Seller desire to deliver to
Buyer such instruments of sale, assignment, transfer, conveyance
and delivery as are required to vest in Buyer all of the
Seller’s right, title and interest in and to the
Assets.
NOW, THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, and pursuant to the Asset Purchase Agreement, the
parties hereto hereby agree as follows:
Agreement
1. Seller hereby
sells, assigns, transfers, conveys and delivers to Buyer, free and
clear of all Liens (other than Permitted Liens), all of the right,
title and interest of Seller in and to all of the
Assets.
2. Buyer acknowledges
that Seller makes no representation or warranty with respect to the
assets being conveyed hereby except as specifically set forth in
the Asset Purchase Agreement.
3. Nothing in this
Xxxx of Sale shall be deemed to supersede, enlarge or modify any of
the provisions of the Asset Purchase Agreement, all of which
survive the execution and delivery of this Xxxx of Sale as
provided, and subject to the limitations set forth in, the Asset
Purchase Agreement, this Xxxx of Sale being intended solely to
effect the transfer of the Assets. If any conflict exists between
the terms of this Xxxx of Sale and the terms of the Asset Purchase
Agreement, the terms of the Asset Purchase Agreement shall govern
and control.
4. This Xxxx of Sale
shall be effective as of the Closing.
5. No provision of
this Xxxx of Sale is intended to confer upon any person other than
the parties hereto any rights or remedies hereunder.
6. This Xxxx of Sale
may not be assigned by any party hereto without the prior written
consent of the other parties. All of the terms and provisions of
this Xxxx of Sale shall inure to the benefit of and be binding upon
the parties hereto and their respective successors and
assigns.
7. The terms and
conditions of this Xxxx of Sale shall be governed and construed in
accordance with the laws of the Commonwealth of Puerto Rico without
giving effect to the conflicts of laws principles thereof or of any
other state.
8. This Xxxx of Sale
may be executed in multiple original, facsimile or electronic
counterparts (including via PDF), each of which will be deemed an
original, but all of which when taken together shall constitute one
and the same agreement.
* * * *
*
B-1
IN WITNESS WHEREOF, each of the Parties
has caused this Xxxx of Sale to be duly executed on its behalf as
of the day and year first above written.
|
ROMARK GLOBAL
PHARMA, LLC
a
Puerto Rico limited liability company
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
Name: Xxxxxxx
Xxxxxx Xxxxxx, attorney-at-law
|
|
|
|
Title: Authorized
Representative
|
|
|
|
|
|
|
SCIENZA LABS, INC.,
a corporation organized under the laws of the Commonwealth of
Puerto Rico
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
Name: Xxxxx
Xxxxxxx
|
|
|
|
Title: Chief
Financial Officer
|
|
|
|
|
|
B-2
EXHIBIT C
FORM OF
ASSIGNMENT AND ASSUMPTION AGREEMENT
ASSIGNMENT AND ASSUMPTION AGREEMENT
THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (the
“Agreement”), dated as of
_______________________, 2018, is entered into by and among Romark
Global Pharma, LLC, a limited liability company organized under the
laws of the Commonwealth of Puerto Rico (“Buyer”) and Scienza Labs,
Inc., a corporation organized under the laws of the Commonwealth of
Puerto Rico (“Seller”). Capitalized
terms used but not defined herein shall have the meaning ascribed
to such terms in the Asset Purchase Agreement (as defined
hereafter).
Recitals
WHEREAS, this Agreement is executed and
delivered pursuant to the terms of the Asset Purchase Agreement,
dated August 13, 2018, by and among Buyer and Seller (the
“Asset Purchase
Agreement”), pursuant to which, among other things,
(a) Seller has assigned to Buyer all rights and entitlements of
Seller pursuant to the contracts listed on Exhibit A attached hereto (the
“Assigned
Contracts”), and (b) Buyer has assumed and agreed to
discharge the Assumed Liabilities, as defined in Exhibit B attached hereto
(together with the Assigned Contacts, the “Assigned Rights and
Liabilities”); and
WHEREAS, pursuant to this Agreement,
each of Buyer and Seller desires to consummate the assignment and
assumption of the Assigned Rights and Liabilities, in each case, to
the extent contemplated in the Asset Purchase
Agreement.
NOW, THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, and pursuant to the Asset Purchase Agreement, the
parties hereto hereby agree as follows:
1. Seller hereby
sells, transfers, assigns and conveys to Buyer the Assigned Rights
and Liabilities free and clear of all Liens (other than Permitted
Liens).
2. Buyer hereby
assumes and agrees to discharge and pay when due in accordance with
their terms the Assigned Rights and Liabilities.
3. Nothing in this
Agreement shall be deemed to supersede, enlarge or modify any of
the provisions of the Asset Purchase Agreement, all of which
survive the execution and delivery of this Agreement as provided,
and subject to the limitations set forth in the Asset Purchase
Agreement. If any conflict exists between the terms of this
Agreement and the terms of the Asset Purchase Agreement, the terms
of the Asset Purchase Agreement shall govern and
control.
4. This Assignment
shall be effective as of the Closing.
5. No provision of
this Agreement is intended to confer upon any person other than the
parties hereto any rights or remedies hereunder.
6. This Agreement may
not be assigned by any party hereto without the prior written
consent of the other parties. All of the terms and provisions of
this Agreement shall inure to the benefit of and be binding upon
the parties hereto and their respective successors and
assigns.
7. This Assignment
shall be governed by and construed and enforced in accordance with
the laws of the Commonwealth of Puerto Rico without regard to the
choice of law principles of any jurisdiction.
8. This Assignment may
be executed in multiple original, facsimile or electronic
counterparts (including via PDF), each of which will be deemed an
original, but all of which when taken together shall constitute one
and the same agreement.
* * * *
*
C-1
IN WITNESS WHEREOF, each of the parties
has caused this Assignment and Assumption Agreement to be executed
in its name and delivered by a duly authorized officer, on the date
first above written.
|
ROMARK GLOBAL
PHARMA, LLC
a
Puerto Rico limited liability company
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
Name: Xxxxxxx
Xxxxxx Xxxxxx, attorney-at-law
|
|
|
|
Title: Authorized
Representative
|
|
|
|
|
|
|
SCIENZA LABS, INC.,
a corporation organized under the laws of the Commonwealth of
Puerto Rico
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
Name: Xxxxx
Xxxxxxx
|
|
|
|
Title: Chief
Financial Officer
|
|
|
|
|
|
C-2
EXHIBIT D
FORM OF
PROMISSORY NOTE
PROMISSORY NOTE
Guaynabo,
Puerto Rico
U.S.
$3,000,000.00 Effective
Date: _______________, 2018
1. Parties.
1.1 Romark
Global Pharma, LLC, a limited liability company organized under the
laws of the Commonwealth of Puerto Rico (the "Maker").
1.2 Scienza
Labs, Inc., a corporation organized under the laws of the
Commonwealth of Puerto Rico (the "Holder").
2. Maker's
Promise to Pay. For value
received, Maker promises to pay to the order of Holder, its
successors and assigns, Three Million and No/100 Dollars
($3,000,000.00) (the "Principal"), plus interest (the "Interest")
accruing on the Principal from time as provided hereunder. Two
Million and No/100's Dollars ($2,000,000) of the Principal
("Tranche A") is secured by certain assets of the Maker pursuant to
that certain Security Agreement of even date herewith from Maker in
favor of Holder. One Million and No/100’s Dollars
($1,000,000) of the Principal ("Tranche B") is
unsecured.
3. Payments.
(a) Interest
shall accrue on the outstanding Principal balance of Tranche A
from the date of this Note at the rate of Three percent (3%) per
annum, provided no Event of Default shall have occurred and is
continuing under this Note.
(b) Interest
shall accrue on the outstanding Principal balance of Tranche B
from the date of this Note at the rate of Five percent (5%) per
annum, provided no Event of Default shall have occurred and is
continuing under this Note.
The
applicable rate of interest provided in each of Section 3.1(a) and
Section 3.1(b) above is referred to herein as the
“Applicable Interest
Rate”.
3.2 Upon
the occurrence and continuance of an Event of Default under this
Note, Interest shall be payable on the outstanding Principal amount
of each of Tranche A and Tranche B at the Applicable Interest Rate
for such Tranche, plus Four percent (4%) per annum (the
"Default
Rate").
3.3 Maker
shall pay all accrued and unpaid Interest hereunder semi-annually
in arrears commencing on that date which is the six-month
anniversary of the date of this Note, and on the like date of each
and every consecutive sixth month thereafter until all payments
required hereunder shall have been made in full.
3.4 Maker
shall make a payment of Principal hereunder in the amount of
$500,000, on that date which is the six-month anniversary of the
date of this Note, which shall be applied to Tranche
B.
D-1
3.5 Maker
shall make a payment of Principal hereunder in the amount of
$1,250,000, on that date which is the one-year anniversary of date
of this Note, of which $500,000 shall be applied to Tranche B and
$750,000 shall be applied to Tranche A.
3.6 Notwithstanding
anything herein to the contrary, the entire unpaid Principal
balance and all accrued and unpaid Interest thereon shall be due
and payable on that date which is the two-year anniversary of the
date of this Note (the "Maturity
Date").
3.7 Interest
shall be calculated on the basis of the actual number of days
elapsed divided by 365.
3.8 All
payments hereunder shall be made in lawful money of the United
States of America.
3.9 Notwithstanding
any provision to the contrary contained in this Note or any other
document, it is expressly provided that in no case or event (A)
shall the aggregate of (i) all Interest on the unpaid balance
hereof accrued or paid from the date hereof and (ii) the aggregate
of any other amounts accrued or paid pursuant hereto which under
applicable laws are or may be deemed to constitute interest upon
the indebtedness evidenced hereby, ever exceed the maximum rate of
interest which could lawfully be contracted for, charged or
received on the unpaid principal balance of this Note; or (B) shall
Maker be obligated to pay interest and other amounts described
above at a rate which could subject Holder to either civil or
criminal liability as a result of such rate being in excess of the
maximum rate which Holder is permitted to charge under applicable
law. In this connection, it is expressly stipulated and agreed that
it is the intent of Maker and Holder to contract in strict
compliance with the applicable usury laws (whichever permit the
higher rate of interest) from time to time in effect.
4. Application
of Payments. So long as no
Event of Default has occurred and is continuing under this Note,
all payments hereunder shall first be applied to Interest, then to
Principal (first to Principal outstanding under Tranche B and then
to Principal outstanding under Tranche A). Upon the occurrence and
continuance of an Event of Default under this Note, all payments
hereunder shall first be applied to costs pursuant to Section 9.2,
then to Interest and the remainder to Principal (provided that any
application of payments to Principal shall first be applied to
principal outstanding under Tranche B and then to Principal
outstanding under Tranche A).
5. Prepayment.
This
Note may be prepaid in whole or in part without penalty. Any
prepayment shall be accompanied by an amount equal to the Interest
accrued thereon to the date of receipt of such prepayment in
collected funds, provided, however, Maker may not make any
prepayment of Principal under Tranche A until the entire
outstanding Principal amount of Tranche B shall have been paid in
full.
6. Place
of Payment. All payments
hereunder shall be made to Holder at Holder's offices at 0 Xxxx
000, Xxxxxx, XX 00000, or such other place as Holder may from time
to time designate in writing.
D-2
7. Reporting
Covenant; Information.
7.1 Promptly
when available but no later than ten (10) days after delivery to
the lenders under Romark Laboratories, L.C.’s
(“Parent”) first
lien senior secured credit facility, furnish a copy of the annual
audit report of Parent and its subsidiaries for the immediately
preceding Fiscal Year of Parent, including therein a consolidated
(and consolidating) balance sheets and statements of earnings and
cash flows of Parent and its subsidiaries (including Maker) as at
the end of such fiscal year, certified by independent auditors of
nationally recognized standing selected by Parent and reasonably
acceptable to Holder.
7.2 Promptly
when available and in any event no later than ten (10) days after
delivery to the lenders under Parent’s first lien senior
secured credit facility, furnish to Holder consolidated balance
sheets of Parent and its subsidiaries (including Maker) as of the
end of each fiscal quarter of Parent (including the last fiscal
quarter of each fiscal year), together with consolidated statements
of earnings and consolidated statements of cash flows for such
fiscal quarter and for the period beginning with the first day of
such fiscal year and ending on the last day of such fiscal quarter,
together with a comparison with the corresponding period of the
previous fiscal year.
7.3 Maker
will permit any representatives designated by the Holder, upon
reasonable prior notice, to visit with and discuss Maker’s
affairs, finances and condition with its officers, all at such
reasonable times and as often as reasonably requested.
8. Events
of Default. An “Event of
Default” shall be deemed to have occurred under this Note
upon the occurrence of any of the following
events:
8.1 If
any payment of Principal, Interest, or any other sum due Holder
hereunder or under the Security Agreement or the Guaranty is not
paid within ten (10) days from the date when due; or
8.2 If
any representation or warranty in any document, certificate, or
affidavit delivered in connection with this Note, including but not
limited to the Security Agreement and the Guaranty, whether
executed by or on behalf of Maker, or any guarantor of this Note is
at any time false, misleading, or breached, except for any such
breach resulting from a state of facts that would not reasonably be
expected to have a Material Adverse Effect (defined below),
provided that this exception shall not apply to the representations
in Sections 3(a) through 3(g), inclusive, of the Security Agreement
or Sections 9(a) through 9(e), inclusive, of the Guaranty;
or
8.3 If
Maker or any guarantor of this Note (a) is voluntarily adjudicated
a bankrupt or insolvent, (b) seeks or consents to the appointment
of a receiver or trustee for itself or for all or any part of its
property, (c) files a petition seeking relief, including
reorganization, arrangement or similar relief, under the present
Bankruptcy Code or other similar present or future applicable laws
of the United States or any state or any other competent
jurisdiction, (d) makes a general assignment for the benefit of
creditors or (e) admits in writing its inability to pay its debts
as they mature; or
8.4 If
a receiver or trustee is appointed for Maker or any guarantor of
this Note, or for all or any part of their respective properties
without their respective consents and such appointment is not
vacated within sixty (60) days, or if a petition is filed against
Maker or any guarantor of this Note, seeking relief, including
reorganization, arrangement or similar relief, under the present
Bankruptcy Code or other similar present or future applicable laws
of the United States or any state or other competent jurisdiction,
and such petition is not dismissed within sixty (60) days after the
filing thereof; or
D-3
8.5 If
Maker or any guarantor of this Note voluntarily or involuntarily
dissolves or liquidates; or
8.6 If
Maker or any guarantor of this Note shall breach or be in default
under any of the terms of this Note (other than as specified in
Subsections 8.1, 8.2, 8.3, 8.4, or 8.5 of this Note) or any of the
Security Agreement or the Guaranty (subject to the cure periods
referenced therein), and such breach or default shall not have been
cured within Ten (10) Business Days; or
8.7 If
Maker or any guarantor of this Note shall fail to make any payment
of principal or interest (regardless of amount), (i) in respect of
any Indebtedness the outstanding principal amount of which equals
or exceeds $50,000, when and as the same shall become due and
payable (after giving effect to any grace, cure or notice periods
as originally in effect, without regard to any extension of any
such periods) and such failure results in the acceleration of any
Indebtedness under any of the Senior Credit Facilities (defined
below) or (ii) under any of the Senior Credit
Facilities.
8.8 If
Maker shall default under that certain Commercial / Industrial
Sublease Agreement dated as of August __, 2018 between Maker and
Pharma-Bio Serv PR Inc. (“Sublease”) and such default
is not cured within the applicable cure period (if any) under the
Sublease.
8.9 If
a Change of Control shall occur. For purposes of this Note
"Change of Control" shall
mean (a) Parent shall cease to, directly or indirectly,
(i) own and control at least more than fifty (50%) percent of
the outstanding voting equity interests of Maker, or
(ii) possess the right to elect (through contract, ownership
of voting securities or otherwise) at all times a
majority1 of the board of directors (or similar
governing body) of the Maker and to direct the management policies
and decisions of the Maker.
9. Default
Remedies.
9.1 Upon
the occurrence and continuance of an Event of Default under this
Note, the Holder, at its option, may declare the entire unpaid
Principal balance of this Note, together with accrued Interest, and
all other sums due to Holder under this Note, the Security
Agreement and the Guaranty, to be immediately due and payable
without notice or demand.
9.2 In
addition to payments of Interest and Principal, if there is a
default in this Note, the Holder shall be entitled to recover from
the Maker all of the Holder's costs of collection, including the
Holder's reasonable attorneys' fees (whether for services incurred
in collection, litigation, bankruptcy proceedings, appeals, or
otherwise), and all other reasonable costs incurred in connection
therewith, and all other amounts payable by Maker to Holder under
the Security Agreement.
1 Subject to review of
the organizational documents.
D-4
10. Certain
Definitions; Security Agreement; Guaranty.
The
term “Business Day” means any day that is not a
Saturday, Sunday or other day on which commercial banks in San
Xxxx, Puerto Rico are authorized or required by law to remain
closed. The term “Material Adverse Effect” means a
material adverse effect on (a) the business, assets,
operations or condition, financial or otherwise, of Maker or
Guarantor, (b) the ability of Maker or Guarantor to pay and
perform any of their obligations under this Note, the Security
Agreement or the Guaranty, (c) the legality, validity, binding
effect or enforceability of this Note, the Security Agreement or
the Guaranty, (d) the rights of or benefits available to the
Holder under this Note, the Security Agreement or the Guaranty, or
(e) a material portion of the Collateral. The term
“Indebtedness” means, (a) all liabilities,
obligations and indebtedness of the referenced party for borrowed
money including, but not limited to, obligations evidenced by
bonds, debentures, notes or other similar instruments of any such
party, (b) all obligations of the referenced party to pay the
deferred purchase price of property or services, except trade
payables arising in the ordinary course of business not more than
90 days past due or payable on such later date as is customary
in the trade, (c) all obligations of the referenced party as
lessee under Capital Leases, (d) all Indebtedness of any other
party secured by a lien on any asset of the referenced party,
(e) all guarantees by the referenced party of Indebtedness of
others, (f) all obligations, contingent or otherwise, of the
referenced party with respect to letters of credit (supporting
payment of Indebtedness), whether or not drawn, including, without
limitation, reimbursement obligations related thereto, and
banker’s acceptances issued for the account of the referenced
party, and (g) all outstanding payment obligations with
respect to performance surety bonds that have been drawn upon.
“Senior Credit Facilities” means any Indebtedness
evidenced by any of (i) that certain Amended and Restated Indenture
dated as of June 28, 2018 by and among, Romark Biosciences S.Á
X.X. LLC., Romark Global Pharma, LLC, Romark Laboratories, L.C. and
US Back National Association, (ii) that certain Credit and Security
Agreement dated as of June 28, 2018 by and among Romark Global
Pharma, LLC and Banco Popular de Puerto Rico, and (iii) that
certain Credit Agreement dated as of June 28, 2018 by and among
Romark Global Pharma, LLC and Popular Mezzanine Fund LLC. This Note
is secured by that certain Security Agreement of even date herewith
from Maker, as Debtor, in favor of Holder, as Secured Party
(“Security Agreement”) and by that certain Guaranty of
Payment from Parent in favor of Holder (“Guaranty”).
Reference is made to the provisions of the Security Agreement and
the Guaranty for a description of the further rights of the
Holder.
11. Waivers.
Except
only for any notices which are specifically required by another
provision of this Note, Maker waives notice (including, but not
limited to, notice of intent to accelerate and notice of
acceleration, notice of protest and notice of dishonor), demand,
presentment for payment, protest, diligence in collecting and the
filing of suit for the purpose of fixing liability. Maker
absolutely, unconditionally and irrevocably waives any and all
right to assert any defense, counterclaim, cross claim or setoff
("Claim") of any nature whatsoever with respect to this Note
(including but not limited to any Claims under, arising as a result
of, or in any way related to that certain Asset Purchase Agreement
(“Asset Purchase Agreement”) dated as of August ___,
2018 between Maker and Holder), except for any defense based upon a
material breach by Seller (as defined therein) of Section 2.2
(Authority and Enforceability) or Section 2.7 (Personal Property)
of the Asset Purchase Agreement.
D-5
12. Assignment.
Holder
may transfer this Note: (i) to any affiliate of Holder without the
consent of Maker, provided that any such affiliate assumes the
obligations of the Holder under the Asset Purchase Agreement, and
(ii) with the prior written consent of the Maker which shall not be
unreasonably withheld or delayed, to any other Person (each, a
“Permitted Transferee”). Holder may deliver to any
Permitted Transferee(s) all or any of the property then held by
Holder as security for the indebtedness evidenced by this Note and
the Permitted Transferees shall thereupon become vested with all
the powers and rights herein given to Holder with respect thereto;
and Holder shall thereafter be forever relieved and fully
discharged from any liability or responsibility in the matter, but
Holder shall retain all rights and powers hereby given with respect
to any property not so transferred. The Holder shall provide Maker
with a courtesy notice of such transfer by Holder under clause (i)
above, provided that failure to provide such notice shall in no way
affect or impair the transfer by Holder.
13. GOVERNING
LAW, VENUE AND JURISDICTION. THIS NOTE SHALL BE
GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE
COMMONWEALTH OF PUERTO RICO. BORROWER IRREVOCABLY AGREES THAT ANY
LEGAL PROCEEDINGS IN RESPECT OF THIS NOTE OR THE SECURITY AGREEMENT
MAY BE BROUGHT IN THE COURT OF FIRST INSTANCE OF THE COMMONWEALTH
OF PUERTO RICO, OR IN THE DISTRICT COURT FOR THE DISTRICT OF PUERTO
RICO AND BORROWER IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE
JURISDICTION OF SUCH COURTS IN ANY SUCH LEGAL
PROCEEDINGS.
14. Miscellaneous
Provisions.
14.1 The
term Holder, as used herein, shall mean any holder of this
Note.
14.2 Time
is of the essence in this Note.
14.3 The
captions of sections of this Note are for convenient reference
only, and shall not affect the construction or interpretation of
any of the terms and provisions set forth in this
Note.
14.4 If
any provision or portion of this Note is declared or found by a
court of competent jurisdiction to be unenforceable or null and
void, such provision or portion thereof shall be deemed stricken
and severed from this Note, and the remaining provisions and
portions thereof shall continue in full force and
effect.
14.5 This
Note may not be amended, extended, renewed or modified nor shall
any waiver of any provision hereof be effective, except by an
instrument in writing executed by an authorized officer of Holder.
Any waiver of any provision hereof shall be effective only in the
specific instance and for the specific purpose for which
given.
14.6 Notice.
Any notice to Maker under this Note shall be in writing and sent to
the address indicated for it under the signature line hereof, and
any notice to Holder shall be sent to the address set forth in
Section 6 above, in each case, by overnight delivery through a
nationally recognized courier service, properly addressed with
delivery charges prepaid and shall be deemed effective when
received or when delivery is refused by the addressee or cannot be
made because of a change in address of which the sending party has
not been notified. Notwithstanding any provision herein to the
contrary concerning modifications, a change in address may be
effected by a notice sent by either party to the other party by the
means set forth in this Section.
15. WAIVER
OF TRIAL BY JURY. MAKER AND HOLDER WAIVE TRIAL BY JURY IN
CONNECTION WITH ANY ACTION OR PROCEEDING OF ANY NATURE WHATSOEVER
(INCLUDING, WITHOUT LIMITATION, ANY COUNTERCLAIM, OFFSET OR
DEFENSE) ARISING UNDER, OUT OF OR IN CONNECTION WITH THIS
NOTE.
[Signature on Next Page]
D-6
IN
WITNESS WHEREOF, the undersigned has executed this Promissory Note
as of this 13th day of August, 2018 intending to be bound hereby
and to be effective as of the day and year first above
written.
ROMARK
GLOBAL PHARMA, LLC
By:
Name:
Title:
Address
for Notices:
X0
Xxxxxxxxx Xxxxxx, Xxxxx 000 Xxx 000
Xxxxxxxx, Xxxxxx
Xxxx
00000
Affidavit
No. _____
Acknowledged
and subscribed before me in _____________, Puerto Rico, this ___
day of _______, 2018 by _________________________, in
representation and on behalf of Romark Global Pharma, LLC, who is
of legal age, single, executive and resident of __________________,
Puerto Rico, personally know to be or identified by
___________________________.
________________________
NOTARY
PUBLIC
D-7
EXHIBIT E
FORM OF
SECURITY AGREEMENT
SECURITY AGREEMENT
THIS SECURITY AGREEMENT (this
"Security Agreement") is effective as of
_________________, 2018 by ROMARK
GLOBAL PHARMA, LLC, a limited liability company organized
under the laws of the Commonwealth of Puerto Rico (the
"Debtor"), having its chief
executive office located at X0 Xxxxxxxx Xxxxxx, Xxxxx 000, Xxx 000,
Xxxxxxxx, XX 00000, in favor of SCIENZA LABS, INC., a corporation
organized under the laws of the Commonwealth of Puerto Rico, having
its chief executive office located at 0 Xxxx 000, Xxxxxx, XX 00000,
as holder (and any of its successors and Permitted Transferee(s),
the “Holder”) of
the Note described below (and its successors and Permitted
Transferee(s), the "Secured
Party"). Capitalized terms used herein and not otherwise
defined herein shall have the meanings assigned to them in the Note
(as defined below).
RECITALS
A. Debtor
and Secured Party entered into that certain Asset Purchase
Agreement dated as of August 13, 2018, providing for the sale of
certain property and assets to Debtor ("Purchase Agreement"), and in
consideration thereof Debtor agreed to deliver and has executed and
delivered a $3,000,000 Promissory Note in favor of Holder, dated as
of the date hereof ("Note").
B. Romark
Laboratories, L.C., a Florida limited liability company
(“Guarantor”)
has delivered to Secured Party its Guaranty of Payment with respect
to the Note (“Guaranty”).
C. Debtor
has agreed to deliver this Security Agreement providing for the
granting of a security interest by Debtor to Secured Party in the
hereinafter defined Collateral to secure certain of Debtor's
obligations to Holder under the Note and certain of
Guarantor’s obligations to Holder under the Guarantee, all on
the terms and conditions set forth in this Security
Agreement.
AGREEMENT
In
consideration of the foregoing, Debtor hereby agrees as
follows:
1. GRANT
OF SECURITY INTEREST.
(a) Collateral.
For valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, Debtor hereby grants Secured Party a
continuing security interest in all of Debtor's estate, right,
title and interest in and to all personal property of Debtor
described on Schedule C to this Security Agreement sold by Holder
to Debtor pursuant to the Purchase Agreement, wherever located,
together with all substitutions and replacements to any of the
foregoing, and all products and proceeds from the sale of any of
the foregoing, and rents, revenues and profits therefrom (for the
avoidance of doubt, excluding such rents, revenues and profits to
the extent the same constitute inventory of the of the Debtor),
including the proceeds of any insurance policies (whether or not
Secured Party is the loss payee thereof) and under any indemnity,
warranty or guaranty, payable by reason of loss or damage to or
otherwise with respect to any of the foregoing ("Collateral"), including, without
limitation those assets sold to Debtor pursuant to the Purchase
Agreement consisting of (i) machinery, equipment, appliances,
tooling, parts, counter space, fixtures, spare parts, maintenance
equipment, cleaning equipment and supplies, printers, furnishings,
computer and other electronic equipment, furniture, and goods
described on Schedule C to this Security Agreement and (ii) all
present or future books, records, documents, computer tapes and
discs, relating to all of the foregoing, in which Debtor may now
have or hereafter acquire an interest. For avoidance of doubt, the
Collateral shall exclude all “Excluded Assets”, as such
term is defined in the Purchase Agreement.
E-1
Where
applicable, and to the extent not otherwise defined herein, all
terms used herein (whether or not capitalized herein) defined in
Chapter 9 of the Puerto Rico Commercial Transactions Act (the
"UCC", as it may be amended
and in effect from time-to-time) shall have the same definitions
herein as specified in the UCC.
Any of
the foregoing terms which are defined in the UCC shall have the
meaning provided in the UCC, as amended and in effect from
time-to-time, as supplemented, expanded or limited by the
foregoing. For avoidance of doubt, it is expressly understood and
agreed that, to the extent the UCC is revised subsequent to the
date hereof such that the definition of any of the foregoing terms
included in the description of the Collateral is changed, the
parties hereto desire that any property which is included in such
changed definitions which would not otherwise be included in the
foregoing grant on the date hereof be included in such grant
immediately upon the effective date of such revision.
Notwithstanding the immediately preceding sentence, the foregoing
grant is intended to apply immediately on the date hereof to all of
the Collateral to the fullest extent permitted by law regardless of
whether any particular item of the Collateral is currently subject
to the UCC.
The
security interests are granted as security only and shall not
subject Secured Party to, or transfer to Secured Party, or in any
way affect or modify, any obligation or liability of Debtor with
respect to any of the Collateral or any transaction in connection
therewith. Debtor will perform and comply in all material respects
with all of its obligations in respect of the Collateral, including
accounts, contracts, leases and other general intangibles, and the
exercise by Secured Party of any of its rights hereunder shall not
release Debtor from any of its duties or obligations. Secured Party
shall not have any obligation or liability under the contracts and
agreements included in the Collateral by reason of this Security
Agreement, nor shall Secured Party be obligated to perform any of
the obligations or duties of Debtor thereunder or to take any
action to collect or enforce any claim for payment assigned
hereunder.
(b) Perfection
of Security Interest.
(i) Filing.
Debtor will execute, deliver, file and record (in such manner and
form as Secured Party may require), and hereby authorizes Secured
Party to file and record, any financing statements, continuation
statements and amendments thereto, or this Agreement (which the
parties hereto agree shall be sufficient as a financing statement
hereunder), any specific assignments or other paper that may be
necessary or desirable, or that Secured Party may request, in order
to create, confirm, preserve, perfect or validate the Security
Interest or to enable Secured Party to exercise and enforce its
rights and remedies hereunder or under applicable law with respect
to any of the Collateral. Debtor hereby appoints Secured Party as
Debtor's attorney-in-fact to execute and file in the name and on
behalf of Debtor such additional financing statements, continuation
statements and amendments thereto as Secured Party may at any time
request or require with respect to the Collateral.
(ii) Other.
Debtor shall, at any time and from time-to-time, take such other
customary steps as Secured Party may reasonably require to permit
Secured Party to insure the perfection and priority of Security
Interest in any of the Collateral and of the preservation of its
rights therein.
E-2
2. OBLIGATIONS.
The grant of the
security interest hereunder shall secure the following obligations
(the "obligations"): (i) the payment of all obligations of debtor,
whether now existing or hereafter arising, with respect to the
payment of the principal constituting tranche a under the note (the
principal amount of which is currently $2,000,000.00), and the
payment of all accrued interest with respect to tranche a under the
note, (ii) the performance of all other obligations of debtor under
the note and this security agreement, exclusive of (x) obligations
consisting of the payment of principal constituting tranche b under
the note, and (y) obligations consisting of the payment of accrued
interest with respect to tranche b under the note, and (iii) the
payment of any and all reasonable costs and expenses incurred by
secured party to enforce its rights under the note and the guaranty
as such rights relate to the payment of the principal constituting
tranche a of the note, and the payment of any interest thereon, and
to enforce any and all of secured party’s rights under this
security agreement, and (iv) the payment and performance of any and
all reasonable costs and expenses incurred by secured party to
protect or preserve the collateral or the security title, lien and
security interest created hereby or for any other purpose provided
herein; provided the maximum amount secured by this agreement at
any time will not exceed $2,000,000 in the aggregate
3. REPRESENTATIONS
AND WARRANTIES. Debtor represents
and warrants to secured party that the following statements are
true, correct and complete:
(a) Title
to Collateral. Debtor has good and marketable title to the
Collateral, free of all adverse claims, interests, liens or
encumbrances, except the security interest in favor of U.S. Bank
National Association, as collateral agent (“US Bank Lien”). The security
interest created under this Security Agreement constitutes a valid
security interest in the Collateral and, upon filing of a financing
statement, a valid perfected security interest in the items and
types of Collateral in which a security interest may be perfected
by the filing of a financing statement.
(b) Validity
of Loan Documents; Authority. Each of this Security
Agreement and the Note is the legally valid and binding obligation
of Debtor, enforceable against Debtor in accordance with its terms,
subject only to limitations on enforceability imposed by (i)
applicable bankruptcy, insolvency, reorganization, moratorium or
similar Laws affecting creditors' rights generally and (ii) general
equitable principles. Debtor has the power and authority to
execute, deliver, perform its obligations under this Security
Agreement and the Note, and to grant the security interest provided
for in this Security Agreement, and has taken all necessary
corporate action to authorize the execution, delivery and
performance of this Security Agreement and the Note, and the grant
of a security interest pursuant to this Security
Agreement.
(c) Location
of Debtor; State of Incorporation. Debtor's chief executive
office is located at the address shown above, and the Debtor's
state of incorporation is the Commonwealth of Puerto
Rico.
(d) Location
of Collateral. All locations at which the Collateral is
located (other than vehicles and property attached thereto) are
specified on Schedule
A attached hereto and made a part hereof.
E-3
(e) Name,
Identity, and Structure. During the past five years,
Debtor's business has not been conducted under any name other than
Debtor's name as set forth above, nor has it changed its structure
or state of incorporation, through incorporation, merger,
consolidation, joint venture or otherwise other than as set forth
on Schedule B
attached hereto and made a part hereof.
(f) Insurance.
Debtor has delivered to Secured Party copies of all insurance
policies, and with certificates of insurance naming Secured Party
as loss payee/additional insured with respect to such insurance
policies, maintained by Debtor with respect to the Collateral, and
the operation thereof, and Debtor will use commercially reasonable
efforts to provide Secured Party with endorsements to such
insurance policies naming Secured Party as loss payee/additional
insured with respect to such insurance policies within sixty (60)
days from the date hereof, and in any event shall provide such
endorsements within one-hundred twenty (120) days from the date
hereof.
(g) Taxes,
Levies, Etc. Debtor has filed or caused to be filed prior to
delinquency all federal, state and local material tax returns that
are required to be filed, and has paid and shall continue to pay
when due all taxes as shown on such returns, unless such taxes are
being contested by it, in good faith and by appropriate proceedings
and then only if and to the extent reserves have been fully set
aside on its books therefor to the extent required by generally
accepted accounting principles.
4. COVENANTS.
Debtor
will comply with all covenants in this section 4, unless debtor has
received the written consent of secured party
(a) Title
to Collateral. Debtor shall not create or permit the
existence of claims, interests, liens, or other encumbrances
against any of the Collateral, other than the US Bank Lien. Debtor
shall provide prompt written notice to Secured Party of any future
claims, interests, liens or encumbrances against any of the
Collateral, and shall defend diligently Debtor's and Secured
Party's interests (including the priority of such interests) in all
Collateral.
(b) Change
in Name, Etc. Debtor shall not (i) change the location of
its place of business or chief executive office; or (ii) change its
name, identity, state of incorporation, state organization number,
or employer identification number, unless it shall have given
Secured Party fifteen (15) days' prior written notice of its
intention to take any action described in clauses (i) and (ii), and
authenticated or executed and delivered to Secured Party all
financing statements, financing statement amendments and other
instruments which Secured Party may reasonably request in
connection therewith.
(c) Change
in Accounts; Location of Collateral. Debtor agrees not to
move any Collateral to or allow any Collateral to be at a location
other than as provided on Schedule A. Debtor will, at its
own cost and expense, cause to be delivered to Secured Party
landlord or other third party agreements, lien search results, or
any other instruments or documents as Secured Party may reasonably
request from time-to-time.
E-4
(d) Change
in Structure. Debtor agrees not to change its corporate
organizational structure or state of incorporation in any manner
unless it shall have given Secured Party fifteen (15) days' prior
written notice of its intention to take any such
action.
(e) Further
Assurances. Upon the reasonable request of Secured Party,
Debtor shall do all acts and things as Secured Party may from
time-to-time deem necessary or advisable to enable it to perfect,
maintain and continue the perfection and priority of the security
interest of Secured Party in the Collateral, or to facilitate the
exercise by Secured Party of any rights or remedies granted to
Secured Party hereunder or provided by law. Without limiting the
foregoing, Debtor agrees to execute, in form and substance
satisfactory to Secured Party, such financing statements,
continuation statements, amendments thereto, supplemental
agreements, assignments, notices of assignments, and other
instruments and documents as Secured Party may from time-to-time
reasonably request. Debtor shall, at any time and from
time-to-time, take such steps as Secured Party may reasonably
request for Secured Party to obtain an acknowledgment, in form and
substance satisfactory to Secured Party, of any bailee having
possession of any of the Collateral that such bailee holds such
Collateral for Secured Party. Secured Party shall use reasonable
care in the custody and preservation of any Collateral in its
possession, but shall not be required to take any steps necessary
to preserve rights against other parties. All reasonable costs and
expenses incurred by Secured Party to establish, perfect, maintain,
determine the priority of, or release the security interest granted
hereunder (including the cost of all filings, recordings, and taxes
thereon and the fees and expenses of any designee of Secured Party)
shall become part of the Obligations secured hereby and be paid by
Debtor on demand.
Debtor
hereby authorizes Secured Party to file one or more financing or
continuation statements, and amendments thereto (or similar
documents required by any laws of any applicable jurisdiction) in
the jurisdiction where this Security Agreement will be given effect
and any other appropriate jurisdiction, relating to all or any part
of the Collateral without the signature of Debtor where permitted
by law.
(f) Insurance.
Debtor shall maintain such insurance with such insurance companies,
in such amounts, and covering such risks, as are at all times
reasonably required by Secured Party. Debtor acknowledges that at
no time shall it maintain insurance coverage with respect to the
Collateral in lesser amounts or coverage than in effect on the date
hereof.
(g) Disposition
and Use of Collateral by the Debtor. Without the prior
written consent of Secured Party, Debtor shall not at any time
sell, transfer, lease, abandon or otherwise dispose of any
Collateral.
(h) Condition
of Collateral. Debtor shall, at its own expense, make all
alterations, replacements and improvements to the Collateral as may
from time-to-time be necessary in order to ensure that the
Collateral remains in good repair, working order and condition,
ordinary wear and tear excepted, subject at all times to good
manufacturing practices and regulatory requirements.
E-5
(i) Condition
of Books and Records. Debtor shall maintain complete,
accurate and up-to-date books, records, accounts, and other
information relating to all Collateral in such form and in such
detail as may be reasonably satisfactory to Secured Party, and
shall allow Secured Party or its representatives to examine and
copy such books, records, accounts and other information upon
reasonable notice and during normal business hours, or at such
other times as the parties may agree. Debtor shall furnish to
Secured Party statements and schedules further identifying and
describing the Collateral and such other reports in connection with
the Collateral as Secured Party may request, all in reasonable
detail, to the extent Debtor possesses such information or can
acquire it without unreasonable effort or expense.
(j) Right
of Inspection. Upon reasonable notice and during normal
business hours, or at such other times as the parties may agree,
Debtor shall allow Secured Party or its representatives to examine
any of Debtor's properties or locations where the Collateral is
located, and the books and records pertaining to the Collateral,
and to have access to Debtor's officers and management personnel so
that Secured Party or its representatives may confirm, physically
inspect and appraise any of the Collateral; provided, however, that
upon the occurrence and continuing existence of an Event of
Default, Secured Party or its representatives may conduct such
visits and inspections and engage in such discussions at the
expense of Debtor, and as frequently as it may specify, provided
any such visits or inspections do not interfere with the normal
operations of the Debtor.
(k) Negative
Pledge. Debtor
shall not grant a negative pledge upon any of the Collateral in
favor of any party.
(l) No
Fixtures. It is the intention of the parties hereto that
none of the Collateral (except for the “Improvements”
(as defined in the Purchase Agreement)) shall become fixtures.
Debtor agrees to take all such reasonable action or actions as may
be reasonably necessary to prevent any of the Collateral from
becoming fixtures (unless the Collateral already exists as a
fixture on such real estate on the date hereof), which actions may
include, without limitation, the use of Debtor's commercially
reasonable efforts to obtain waivers of liens, in form satisfactory
to Secured Party, from each lessor of real property on which any of
the Collateral is or is to be located, to the extent reasonably
requested by Secured Party.
5. EVENT
OF DEFAULT. For purposes of this security agreement, an
"event of default" shall
exist hereunder upon the occurrence of any event of default under
the note, or (b) the breach of or failure by debtor to perform or
observe any covenant or agreement contained in this security
agreement or the purchase agreement, to the extent debtor does not
cure such default within 10 days from notice from secured
party.
6. RIGHTS
AND REMEDIES. Upon the occurrence
and during the continuation of any event of default hereunder,
secured party may declare all obligations to be immediately due and
payable and proceed against debtor directly for payment, and, to
the extent permitted by law, may exercise any and all rights and
remedies of a secured party in the enforcement of its security
interest under the ucc, this security agreement, or any other law.
Without limiting the foregoing:
E-6
(a) Disposition
of Collateral. Secured Party may sell, lease, or otherwise
dispose of all or any part of the Collateral, in its then condition
or following any commercially reasonable preparation or processing
thereof, whether by public, judicial or private sale or at any
brokers' board, in lots or in bulk, for cash, on credit or
otherwise, with or without representations or warranties, and upon
commercially reasonable terms, and Secured Party may purchase such
Collateral at any public or judicial sale, or, if such Collateral
is of a type that is customarily sold on a recognized market or is
of a type which is the subject of widely distributed standard price
quotations, at any private sale. To the extent permitted by law,
Debtor hereby specifically waives all rights of redemption, stay or
appraisal which it has or may have under any law now existing or
hereafter adopted. At any time when advance notice of sale is
required, Debtor agrees that ten (10) business days' prior written
notice shall be reasonable notification within the meaning of the
UCC. In connection with the foregoing, Secured Party
may:
(i) require
Debtor to assemble the Collateral and all records pertaining
thereto and make such Collateral and records available to Secured
Party at a place to be designated by Secured Party which is
reasonably convenient to both parties;
(ii) enter
the premises occupied by Debtor or premises under Debtor's control
and take possession of the Collateral;
(iii) without
charge by Debtor, use or occupy the premises of Debtor or premises
under Debtor's control, including warehouse and other storage
facilities;
(iv) without
charge by Debtor, use or sublicense the use of any intellectual
property necessary for the operation (for example, operating
software) of any of the Collateral (and such use or right of use
shall inure to the benefit of all successors, assigns and
transferees of Secured Party and their respective successors,
assigns and transferees, whether by voluntary conveyance, operation
of law, assignment, transfer, foreclosure, deed in lieu of
foreclosure or otherwise); provided however, for the avoidance of
doubt, the foregoing right of use shall not extend to any
intellectual property developed by the Debtor in its use of the
Collateral or resulting from Debtor’s research and
development activities;
(v) rely
upon the advice or instructions of any one or more brokers or other
experts selected by Secured Party to determine the method or manner
of disposition of any of the Collateral and, in such event, any
disposition of the Collateral by Secured Party in accordance with
such advice or instructions shall be presumptively deemed to be
commercially reasonable; and
(vi) compromise
and settle or sell, assign or transfer or ask, collect, receive or
issue any and all claims possessed by Debtor which constitute a
portion of the Collateral, all in the name of Debtor.
(b) Proceeds.
Secured Party may collect and apply all proceeds of the Collateral,
and may endorse the name of Debtor in favor of Secured Party on any
and all checks, drafts, money orders, notes, acceptances, or other
instruments of the same or a different nature, constituting,
evidencing, or relating to the Collateral which may come into the
possession of Secured Party. Secured Party may receive and open all
mail addressed to Debtor and remove therefrom any cash or non-cash
items of payment constituting proceeds of the
Collateral.
E-7
(c) Insurance
Adjustments. Secured Party may adjust, settle, and cancel
any and all insurance covering any Collateral, endorse the name of
Debtor in favor of Secured Party on any and all checks or drafts
drawn by any insurer, whether representing payment for a loss or a
return of unearned premium, and execute any and all proofs of claim
and other documents or instruments of every kind required by any
insurer in connection with any payment by such
insurer.
(d) Appointment
of Receiver. Without demand or notice to Debtor, except to
the extent required by law, Secured Party shall have the right to
the appointment of a receiver for the properties and assets of
Debtor, and Debtor hereby consents to such right and to such
appointment and hereby waives any objection Debtor may have thereto
and hereby waives the right to have a bond or other security posted
by Secured Party or any other person in connection
therewith.
The net
proceeds of any disposition of the Collateral shall be applied by
Secured Party, after deducting its reasonable expenses incurred in
such disposition, including, but not limited to, the reasonable
attorneys' fees and legal expenses incurred by Secured Party, to
the extent not prohibited by law, to the payment in whole or in
part of the Obligations in the manner as Secured Party elects in
its sole and absolute discretion.
(e) Remedies
Cumulative. The enumeration of the foregoing rights and
remedies is not intended to be exhaustive, and such rights and
remedies shall be separate and cumulative, and the exercise of any
right or remedy or both shall not preclude the exercise of any
other rights or remedies, all of which are cumulative and
non-exclusive.
7. DEBTOR'S
WAIVERS. Debtor hereby
waives (a) any defense based upon any lack of authority of the
officers, directors, partners or agents acting or purporting to act
on behalf of debtor or any principal thereof or any defect in the
formation of debtor; (b) all rights and defenses
arising out of an election of remedies by secured party; (c) any
rights and defenses based upon any borrowing or any grant of a
security interest under section 364 of the bankruptcy code;(d) any
rights and defenses based upon any waiver by secured party of its
rights, powers or remedies under this security agreement, the note,
the purchase agreement, the guaranty or any other agreement, or any
delay by secured party in exercising the same; (e) presentment,
demand, protest and notice of any kind, including, without
limitation, notice of default, and any defenses relating thereto
arising under applicable law; (f) any rights and defenses based on
the fair value limitations of applicable law;(g) any rights and
defenses based on any transfer of all or part of any security for
the obligations to secured party by deed in lieu of foreclosure;
(h) any rights and defenses based on release of any guarantor,
surety, collateral or other security for any of the obligations;
(i) any claim in defense arising under or related to the purchase
agreement; and (k) any principle or provision of law, statutory or
otherwise, which is or might be in conflict with the terms and
provisions of this agreement. Debtor hereby agrees that the payment
of any sums payable under the note or the guaranty or other act
which tolls any statute of limitations applicable to the note or
the guaranty shall similarly operate to toll the statute of
limitations applicable to debtor's liability
hereunder.
E-8
8. OTHER
PROVISIONS.
(a) Amendment
and Waiver. Without the prior written consent of Secured
Party, no amendment or waiver of, or consent to any departure by
Debtor from, any provision hereunder shall be effective. Any such
amendment, waiver or consent shall be effective only in the
specific instance and for the specific purpose for which given. No
delay or failure by Secured Party to exercise any remedy hereunder
shall be deemed a waiver thereof or of any other remedy hereunder.
A waiver on any one occasion shall not be construed as a bar to or
waiver of any remedy on any subsequent occasion.
(b) Costs
and Attorneys' Fees. Except as prohibited by law, if at any
time Secured Party employs counsel in connection with the creation,
perfection, preservation, or release of the security interest of
Secured Party in the Collateral or the enforcement of any of
Secured Party's rights or remedies hereunder or under the Note or
with respect to any other Obligations, all of Secured Party's
reasonable attorneys' fees arising from such services and all other
reasonable expenses, costs, or charges relating thereto shall
become part of the Obligations secured hereby and be paid by Debtor
on demand.
(c) No
Obligation to Make Loans. Nothing contained herein or in any
financing statement or other collateral document executed or filed
in connection herewith shall be construed to obligate Secured Party
to make any loan, advance or extension of credit to
Debtor.
(d) Termination;
Reinstatement. This Security Agreement, the security
interest of Secured Party in the Collateral, and all other
documents or instruments contemplated hereby shall continue in full
force and effect until all Obligations have been paid in full, and
(ii) the Note has been terminated in accordance with its terms and
any preference period applicable to payments made on or security
given for the Obligations has expired under law. To the extent
Debtor or any third party makes a payment or payments to Secured
Party or Secured Party receives any payment or proceeds of the
Collateral for the Obligations, enforces its security interest or
exercises any right of set off, and such payment or payments or the
proceeds thereof are subsequently invalidated, declared to be
fraudulent or preferential, set aside, or required to be repaid to
a trustee, receiver, or any other party under any bankruptcy,
insolvency or other law or in equity, or any combination of the
foregoing, then, to the extent of such recovery, the Obligations or
any part thereof originally intended to be satisfied shall be
revived and continued in full force and effect, and this Security
Agreement, if earlier terminated, shall be revived and continued in
full force and effect, as if such payment or payments had not been
made, or such enforcement or set off had not occurred. Upon
termination of this Security Agreement, Secured Party (at the
written request of Debtor and at the sole expense of Debtor) will
(a) execute and deliver to Debtor such documents as Debtor may
reasonably request to evidence such termination and (b) file such
termination statements, release all liens of record and take all
other action as reasonably requested by Debtor to effectuate the
same.
(e) Performance
by Secured Party. Upon the occurrence of an Event of Default
hereunder, Secured Party may, at its option and without prior
notice to or demand upon Debtor, without obligation and without
waiving or diminishing any of its other rights or remedies
hereunder, fully perform or discharge any of such duties,
provided that
Secured Party shall use good faith efforts to give written notice
to Debtor promptly after taking any such action; further provided that Secured
Party shall have no liability for failing to give such notice. Upon
the occurrence of an Event of Default hereunder, all costs and
expenses incurred by Secured Party in connection therewith,
together with interest thereon at the default rate applicable to
the Note balance or advance secured hereby shall become part of the
Obligations secured hereby and be due and paid by Debtor upon
demand.
E-9
(f) Indemnification,
Etc. Debtor hereby expressly indemnifies and holds Secured
Party harmless from any and all claims, causes of action, or other
proceedings, and from any and all liability, loss, damage, and
reasonable expense of every nature, arising by reason of Secured
Party's enforcement of its rights and remedies hereunder, or by
reason of Debtor's failure to comply with any law, other than any
such claim, cause of action or other proceeding, liability, loss,
damage or expense arising by reason of gross negligence or willful
misconduct on the part of Secured Party. The obligations of Debtor
under this Section
8(f) shall survive the termination of the other provisions
of this Security Agreement.
(g) Power
of Attorney. Debtor hereby constitutes and appoints Secured
Party during the term of any Obligations as its attorney-in-fact,
effective upon the occurrence and during the continuance of an
Event of Default, which appointment is an irrevocable, durable
agency, coupled with an interest, with full power of substitution.
This power of attorney and mandate is for the purpose of taking,
whether in the name of Debtor or in the name of Secured Party, any
action which Debtor is obligated to perform hereunder or which
Secured Party may reasonably deem necessary or advisable to
accomplish the purposes of this Security Agreement (including the
power to continue operations). The powers conferred upon Secured
Party in this Section
8(g) are solely to protect its interest in the Collateral
and shall not impose any duty upon Secured Party to exercise any
such powers.
(h) Binding
Effect. This Security Agreement shall be binding upon and
inure to the benefit of Secured Party and its successors and
assigns, and in the event of an assignment of all or any of the
Obligations, the rights hereunder, to the extent applicable to the
indebtedness so assigned, may be transferred with such
indebtedness. This Security Agreement shall be binding upon and
inure to the benefit of Debtor and its successor and assigns;
provided, that
Debtor may not assign any of its rights or obligations hereunder
without the prior written consent of Secured Party.
(i) Notices.
All notices hereunder shall be delivered in accordance with the
terms and conditions set forth in and to the address provided for
the parties in the Note.
(j) Governing
Law. Without giving effect to the principles of conflict of
laws and except to the extent governed by federal law, the laws of
the Commonwealth of Puerto Rico, without reference to choice of law
doctrine, shall govern this Security Agreement, and all disputes
and matters between the parties to this Security
Agreement.
(k) Waiver
of Jury Trial. DEBTOR AND SECURED PARTY HEREBY WAIVE THEIR
RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION
BASED UPON OR ARISING OUT OF THIS SECURITY AGREEMENT AND ANY OTHER
DOCUMENT EVIDENCING ANY OTHER OBLIGATION, OR ANY DEALINGS BETWEEN
THEM RELATING TO THE SUBJECT MATTER OF THIS SECURITY AGREEMENT AND
SECURED PARTY/DEBTOR RELATIONSHIP THAT IS BEING ESTABLISHED. THE
SCOPE OF THIS WAIVER IS INTENDED TO BE ALL ENCOMPASSING OF ANY AND
ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE
SUBJECT MATTER OF THIS SECURITY AGREEMENT, INCLUDING CONTRACT
CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON
LAW AND STATUTORY CLAIMS. DEBTOR AND SECURED PARTY ACKNOWLEDGE THAT
THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS
RELATIONSHIP, THAT EACH HAS ALREADY RELIED ON THE WAIVER IN
ENTERING INTO THIS SECURITY AGREEMENT AND THAT EACH WILL CONTINUE
TO RELY ON THE WAIVER IN THEIR RELATED FUTURE DEALINGS. DEBTOR AND
SECURED PARTY FURTHER WARRANT AND REPRESENT THAT EACH HAS REVIEWED
THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT EACH KNOWINGLY AND
VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION
WITH LEGAL COUNSEL. THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY
NOT BE MODIFIED EITHER ORALLY OR IN WRITING, AND THE WAIVER SHALL
APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR
MODIFICATIONS TO ANY DOCUMENTS OR AGREEMENTS RELATING TO THIS
SECURITY AGREEMENT, INCLUDING THE NOTE. IN THE EVENT OF LITIGATION,
THIS SECURITY AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A
TRIAL BY THE COURT. DEBTOR AND SECURED PARTY ALSO WAIVE ANY BOND OR
SURETY OR SECURITY UPON SUCH BOND WHICH MIGHT, BUT FOR THIS WAIVER,
BE REQUIRED OF SECURED PARTY.
(l) Severability.
The determination that any term or provision of this Security
Agreement is unenforceable or invalid shall not affect the
enforceability or validity of any other term or provision
hereof.
(m) Entire
Agreement. This Security Agreement, together with all
documents referred to herein, constitute the entire agreement
between Debtor and Secured Party with respect to the matters
addressed herein.
[Remainder of Page Intentionally Left Blank; Signature Page
Follows]
E-10
EXECUTED as of this 13th day of August,
2018, by duly authorized representative of Debtor intending to be
bound hereby and to be effective as of the date first shown
above.
ROMARK
GLOBAL PHARMA, LLC
By:
Name:
Title:
Affidavit
No. _____
Acknowledged
and subscribed before me in _____________, Puerto Rico, this ___
day of _______, 2018 by _________________________, in
representation and on behalf of Romark Global Pharma, LLC, who is
of legal age, single, executive and resident of __________________,
Puerto Rico, personally know to be or identified by
___________________________.
________________________
NOTARY
PUBLIC
E-11
EXHIBIT F
FORM OF
GUARANTY AGREEMENT
GUARANTY OF PAYMENT
THIS
GUARANTY OF PAYMENT (this "Guaranty")
is effective as of the ______ day of _________________, 2018 by
Romark Laboratories, L.C., a Florida limited liability company (the
“Guarantor”),
in favor of each of Scienza Labs,
Inc., a corporation organized under the laws of the
Commonwealth of Puerto Rico (“Scienza”),
in connection with that certain Promissory Note dated of even date
herewith issued by Romark Global Pharma, LLC (“RGP”)
to Scienza, in the original principal amount of $3,000,000 (the
"Note").
Capitalized terms used herein and not otherwise defined herein
shall have the meaning given to such terms in the
Note.
R E C I T A L S:
WHEREAS, Guarantor, as an affiliate of
the RGP, will receive substantial benefit as a result of the
extension of credit by Scienza evidenced by the Note and has agreed
to enter into this Guaranty to provide assurance for the payment of
the obligations of RGP arising out of or in connection with the
Note and the Security Agreement.
WHEREAS, Guarantor has agreed that the
payment obligations of RGP arising out of or in connection with the
Note and the Security Agreement are jointly and severally
(solidariamente) the
obligations of Guarantor, pursuant to the terms of this
Guaranty.
NOW THEREFORE, in consideration of the
premises and mutual covenants herein contained and for other good
and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto agree as
follows:
1. Guarantee.
Guarantor unconditionally guarantees, as a primary obligor and not
merely as a surety, the due and punctual payment of all
obligations and liabilities of the rgp arising out of, in
connection with, or related to the note and the security agreement,
whether contingent, liquidated, unmatured or matured, including
without limitation, (i) rgp's payment obligations under note and
(ii) all other monetary obligations, including fees, costs,
expenses and indemnities, however arising (including but not
limited to under the note and the security agreement), whether
primary, secondary, direct, contingent, fixed or otherwise
(including monetary obligations incurred during the pendency of any
bankruptcy, insolvency, receivership or other similar proceeding,
regardless of whether allowed or allowable in such proceeding),
owing by rgp to scienza, all the obligations referred to in the
preceding sentence collectively called the “guaranteed
obligations”).
Guarantor
further agrees that the guaranteed obligations may be extended,
renewed or increased, in whole or in part, without notice to or
further assent from guarantor, and that guarantor will remain bound
upon its guarantee notwithstanding any extension, renewal, or
increase of any guaranteed obligations. “payment
in full” or “paid
in full” means, with respect to the guaranteed
obligations, the indefeasible payment in cash in full of all
monetary obligations.
F-1
2. Obligations
not waived. To the fullest extent permitted by applicable
law, guarantor waives presentment or protest to, demand of or
payment from the rgp or any other obligor of any of the guaranteed
obligations, and also waives notice of acceptance of its guarantee
and notice of protest for nonpayment. To the fullest extent
permitted by applicable law, the obligations of guarantor hereunder
shall not be affected by (a) the failure of scienza to assert
any claim or demand or to enforce or exercise any right or remedy
against rgp under the provisions of the note or the security
agreement or otherwise, or (b) any rescission, waiver,
amendment or modification of, or any release from any of the terms
or provisions of, this guaranty, the note or the security
agreement.
3. Guaranty
of payment; obligations joint and several; separate actions; waiver
of statute of limitations; reinstatement of
liability. Guarantor
further agrees that its guaranty constitutes a guaranty of payment
when due and not of collection, and waives any right to require
that any resort be had by scienza to any security that may be held
for payment of the guaranteed obligations. The obligations
hereunder are independent of the obligations of rgp, and a separate
action or actions may be brought and prosecuted against guarantor
whether action is brought against rgp or any other person, or
whether rgp or any other person is joined in any such action or
actions. Guarantor acknowledges that this guaranty is absolute and
unconditional, there are no conditions precedent to the
effectiveness of this guaranty, and this guaranty is in full force
and effect and is binding on guarantor as of the date written
below, regardless of whether scienza obtains any guaranties from
others or takes any other action contemplated by guarantor.
Guarantor waives the benefit of any statute of limitations
affecting guarantor's liability hereunder orthe enforcement
thereof, and guarantor agrees that any payment of any of the
guaranteed obligations or other act which shall toll any statute of
limitations applicable thereto shall similarly operate to toll such
statute of limitations applicable to guarantor's liability
hereunder. The liability of guarantor hereunder shall be reinstated
and revived and the rights of scienza shall continue if and to the
extent for any reason any amount at any time paid on account of any
guaranteed obligation guaranteed hereby is rescinded or must
otherwise be restored by scienza, whether as a result of any
proceedings in bankruptcy or reorganization or otherwise, all as
though such amount had not been paid. The determination as to
whether any amount so paid must be rescinded or restored shall be
made by scienza in its sole discretion; provided however, that if
scienza chooses to contest any such matter at the request of
guarantor, guarantor agrees to indemnify and hold scienza harmless
from and against all reasonable costs and expenses, including
reasonable attorneys' fees, expended or incurred by scienza in
connection therewith, including without limitation, in any
litigation with respect thereto.
4. Security.
To the extent that any of the guaranteed obligations are secured,
guarantor authorizes scienza to (a) take and hold security for
payment of guarantor’s obligations under this guaranty and
the guaranteed obligations and exchange, enforce, waive and release
any such security, (b) apply such security and direct the order or
manner of sale thereof as scienza in their sole discretion may
determine and (c) release or substitute any one or more endorsees,
other guarantors or other obligors.
F-2
5. [reserved].
6. No
discharge or diminishment of guaranty; defenses waived; agreement
to pay. Except with
to the extent the specific defenses to payment expressly reserved
by rgp pursuant to section 11 of the note are
applicable:
(a) the
obligations of guarantor hereunder shall not be subject to any
reduction, limitation, impairment or termination for any reason
(other than for payment in full), including any claim of waiver,
release, surrender, alteration or compromise of any of the
guaranteed obligations, and shall not be subject to any defense or
setoff, counterclaim, recoupment or terminationwhatsoever by reason
of the invalidity, illegality or unenforceability of the guaranteed
obligations or otherwise. Without limiting the generality of the
foregoing, the obligations of guarantor hereunder shall not be
discharged or impaired or otherwise affected by the failure of
scienza to assert any claim or demand or to enforce any remedy
under the note, the security agreement, the asset purchase
agreement or any other document or agreement, by any waiver or
modification of any provision of any thereof, by any default,
failure or delay, willful or otherwise, in the performance of the
guaranteed obligations, or to the fullest extent that guarantor may
prospectively waive such defenses under applicable law, by any
other act or omission that may or might in any manner or to the
extent vary the risk of such guarantor or that would otherwise
operate as a discharge of guarantor as a matter of law or equity
(other than payment in full); and
(b) to
the fullest extent permitted by applicable law, guarantor waives
any defense based on or arising out of any defense of rgp or the
unenforceability of the guaranteed obligations or any part thereof
from any cause, or the cessation from any cause of the liability of
rgp, other than payment in full. Scienza may, attheir election,
compromise or adjust any part of the guaranteed obligations, make
any other accommodation with any other guarantor or obligor or any
other guarantor, without affecting or impairing in any way the
liability of guarantor hereunder except forpayment in full.
Pursuant to applicable law, guarantor waives any defense arising
out of any such election even though such election operates,
pursuant to applicable law, to impair or to extinguish any right of
reimbursement or subrogation or other right or remedy of guarantor
against rgp or any other guarantor, as the case may be, or any
security.
(c) in
furtherance of the foregoing and not in limitation of any other
right that scienza has at law or in equity against guarantor by
virtue hereof, upon the failure of rgp to pay any guaranteed
obligation when and as the same shall become due, whether at
maturity, by acceleration, after notice of prepayment or otherwise,
guarantor hereby promises to and will forthwith pay, or cause to be
paid, to scienza, in cash the amount of such unpaid guaranteed
obligation.
7. Subordination.
Upon payment by guarantor of any sums to scienza, all rights of
guarantor against rgp arising as a result thereof by way of right
of subrogation, contribution, reimbursement, indemnity or otherwise
shall in all respects be subordinate and junior in right of payment
to the prior payment in full. If any amount shall erroneously be
paid to guarantor on account of such subrogation, contribution,
reimbursement, indemnity or similar right, such amount shall be
held in trust for the benefit of scienza and shall forthwith be
paid to scienza to be credited against the payment of the
guaranteed obligations, whether matured or unmatured, in such order
as in the note.
F-3
8. Information.
Guarantor assumes all responsibility for being and keeping itself
informed of the rgp’s financial condition and assets, and of
all other circumstances bearing upon the risk of nonpayment of the
guaranteed obligations and the nature, scope and extent of the
risks that guarantor assumes and incurs hereunder, and agrees that
scienza will not have any duty to advise guarantor of information
known to it regarding such circumstances or risks.
9. Representations
and warranties.
Guarantor represents and warrants as follows:
(a) it
is duly organized, validly existing and in good standing under the
laws of the jurisdiction of its organization;
(b) guarantor
has full power and legal right to execute and deliver, and to
perform and observe the provisions of this guaranty;
(c) the
execution, delivery and performance by guarantor of this guaranty
have been duly authorized by all necessary action, and do not
contravene any law or contractual restriction binding on or
affecting guarantor or any of guarantor’s property, and
guarantor is not included on the u.s. office of foreign asset
control list;
(d) no
authorization or approval or other action by, and no notice to or
filing with, any governmental authority or regulatory body or other
person is required for the due execution, delivery and performance
by guarantor of this guaranty; and
(e) this
guaranty is the legal, valid and binding obligation of guarantor,
enforceable against guarantor in accordance with its terms, except
as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting
the enforcement of creditors' rights generally and by general
equitable principles (whether enforcement is sought by proceeding
in equity or at law).
10. Binding
effect; several agreement; assignments. Whenever in this guaranty any of the
parties hereto is referred to, such reference shall be deemed to
include the successors and assigns of such party; and all
covenants, promises and agreements by or on behalf of the guarantor
that are contained in this guaranty shall bind and inure to the
benefit of each party hereto and their respective successors and
assigns. This guaranty shall become effective as to guarantor when
a counterpart hereof executed on behalf of guarantor shall have
been delivered to scienza and thereafter shall be binding upon
guarantor and their respective successors and assigns, and shall
inure to the benefit of guarantor, scienza, and their respective
successors and assigns, except that guarantor shall not have the
right to assign its rights or obligations hereunder or any interest
herein (and any such attempted assignment shall be void
ab initio). Scienza may
assign its rights under this guaranty in connection with the
assignment of the underlying guaranteed obligations, in whole or in
part, to the extent permitted under the note.
F-4
11. Waivers;
amendment.
(a) no
failure or delay of scienza of any kind in exercising any power or
right hereunder shall operate as a waiver thereof, nor shall any
single or partial exercise of any such right or power, or any
abandonment or discontinuance of steps to enforce such a right or
power, preclude any other or further exercise thereof or the
exercise of any other right or power. The rights of scienza
hereunder and under the note and the security agreement are
cumulative and are not exclusive of any rights or remedies that it
would otherwise have. No waiver of any provision of this guaranty
or consent to any departure by guarantor therefrom shall in any
event be effective unless the same shall be permitted by this
subsection (b) below, and then such waiver and consent shall
be effective only in the specific instance and for the purpose for
which given. No notice or demand on guarantor in any case shall
entitle guarantor to any other or further notice in similar or
other circumstances.
(b) neither
this guaranty nor any provision hereof may be waived, amended or
modified except pursuant to a written agreement entered into
between (i) scienza and (ii) the guarantor with respect to which
such waiver, amendment or modification relates.
12. Governing Law. GOVERNING LAW,
VENUE AND JURISDICTION. THIS
GUARANTY SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE COMMONWEALTH OF PUERTO RICO. GUARANTOR IRREVOCABLY
AGREES THAT ANY LEGAL PROCEEDINGS IN RESPECT OF THIS GUARANTY OR
ANY OF THE OTHER LOAN DOCUMENTS MAY BE BROUGHT IN THE COURT OF
FIRST INSTANCE OF THE COMMONWEALTH OF PUERTO RICO, OR IN THE
DISTRICT COURT FOR THE DISTRICT OF PUERTO RICO AND GUARANTOR
IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF SUCH
COURTS IN ANY SUCH LEGAL PROCEEDINGS. GUARANTOR AGREES THAT SERVICE
OF PROCESS MAY BE MADE BY DELIVERY BY CERTIFIED OR REGISTERED MAIL,
RETURN RECEIPT REQUESTED, OR COURIER OR OVERNIGHT DELIVERY SERVICE,
TO GUARANTOR'S ADDRESS AS THEN SHOWN ON THE RECORDS OF
SCIENZA.
13. Waiver of Jury Trial.
GUARANTOR AND SCIENZA WAIVE TRIAL
BY JURY IN CONNECTION WITH ANY ACTION OR PROCEEDING OF ANY NATURE
WHATSOEVER (INCLUDING, WITHOUT LIMITATION, ANY COUNTERCLAIM, OFFSET
OR DEFENSE) ARISING UNDER, OUT OF OR IN CONNECTION WITH THIS
GUARANTY.
14. Notices.
Except as otherwise herein provided, any notice or other
communication required hereunder shall be delivered in accordance
with the terms and conditions set forth in and to the address
provided for the parties in the note.
F-5
15. Survival
of agreement; severability.
(a) all
covenants, agreements representations and warranties made by the
guarantor herein and in the certificates or other instruments
prepared or delivered in connection with or pursuant to this
guaranty or any other agreement shall continue in full force and
effect until the guaranteed obligations have been paid in
full.
(b) if
one or more of the provisions contained in this guaranty or in any
other agreement should be held invalid, illegal or unenforceable in
any respect, the validity, legality and enforceability of the
remaining provisions contained herein and therein shall not in any
way be affected or impaired thereby (it being understood that the
invalidity of a particular provision in a particular jurisdiction
shall not in and of itself affect the validity of such provision in
any other jurisdiction). The parties shall endeavor in good-faith
negotiations to replace the invalid, illegal or unenforceable
provisions with valid provisions the economic effect of which comes
as close as possible to that of the invalid, illegal or
unenforceable provision.
16. Counterparts.
This guaranty may be executed in counterparts, each of which shall
constitute an original, but all of which when taken together shall
constitute a single contract (subject to section 10), and shall become
effective as provided in section 10. Delivery of an
executed signature page to this guaranty by facsimile or electronic
transmission shall be as effective as delivery of a manually
executed counterpart of this guaranty.
17. Rules
of interpretation. The definitions of terms herein shall
apply equally to the singular and plural forms of the terms
defined. Whenever the context may require, any pronoun shall
include the corresponding masculine, feminine and neuter forms. The
words “include,”
“includes”
and “including”
shall be deemed to be followed by the phrase “without
limitation.” The word “will”
shall be construed to have the same meaning and effect as the word
“shall.”
Unless the context requires otherwise, (a) any definition of
or reference to any agreement, instrument or other document shall
be construed as referring to such agreement, instrument or other
document as from time to time amended, supplemented, restated or
otherwise modified, (b) any reference herein to any person or
entity shall be construed to include such person’s or
entity’s successors and assigns permitted hereunder, and
(c) the words “herein,”
“hereof”
and “hereunder,”
and words of similar import when used herein, shall be construed to
refer to this guaranty in its entirety and not to any particular
provision thereof. Each of the parties hereto has been represented
by counsel and this guaranty has been jointly drafted. No doctrine
construing ambiguities against a drafter shall be employed in the
interpretation hereof.
18. Savings
clause.
(a) it
is the intent of guarantor and scienza that the liability of
guarantor under this guaranty as of any date shall be limited to a
maximum aggregate amount equal to the greatest amount that would
not render guarantor’s obligations under this guaranty
subject to avoidance, discharge or reduction as of such date as a
fraudulent transfer or conveyance under applicable federal and
state laws pertaining to bankruptcy, reorganization, arrangement,
moratorium, readjustment of debts, dissolution, liquidation or
other debtor relief, specifically including, without limitation,
the united states bankruptcy code and any fraudulent transfer and
fraudulent conveyance laws (collectively, “insolvency
laws”), in each instance after giving effect to all
other liabilities of guarantor, contingent or otherwise, that are
relevant under applicable insolvency laws of any rights to
subrogation, contribution, reimbursement, indemnity or similar
rights of guarantor pursuant to (y) applicable law or (z) any
agreement (including this guaranty) providing for an equitable
allocation among guarantor and other affiliates of the guarantor of
obligations arising under guaranties by such parties.
F-6
(b) the
substantive laws under which the possible avoidance or
unenforceability of the guaranteed obligations as may be determined
in any case or proceeding shall hereinafter be referred to as the
“avoidance
provisions”. To the extent set forth in section 18(a), but only to the
extent that the guaranteed obligations would otherwise be subject
to avoidance or found unenforceable under the avoidance provisions,
if guarantor is not deemed to have received valuable consideration,
fair value or reasonably equivalent value for the guaranteed
obligations, or if the guaranteed obligations would render
guarantor insolvent, or leave guarantor with an unreasonably small
capital to conduct its business, or cause guarantor to have
incurred debts (or to have intended to have incurred debts) beyond
its ability to pay such debts as they mature, in each case as of
the time any of the guaranteed obligations are deemed to have been
incurred under the avoidance provisions and after giving effect to
the contribution by guarantor, the maximum guaranteed obligations
for which guarantor shall be liable hereunder shall be reduced to
that amount which, after giving effect thereto, would not cause the
guaranteed obligations (or any other obligations of guarantor to
scienza), as so reduced, to be subject to avoidance or
unenforceability under the avoidance provisions.
(c) this
section 18 is
intended solely to preserve the rights of scienza hereunder to the
maximum extent that would not cause the guaranteed obligations of
guarantor to be subject to avoidance or unenforceability under the
avoidance provisions, and neither the guarantor nor any other
person or entity shall have any right or claim under this
section 18 as
against scienza that would not otherwise be available to such
person or entity under the avoidance provisions.
[SIGNATURE APPEARS ON FOLLOWING PAGE]
F-7
IN
WITNESS WHEREOF, Guarantor has duly executed this Guaranty as of
this 13th day of August, 2018 intending to be bound hereby and to
be effective as of the day and year first above
written.
GUARANTOR:
ROMARK
LABORATORIES L.C.
By:
________________________________
Name:
________________________________
Title:
________________________________
Affidavit
No. _____
Acknowledged
and subscribed before me in _____________, Puerto Rico, this ___
day of _______, 2018 by _________________________, in
representation and on behalf of ________________________, who is of
legal age, single, executive and resident of __________________,
Puerto Rico, personally know to be or identified by
___________________________.
________________________
NOTARY
PUBLIC
F-8
EXHIBIT G
PROCESS
OF OBTAINING FDA ESTABLISHMENT IDENTIFIER NUMBER
1.
Requirements for
obtaining a Federal Drug Administration (the “FDA”) Establishment
Identifier Number (the “FDA FEI Number”) are
outlined in Section
510 of the Federal Food, Drug, and Cosmetic Act which can be
found in the following hyperlink:
xxxx://xxxxxx.xxxxx.xxx/xxxx.xxxxx?xxxxx/xxxxxx@xxxxx00/xxxxxxx0/xxxxxxxxxx0&xxxxxxxxxxxxxx.
and in
Part 207 of Title
21 of the Code of Federal Regulations whi can be found in
the following hyperlink:
xxxxx://xxx.xxx.xxx/xxxxx/xxxxxx/xxxxxxxxxxx.xxxxxx?xxxxxxxxxxXxxxxXX&xxxxxxXxxxx0000%0X00%0X00-00%0X%0X0%0XXxxx%00xxx%00Xxxx%00Xxxxxxxxxxxxxx&xxxxxxxXxx0000-00000&xxxxxxxXxxXX-0000-00-00&xxxxXxxxxxxxxxx.
2.
The FDA provides an
electronic gateway to register (the establishment), list (drugs, if
any) and contact information if help is needed for any of these
process at the following hyperlink:
xxxxx://xxx.xxx.xxx/Xxxxx/XxxxxxxxXxxxxxxxxxXxxxxxxxxxXxxxxxxxxxx/XxxxXxxxxxxxxxxxxxxXxxxxxx/xxx000000.xxx.
3.
Basic information
for registering facilities and products, and how to update
registrations can be found at the following hyperlink:
xxxxx://xxx.xxx.xxx/xxxxxxxxxxx/xxxxxxxxxxxxxxxxxxxx/xxx000000.xxx.
4.
Following the
hyperlink link in Item #3 above, the process and steps for
obtaining a FDA Establishment Number can be found under the
“Drugs” subsection.
5.
An explanation of
the registration process can be found in the following
hyperlink:
xxxxx://xxx.xxx.xxx/Xxxxx/XxxxxxxxXxxxxxxxxxXxxxxxxxxxXxxxxxxxxxx/XxxxXxxxxxxxxxxxxxxXxxxxxx/xxx000000.xxx.
6.
Buyer will need to
obtain a new DUNS, a new FDA FEI Number and describe the type of
activities Buyer will perform. It is important that Buyer
accurately describe the activities as the Buyer will be assigned a
code letter based on the activity. For example, in the case of
manufacturing activities, the FDA will assign the code letter
“M”. Seller has included below a screen shot of
Seller’s registration as an example.
G-1
EXHIBIT H
FORM OF
SUBLEASE
COMMERCIAL / INDUSTRIAL SUBLEASE AGREEMENT
-----This
Commercial Sublease Agreement ("Sublease") is effective as of the
_____ day of ________, 2018 (the "Effective Date"), by and between
PHARMA-BIO SERV PR INC., Federal Identification Number 00-0000000,
a corporation duly organized and validly existing under the laws of
the Commonwealth of Puerto Rico, hereinafter referred to as
"Sublandlord," and ROMARK GLOBAL PHARMA, LLC, a limited liability
company duly organized and validly existing under the laws of the
Commonwealth of Puerto Rico, hereinafter referred to as
"Subtenant."
-----
Plaza Professional Center, Inc., a corporation duly organized and
validly existing under the laws of the Commonwealth of Puerto Rico
("Landlord") is the fee simple owner to the commercial and
industrial land, structure and improvements commonly known and
numbered as Xxxxxx 0, Xxx 00, Xxxxxxxxx Xxxx, Xxxxxx, Xxxxxx Xxxx,
which is identified in the Registry of the Property of Puerto Rico
at Section IV of Bayamón (the “Registry”) as
Property Number 7,950, recorded at page 73 of volume 161 of Dorado
(collectively the land, structure and improvements hereinafter
referred to as the "Building") and legally described in the Spanish
language as follows:
-----"URBANA:
Parcela de terreno localizada en el Barrio Pueblo y Zona Urbana de
Dorado, identificada con el numero catorce (14) con un area de seis
mil trescientos cincuenta y dos punto quinientos veinte
(6,352.520) metros cuadrados equivalentes a uno punto seis mil
ciento sesenta y tres (1.6163) cuerdas. En lindes por el
Norte, con el solar numero doce (12); por el Sur, con el solar
numero quince (15); por el Este, con la calle numero uno (1) todas
de la misma Urbanizacion; y por el Oeste, con Xxxxxxx xx Xxxxxx
Development."----------------------------------------------------
-----Landlord
acquired fee simple, good and marketable title to the Building
pursuant to Deed Number 22 executed on September 19, 2006 before
Notary Public Xxxxxx Xxxxxxx Xxxxxx, recorded in the Registry
at page 215 of volume 256 of Dorado, third inscription, over the
Building.
-----Landlord
entered into that certain Commercial Lease Agreement dated January
1, 2016 (the "Original Lease"), pursuant to which Landlord leased
to Sublandlord, among other space in the Building, 11,600 square
feet on the first floor of the Building as more particularly
described in Section 5a of
the Original Lease, a complete copy of which is attached hereto as
Exhibit A (the "Leased
Premises").
-----
Sublandlord desires to sublease to Subtenant a portion of the
Leased Premises more particularly described in Section 5 hereof (the “Subleased
Premises”), and Subtenant desires to sublease the Subleased
Premises from Sublandlord for the Sublease Term (defined in Section
1 below), pursuant to the terms, covenants, conditions and
provisions herein set forth.
-----
Therefore, in consideration of the mutual promises contained
herein, and for other good, adequate and valuable consideration,
the parties hereto hereby agree as follows:
1.
SUBLEASE TERM: From
the Commencement Date through the Termination Date (the
“Initial Term”), with optional renewals (at
Subtenant’s sole discretion upon three (3) months' notice to
Sublandlord) of (a) a one (1) year renewal option and (b) one (1)
five (5) year renewal option (each, a “Renewal”,
collectively with the Initial Term, the “Sublease
Term”); provided (x) Subtenant is not in default of any of
the terms and conditions of this Sublease, and (y) with respect to
the five (5) year Renewal option only, Sublandlord exercises its
renewal option under the Original Lease, and Sublandlord’s
determination to renew or not the term of the Original Lease shall
be delivered in writing to the Subtenant within six (6) months
prior to the termination of the Original Lease. Subtenant shall
have the right to terminate this Sublease at any time during the
five (5) year Renewal term if (a) Subtenant is moving its operation
from the Subleased Premises to its manufacturing facility in
Manati, Puerto Rico, and (b) Subtenant provides six (6) months'
notice of such termination.
2.
LEASE YEAR: Lease
year shall mean the twelve (12) month period commencing on the
Commencement Date and each succeeding twelve (12) month period
thereafter.
3.
COMMENCEMENT DATE
and TERMINATION DATE
a.
Commencement
Date: the Effective Date.
b.
Termination
Date: December 31, 2019
4.
RENT START
DATE: The Commencement Date.
H-1
5.
SUBLEASED PREMISES:
From the Commencement Date, approximately 10,360 square feet of
office space and Laboratory space. The Gross Leasable area lay-out
is composed of the First floor with a
superficial area equivalent to 10,360 Sq. Ft., which includes
Laboratory, Offices, Library, Utilities Room, Storage, others (as
more particularly described on Appendix 1).
All
construction and modifications to the Sublease Premises, shall be
in accordance with the plans and specifications agreed to in
writing by Landlord and Subtenant, and completed solely at
Subtenant’s expense and discretion. Landlord and Sublandlord
shall cooperate with Subtenant’s construction of a private
entrance and reception area of approximately 3,735 Sq Ft which are
part of the Subleased Premises. Subtenant at its sole discretion
may opt not to construct said private entrance and reception area.
Except for the foregoing provisions regarding the construction of a
private entrance and reception area and future modifications, the
Subleased Premises are being accepted by Subtenant in an
“as-is” condition, subject to the Sublandlord’s
representation and warranties set forth herein.
6.
YEARLY RENT: The
annual rent shall be payable in advance in equal monthly
installments of one-twelfth (1/12th) of the total annual rent
equivalent to an aggregate amount of Two Hundred Fifteen Thousand
Four and No/100 Hundred Dollars ($215,400.00), which monthly
installment shall be equal to Seventeen Thousand Nine Hundred Fifty
and No/100 Dollars ($17,950.00) per month (the
“Rent”), payable on the first day of each and every
calendar month during the Sublease Term. Notwithstanding the
foregoing, on the Commencement Date, Tenant shall deliver to
Landlord the Security Deposit and the
first monthly installment, which amount shall be prorated for the
partial month. The rental payment amount for any partial
calendar months included in the Sublease Term shall be prorated on
a daily basis.
a.
Yearly
Rent is based on 10,360 Sq. Ft of Laboratory Space at a rate of
$20.00 per square feet: $207,200.00/yr.
b.
$10.00
on common area (approx. 820 Sq. Ft.): $8,200.00/yr.
The
Yearly Rent shall be adjusted for the applicable portion
attributable to the common area once Subtenant’s private
entrance and lobby area are completed as provided in Section 5 and
the use of the common area by Subtenant has ceased.
The
land area of the Subleased Premises is hereby stipulated and agreed
to be the amount shown above, and is not subject to re-measurement
unless otherwise set forth herein.
7.
DEFAULT: A late fee
in the amount of $897.50 (5% of monthly rent) shall be assessed if
payment is not postmarked or received by Sublandlord on or before
the fifth (5th) day of each month.
If default shall at any time be made by Subtenant in the payment of
rent when due to Sublandlord as herein provided, and if said
default shall continue for fifteen (15) days after written notice
thereof shall have been received by Subtenant from Sublandlord
(provided, however, that such notice of non-payment shall not be
required from Sublandlord more than two (2) times per calendar
year), or if default shall be made in any of the other covenants or
conditions to be kept, observed and performed by Subtenant, and
such default shall continue for thirty (30) days after notice
thereof in writing to Subtenant by Sublandlord (the “Curing
Period”), without correction thereof then having been
commenced and Subtenant shall thereafter diligently prosecute
completion thereof, Sublandlord may declare Subtenant in default
and Sublandlord may declare the Sublease Term ended and this
Sublease terminated by giving Subtenant written notice of such
intention, and if possession of the Subleased Premises is not
surrendered, Sublandlord may reenter the Subleased
Premises; provided,
however, that Subtenant shall not be in default under the
circumstances described in this paragraph if Subtenant has made
diligent efforts to cure a non-monetary default within the thirty
(30) day period described above, and thereafter proceeds
continuously and diligently to cure such default within a
commercially reasonable time. Sublandlord shall have, in addition
to the remedy above provided, any other rights or remedies
available to Sublandlord on account of any Subtenant default,
either in law or equity. Concurrently with the execution and
delivery of this Sublease, the parties and-or its affiliates, have
entered into a financing agreement. The parties have agreed that it
shall also be a default under this Sublease if Subtenant at any
point shall be (a) in monetary default, or (b) in default due to
failure to comply with any requirements pertaining to any
collateral assets, both as set forth under any other agreements,
such as the one previously mentioned, contracts, or obligations
between Subtenant and Sublandlord, or between Subtenant and any
affiliates of Sublandlord, including, but not limited to Landlord
and Sciencza Labs, Inc.
Sublandlord shall
be in default under this Sublease, and
Subtenant shall have all the rights and remedies
provided in this Section or elsewhere in this Sublease (including
the right to immediately terminate this Sublease, insist on
specific performance and/or collect damages from Sublandlord), in
the event that, and for as long as the same shall continue (each, a
“Sublandlord Event of Default”): (i) if Sublandlord
defaults under the Original Lease with Landlord and/or loses any of
its rights, title and interests in and to the Building or the
Subleased Premises; (ii) if for any reason Subtenant loses at any
moment during the term of this Sublease, the quiet and peaceful
enjoyment of the Building and Subleased Premises as herein
described in Section 29 hereof; (iii) if at any time during the
Term of the Sublease, Subtenant discovers any hidden structural
damages to the Building or Leased Premises and Landlord and/or
Sublandlord fails to promptly repair such damage; (iv) if
Sublandlord fails to perform any of its obligations required of
Sublandlord in this Sublease within a reasonable time, but in no
event later than thirty (30) days after written notice by Subtenant
to Sublandlord specifying the default; or (v) Landlord and/or
Sublandlord fails to maintain or cause to maintain at all times the
Common Areas in the same or better condition as existing on the
date of execution of this Sublease and such failure is not remedied
by Landlord and/or Sublandlord within thirty (30)
days.
H-2
Following the
occurrence and continuance of an Event of Default by any of the
parties, the other party shall be entitled and may (i) terminate
this Sublease by giving written notice of termination to the party
that is in default, (ii) seek specific performance of the
obligations of the party that is in default in a civil action, plus
actual compensatory damages, costs and attorney’s fees
incurred as a result of such default (if such court finds that the
party was in default), including those incurred in enforcing its
rights hereunder, and (iii) perform any actions necessary to cure
the Event of Default using commercially reasonable efforts. If the
Event of Default is caused by the Sublandlord, the Sublandlord
shall return and deliver to Subtenant the Security
Deposit.
8.
SECURITY DEPOSIT:
Subtenant shall pay to Sublandlord a security deposit in the amount
equivalent to one month of rent ("Security Deposit"). If Subtenant
elects to construct the private entrance and reception area as
permitted in Section 5 of this Sublease, the Security Deposit will
be reduced proportionally according to the rent reduction as
provided in Section 6 of this Sublease, and the excess portion of
the Security Deposit immediately return to Subtenant. The Security
Deposit shall be held by Sublandlord without liability for interest
and as security for the performance by Subtenant of Subtenant's
covenants and obligations under this Sublease, it being expressly
understood that the Security Deposit shall not be considered an
advance payment of rental or a measure of Sublandlord's damages in
case of default by Subtenant. Sublandlord may not commingle the
Security Deposit with Sublandlord's other funds nor accumulate
interest thereto. Sublandlord may, from time to time, without
prejudice to any other remedy, subject to all grace, Cure Period
and/or notice periods hereunder, use the Security Deposit to the
extent necessary to make good any arrearages of Rent or to satisfy
any other covenant or obligation of Subtenant hereunder. Following
any such application of the Security Deposit, Subtenant shall pay
to Sublandlord on demand the amount so applied in order to restore
the Security Deposit to its original amount. If Subtenant is not in
default at the termination of this Lease, the balance of the
Security Deposit remaining after any such application shall be
returned by Sublandlord to Subtenant. If Sublandlord transfers its
interest in the Subleased Premises during the Sublease Term,
subject to the terms and conditions set forth herein, Sublandlord
may assign the Security Deposit to the transferee as part of the
transfer of the Sublease, and thereafter shall have no further
liability for the return of such Security Deposit.
9.
BASIC RENT
INCREASE: Subtenant shall pay Sublandlord a 5% annual rent increase
beginning on the second lease year and thereafter until the
expiration of the Sublease Term or the first renewal option, if
exercised. No rent increase will apply to the five (5) year term
renewal option is exercised.
10.
COMMON AREA
EXPENSES / MAINTENANCE / TRASH REMOVAL: Maintenance services will
be billed by Sublandlord, based on a prorate formula for the
distribution of common expenses charged to the Sublandlord under
the Original Lease, in addition to paying fixed annual minimum Rent
and Subtenant’s Taxes, which common expenses include the
maintenance and cleanup costs of common areas, including but not
limited to green areas, parking, building, utilities lines, fences,
service driveways, security systems, security guard, electrical
generator and supplies such as diesel, water tanks, and related
facilities (collectively, the “Common Areas”);
provided, however, (i) Subtenant has the right to use, possess
and/or enjoy any of such Common Areas throughout the Term of this
Sublease, and (ii) that if and to the extent applicable,
Sublandlord shall make any insurance proceeds that it may receive
in connection with any such repairs available to Subtenant to be
applied towards the cost of any such repairs. Sublandlord shall
deliver to Subtenant evidence of the paid invoice related to
payments of maintenance and cleanup of Common Areas, which amount
shall be reasonable in accordance to market prices.
Sublandlord shall
use commercially reasonable efforts to enforce its rights under the
Original Lease to cause Landlord to maintain in good condition and
repair the Building and the Common Areas in a clean, safe, and
serviceable condition. Sublandlord further covenants and agrees
that during the term of the Sublease it will use commercially
reasonable efforts to enforce its rights under the Original Lease
to cause Landlord to maintain the Common Areas in the same or
better condition as existing on the date of execution of this
Sublease.
a.
Subtenant
will have no responsibility to provide services to other parties
occupying/using the Building. In addition, Sublandlord will
indemnify and hold harmless Subtenant from any liability that may
arise from other parties/entities occupying/using the Building
facilities, including any of Sublandlord’s negligence
thereunder, and their related use of Common Areas and/or
services.
Notwithstanding the
foregoing, Landlord shall maintain all exterior portions of the
Building, including without limitation the columns, all structural
components of the Premises, roof, all walls, external plate glass,
foundations, building slabs, main substation, electrical stand by
generators to provide power to the Building or Leased Premises,
electrical transformers, pipes, and all plumbing, electrical,
lighting and mechanical equipment and systems serving the Leased
Premises or Building and components of its land, in good condition
and fully operational at Landlord’s sole cost and expense
without reimbursement from Subtenant. Landlord’s obligations
hereunder shall include the replacement, where necessary, of the
foregoing. Throughout the term of this Sublease, Subtenant agrees
to promptly notify Sublandlord and Landlord of any and all repairs
of which it becomes aware that are needed on all structural and
exterior portions of the Building and/or any of its components
which Landlord is responsible to maintain under this Sublease or
the Original Lease.
H-3
Additionally,
Subtenant shall coordinate and comply with Sublandlord and Landlord
regarding the procedures to follow in case of an emergency
affecting the Subleased Premises, including responses and access to
the Subleased Premises in connection with the fire alarm system and
the access control system and its day to day operation and/or
compliance, as applicable.
11.
SUBLANDLORD TAXES:
Subtenant shall reimburse Sublandlord all general real estate taxes
and installments of special assessments on the Subleased Premises
which are charged to Sublandlord under the Original Lease during
the Sublease Term. All special real estate assessments or other
related governmental charges levied on the Subleased Premises,
shall be and remain the Sublandlord’s sole obligation (by way
of example, such as inheritance, estate, succession, transfer,
gift, corporation, income or profit tax or capital levy that is or
may be proportionately imposed upon the Sublandlord).
Sublandlord
represents and warrants to Subtenant that it engaged in a trade or
business in Puerto Rico and that, therefore, the Rent and any other
sums payable by Subtenant to Sublandlord under this Lease are not
subject to the Puerto Rico income tax withholding, including,
without limitation, as prescribed by Section 1150 of the PR
Code.
12.
SUBTENANT TAXES:
Subtenant shall pay prorated real estate taxes (property taxes)
based on the Gross Leasable Area of the Subleased Premises
identified in Section 5 of this Agreement. Subtenant covenants and
agrees to pay within thirty (30) days of Subtenant’s receipt
of Sublandlord’s invoice together with the tax xxxx and
evidence of payment by Sublandlord, all general real estate taxes
levied against the Subleased Premises for tax periods beginning on
or after the Commencement Date. Subtenant shall pay before any
fine, penalty or interest accrues, and in any event before
delinquency, every tax, assessment, license fee, excise, fine or
penalty for violation of the law, however described, which is
separately imposed on or levied, assessed or charged against
Subtenant by any governmental or quasi-governmental authority
having jurisdiction, including, without limitation, upon or on
account of:
a.
operations
at, occupancy of, or conduct of business in or from, the Subleased
Premises, by or with the permission of Subtenant;
b.
fixtures
or personal property in the Subleased Premises which do not belong
to Sublandlord; and
c.
the
Rent paid or payable by Subtenant to Sublandlord for the Subleased
Premises or for the use and occupancy of all or any part thereof;
provided that if the fine, penalty, tax or other charge is imposed
or levied on Sublandlord, Subtenant shall pay to or reimburse
Sublandlord such portion of any amounts payable under this Section.
Notwithstanding the foregoing, Sublandlord shall pay all real
estate taxes before delinquency and penalties and in the event
Sublandlord fails to timely pay such real estate tax bills, any
penalties, interest payments, additional assessment or delinquency
charges resulting from the late payment of any such real estate tax
xxxx, shall be paid by the Sublandlord without contribution by
Subtenant
13.
PERMITTED USE: The
Subleased Premises may be occupied and used by Subtenant and its
affiliates exclusively as a laboratory or similar operation related
to the business activities of a pharmaceutical business. Nothing
herein shall give Subtenant the right to use the property for any
other purpose or to sublease, assign, or license the use of the
property to any sub-lessee, assignee, or licensee without
Sublandlord’s prior consent, which consent may not be
unreasonably withheld or delayed.
14.
REPAIRS,
ALTERATIONS AND IMPROVEMENTS: Subtenant, at Subtenant's expense,
shall not remodel, make additions, improvements or alterations of
and to all or any part of the Subleased Premises without
Sublandlord's consent, which may not be unreasonably withheld or
delayed.
15.
CLEANING: Subtenant
shall arrange for its own janitorial, cleaning services, pest
control and trash removal for the Subleased Premises, at its sole
cost and expense. Such services shall be performed by contractors
or employees consented to in writing by Sublandlord, subject to
such conditions as Sublandlord may reasonably specify. Subtenant
shall keep the Subleased Premises in a clean, neat and orderly
manner at all times. Subtenant shall reasonably keep the Subleased
Premises free of insects, rodents and other pests, and free of
objectionable or offensive odors. Subtenant shall also keep the
loading docks and service corridors and Common Areas free of trash
and refuse generated by its operations and its employees. In the
event that Subtenant fails to clean as required in this Section or
elsewhere in this Lease, Sublandlord may, but need not to, perform
such cleaning, and Subtenant shall pay Sublandlord the reasonable
cost thereof on demand and upon receipt of invoice evidencing
payment. The amount of any such charge shall be considered an
additional element of Rent.
H-4
16.
ENVIRONMENTAL and
HAZARDOUS MATERIALS: Subtenant shall
not (either with or without negligence) cause or permit the escape,
disposal or release of any biologically or chemically active or
other hazardous substances or materials. Subtenant shall not allow
the storage or use of such substances or materials in any manner
not sanctioned by law or by the highest standards prevailing in the
industry for the storage and use of such substances except to use
in the ordinary course of Subtenant’s business, and then only
after written notice is given to Landlord of the identity of such
substances or materials. Without limitation, hazardous substances
and materials shall include those described in the Comprehensive
Environmental Response, Compensation and Liability Act of 1980, as
amended, 42 U.S.C. Section 9601 et seq., any applicable state
or local laws and the regulations adopted under these acts. If due
to the actions or omissions of Subtenants, its employees,
agents, or invitees, any lender or
governmental agency shall ever require testing to ascertain whether
or not there has been any release of hazardous materials, then the
reasonable costs thereof shall be reimbursed by Subtenant to
Sublandlord or Landlord, as applicable, upon demand as additional
charges if such requirement applies to the Subleased Premises. In
addition, Subtenant shall execute affidavits, representations and
the like from time to time at Landlord’s or Sublandlord's
request concerning Subtenant’s best knowledge and belief
regarding the presence of hazardous substances or materials on the
Subleased Premises. In all events, Subtenant shall indemnify
Sublandlord and Landlord in the manner elsewhere provided in this
Sublease from any release of hazardous materials on the Subleased
Premises occurring while Subtenant is in possession, or elsewhere
if caused by Subtenant or persons acting under Subtenant. The
within covenants shall survive the expiration or earlier
termination of the Sublease Term.
a.
Both
Subtenant and Sublandlord must comply with all applicable federal,
state and local statutes related to the environment now or
hereafter enacted and any additions and amendments thereto and
regulations enacted thereunder, ordinances, regulations, orders and
requirements of common law, regarding, but not limited to,
(i) discharges to the air, soil, surface or groundwater; and
(ii) handling, utilizing, storage, treatment or disposal of
any hazardous substances or toxic substances as defined therein
(“Environmental Statutes”). Subtenant hereto shall
obtain all permits, licenses or approvals and shall make all
notifications and registrations required by Environmental Statutes
and shall submit to Sublandlrod or Landlord, as applicable, upon
request, for inspecting and copying all documents, permits,
licenses, approvals, manifests and records required to be submitted
and/or maintained by the provisions of the Environmental Statutes.
Subtenant or Sublandlord, as the case may be, shall provide
promptly to either Sublandlord or Subtenant, as the case may be,
copies of any correspondence, notice of violation, summons, order,
complaint or other document received by Subtenant or Sublandlord,
as the case may be, pertaining to compliance with Environmental
Statutes.
b.
Subtenant
shall not install at the Subleased Premises any temporary or
permanent tanks for the storage of any liquid or gas above or below
ground except as in compliance with the other provisions of this
section and after obtaining written permission to do so from
Sublandlord.
c.
If,
exclusively because of negligence in the manner in which Subtenant
operates its business, the Sublandlord, Landlord, Landlord’s
mortgage lender or a governmental agency shall require testing by
an environmental testing entity of its choice, to ascertain whether
there has been a release of Hazardous Materials by Subtenant, its
agents, servants, employees or business invitees, in or around the
Subleased Premises, the reasonable costs of such testing shall be
reimbursed by Subtenant to Sublandlord or Landlord, as applicable.
Subtenant shall execute affidavits or representations, at
Sublandlord’s or Landlord's request, stating that, to the
best of Subtenant’s knowledge and belief, since the time that
Subtenant took possession of the Subleased Premises, there have
been no and there presently are no Hazardous Materials present in
the Subleased Premises. Subtenant hereby agrees to indemnify
Sublandlord and Landlord and to hold Sublandlord Landlord harmless
of, from and against all expense, loss, cost, fines, penalties, or
liability suffered by Sublandlord and Landlord by reason of
Subtenant’s breach of any of the provisions of this Section,
provided the same were not caused or due to Landlord or
Sublandlord’s negligence or willful misconduct.
d.
In the event that
(i) prior to the Commencement Date the Subleased Premises are
contaminated, or (ii) prior to or after the Commencement Date any
other portion of the Subleased Premises is contaminated, by
Hazardous Material released by Landlord, Sublandlord, or any
previous tenant or any of their officers, employees, or agents
(hereinafter called “Landlord Release”), Landlord and
Sublandlord, jointly and severally (“solidariamente”) shall indemnify,
defend and hold Subtenant harmless from any and all claims,
judgments, damages, penalties, fines, costs, liabilities, or losses
(including without limitation, attorneys’ fees, consultant
fees and expert fees) which shall arise during or after the term of
this Sublease as a result of such contamination. Without limiting
the generality of the foregoing, the indemnification provided by
this Section shall specifically cover costs incurred in connection
with any clean-up, remedial, removal or restoration work required
by any federal, state or local government agency or political
subdivision because of the presence of Hazardous Material in the
soil or groundwater on or under the Subleased Premises resulting
from the Landlord Release. Landlord or Sublandlord, at its sole
costs and expense, shall provide Subtenant an environmental study
or report of the hazardous condition of the Subleased Premises. The
provision of this Section shall survive the termination of this
Lease. Additionally, Landlord or Sublandlord may at any time obtain
a Phase I environmental report for the Subleased Premises, and
Subtenant shall provide access to the Subleased Premises to
Landlord, Sublandlord and/or their consultants to complete such
report, provided that (a) Landlord and/or Sublandlord have given
five (5) days prior notice to Subtenant, and (b)
Sublandlord’s and/or Landlord’s access to the Subleased
Premises shall not interrupt or hinder Subtenant's possession and
business operations on the Subleased Premises.
H-5
e.
The
provisions of this section shall survive the termination of
Subtenant’s tenancy or of this Sublease.
“Hazardous
Materials” as used herein shall mean any pollutant, toxic
substance, hazardous material, hazardous substance, or petroleum ,
as defined in or pursuant to the Resource Conservation and Recovery
Act, as amended, the Comprehensive Environmental Response,
Compensation and Liability Act, as amended, the Federal Clean Water
Act, as amended, or any other federal, state or local environmental
law, regulation, ordinance, rule or bylaw, whether existing as of
the Commencement Date of this Sublease, previously enforced or
subsequently enacted. Landlord and Sublandlord represent and
warrant that, as of the Commencement Date, the Subleased Premises
and the rest of the Building are free of Hazardous Materials and
that no Hazardous Materials have been released in any portion
thereof.
17.
INSURANCE:
a.
If
the Subleased Premises or any other part of the Building is damaged
by fire or other casualty resulting from any act or negligence of
Subtenant or any of Subtenant's agents, employees or invitees, rent
shall not be diminished or abated while such damages are under
repair, and Subtenant shall be responsible for the costs of repair
not covered by insurance.
b.
Landlord
shall maintain fire and extended coverage insurance on the
Subleased Premises in such amounts as Landlord shall deem
appropriate. Subtenant shall be responsible, at its expense, for
fire and extended coverage insurance on all of its personal
property, including removable trade fixtures, located in the
Subleased Premises. In addition, Subtenant shall be responsible to
maintain environmental insurance coverage for the Subleased
Premises and name Landlord and Sublandlord as additional insureds
under such environmental insurance policy and provide a current
Certificate of Insurance evidencing compliance with this
Paragraph.
c.
Subtenant and Landlord shall, each at its own
expense, maintain a policy or policies of comprehensive general
liability insurance with respect to the respective activities of
each in the Building with the premiums thereon fully paid on or
before due date, issued by and binding upon some insurance company
approved by Landlord and Subtenant, such insurance to afford
minimum protection of not less than $2,000,000 combined single
limit coverage of bodily injury, property damage or combination
thereof. All parties shall be listed as an additional insureds on
each of their policy or policies of comprehensive general liability
insurance, and each shall provide to the other with current
Certificates of Insurance evidencing their compliance with this
Paragraph. All parties shall obtain the agreement of their insurers
to notify the other parties hereto that a policy is due to expire
at least (10) days prior to such expiration. Neither Sublandlord
nor Landlord shall not be required to maintain insurance against
thefts within the Subleased Premises or the Building. If the
Subleased Premises are substantially destroyed by a casualty, which
shall include all causes, and not be limited to fire, explosion,
flood, hurricane, etc., the Sublease shall terminate. If a portion
of the Subleased Premises is so destroyed, and in the
Subtenant’s reasonable judgment the remainder of the
Subleased Premises is suitable for the Subtenant to continue its
business therein, there shall be a
proportionate rent abatement and the Landlord shall have an
obligation to restore as soon as practical, except that, (i) if the
casualty occurs during the last 18 months of the Sublease, either
party should be able to terminate the Sublease, or (ii)
repairs cannot reasonably be completed within one hundred and
eighty (180) days, either Subtenant or Sublandlord, at its option,
may terminate this Sublease by giving written notice to the other
party with no penalty whatsoever, whereupon all rights and
obligations hereunder shall cease effective as of the date of the
casualty.
d.
Notwithstanding anything in this Sublease to the
contrary, Sublandlord and Subtenant each hereby waives any and all
rights of recovery, claim, action or cause of action, against the
other, its agents, servants, partners, shareholders, officers,
directors or employees, for any loss or damage that may occur to
the Subleased Premises or the Building, or any personal property of
such party therein, by reason of fire, or other peril, the
elements, or any other cause which could be insured against under
the terms of standard fire and extended coverage insurance policies
regardless of cause or origin, including
negligence of the other party hereto, its agents, officers,
partners, shareholders, servants, or employees, and covenants that
no insurer under any such policies shall hold any right of
subrogation against such other party. The effect of such waiver is
not limited by the amount of insurance actually carried or required
to be carried, to the actual proceeds received after a loss or to
any deductibles applicable thereto. Landlord and Subtenant will
cause their respective insurers to issue appropriate waiver of
subrogation rights endorsements to all policies of insurance
carried in connection with the Building and the Subleased Premises
and the personal property therein. Either parties' failure to
obtain such endorsements shall not invalidate this waiver. Any
costs associated with obtaining such a waiver from each party's
insurance company shall be borne by that party.
H-6
18.
UTILITIES:
Subtenant shall pay all charges for water, sewer, gas, internet,
electricity, telephone and other services and utilities used by
Subtenant on the Subleased Premises during the Sublease Term unless
otherwise expressly agreed in writing by Sublandlord. Subtenant, at
its expense, shall be responsible to ensure that all utilities are
separately metered and if so, any payments shall be made directly
to the utilities company or Sublandlord is an internal meter is
used. In the event that any utility or service provided to the
Subleased Premises is not separately metered with Sublandlord's
consent, Sublandlord shall pay the amount due and separately
invoice Subtenant for Subtenant's pro rata share of the charges.
Subtenant shall pay such amounts within fifteen (15) days of
invoice and receipt of evidence from Landlord’s payment.
Subtenant shall not be liable for any penalties, charges or fees
charged to Landlord due to Sublandlord’s late payment.
Subtenant acknowledges that the Subleased Premises are designed to
provide standard office use electrical facilities and standard
office lighting. Subtenant shall not use any equipment or devices
that utilize excessive electrical energy or which may, in
Sublandlord's reasonable opinion, overload the wiring or interfere
with electrical services to other tenants.
Notwithstanding the
foregoing, Sublandlord hereby provides, all in its as-is condition,
infrastructure, installations, utility lines, and systems
(Electrical, Fire Protection, Fire Alarm, Potable Water, Sanitary)
up to the point of connection within the Subleased Premises.
Thereby, Subtenant, at its expense, shall be able to use existing
conduits, utility lines and infrastructure in order to facilitate
connections towards the Subleased Premises and is hereby authorized
to install any and all necessary equipment, meters or antenas
within the Building or on the roof of the Subleased Premises to
make the necessary connections and utility services. These
infrastructure installations will be made by the vendors contracted
by Subtenant for the corresponding services. Furthermore, Subtenant
may request from Sublandlord, and Sublandlord agrees to not
unreasonably withhold consent, the right to install its own
stand-by electrical generator. Upon such installation Subtenant
will not be charged for the cost of maintaining and operating the
electrical generator serving the rest of the Building.
19.
SIGNS: Subject to
Sublandlord's consent, Subtenant shall have the right to place on
the Subleased Premises, at locations selected by Subtenant, any
signs which are permitted by applicable zoning ordinances and
private restrictions. Sublandlord may refuse consent to any
proposed signage that is in Sublandlord's reasonable opinion too
large, deceptive, unattractive or otherwise inconsistent with or
inappropriate to the Subleased Premises or use of any other tenant,
or which is not permitted under the Original Lease. Subtenant shall
repair all damage to the Subleased Premises resulting from the
removal of signs installed by Subtenant.
20.
ENTRY: Sublandlord
shall have the right to enter upon the Subleased Premises during
business hours on reasonable prior three (3) Business Days’
notice to Subtenant to inspect the same, provided Sublandlord shall
not thereby unreasonably interfere with Subtenant's business on the
Subleased Premises and further provided that Sublandlord shall
follow all protocols established by Subtenant for entry into any
laboratory areas of the Subleased Premises. Notwithstanding the
above, in case of emergency and ordinary repairs/maintenance,
Subtenant grants full access to Landlord and/or Sublandlord to the
Subleased Premises, provided Landlord and/or Sublandlord shall use
commercially reasonable efforts not to thereby unreasonably
interfere with Subtenant's business on the Subleased
Premises.
21.
PARKING: During the
Sublease Term, Subtenant shall have non-exclusive use in common
with Landlord, Sublandlord, other tenants of the Building, their
guests and invitees, at no cost to Subtenant, of the non-reserved
common automobile parking areas, driveways, and footways, subject
to rules and regulations for the use thereof as prescribed from
time to time by Landlord. Additionally, provided Sublandlord is
first able to obtain such rights from Landlord under the Original
Lease, then Subtenant shall have the rights to three (3) reserved
parking spaces designated as: one (1) regulatory agencies parking,
two (2) Subtenant reserved parking spaces for Subtenant’s
executives. Sublandlord and Landlord reserve the right to designate
other reasonable number of designated parking places for Subtenant
and Subtenant's agents and employees.
22.
CONTROL OF
DRIVEWAYS, ACCESS AND FACILITIES: All driveways, entrances and
exits thereto, and other facilities furnished as part of the
Subleased Premises shall always be subject to the exclusive control
and management of Sublandlord; provided, that, such control shall
not limit, impair or in any way interrupt Subtenant’s or its
agent, employees, and/or visitors access, entry or exit to or from
the Subleased Premises. Landlord and Sublandlord reserve the right,
but without assuming any duty, to institute additional access
control measures, to further control and regulate access to the
Building or any part thereof. Subtenant will enjoy rights to access
the Subleased Premises while obligations pursuant to this Sublease
are complied with. Without breaching the law, Sublandlord and
Landlord reserve the right to cancel access to facilities if
Subtenant is in default hereunder, after any and all Curing Periods
and/or notice period have elapsed; provided, however, that if
Sublandlord or Landlord cancel access to any portion of the
Subleased Premises, Subtenant shall not be required to pay rent for
any such portions of the Subleased Premises for which access has
been cancelled for the period of such cancelled access. Sublandlord
and Landlord shall not, under any circumstances, be responsible for
providing or supplying security services to the Subleased Premises
or any part of the Building in excess of the Sublandlord’s
Access Control Systems (and, unless expressly agreed in writing by
Sublandlord, Sublandlord shall not under any circumstances be
deemed to have agreed to provide any access control services in
excess of the above specified Sublandlord’s Access Control
Systems).
H-7
23.
BUILDING RULES:
Subtenant will comply with the rules of the Building adopted and
altered by Landlord from time to time and will cause all its
agents, employees, invitees and visitors to do so; all changes to
such rules will be sent by Landlord to Subtenant in writing prior
to implementing such change. Attached in Schedule 23 is a copy of the
actual Building Rules.
24.
CONDEMNATION: If
any legally, constituted authority condemns the Building or such
part thereof which shall make the Subleased Premises unsuitable for
leasing, this Sublease shall cease when the public authority takes
possession, and Sublandlord and Subtenant shall account for rental
as of that date. Such termination shall be without prejudice to the
rights of either party to recover compensation from the condemning
authority for any loss or damage caused by the condemnation.
Neither party shall have any rights in or to any award made to the
other by the condemning authority.
25.
SUBORDINATION:
Upon the satisfaction of the
conditions set forth in the last sentence of this Section,
the parties accept this Sublease subject and subordinate to any
mortgage, deed of trust or other lien presently existing or
hereafter arising upon the Subleased Premises, or upon the Building
and to any renewals, refinancing and extensions thereof, but
Subtenant agrees that any such mortgagee shall have the right at
any time to subordinate such mortgage, deed of trust or other lien
to this Sublease on such terms and subject to such conditions as
such mortgagee may deem appropriate in its discretion. Sublandlord
is hereby irrevocably vested with full power and authority to
subordinate this Sublease to any mortgage, deed of trust or other
lien now existing or hereafter placed upon Sublandlord's interest
in the Subleased Premises or the Building, subject to the terms of
this Sublease, and Subtenant agrees upon demand to execute such
further instruments subordinating this Sublease or attorning to the
holder of any such liens as Sublandlord may request. In the event
that Subtenant should fail to execute any instrument of
subordination herein required to be executed by Subtenant promptly
as requested, Subtenant hereby irrevocably constitutes Sublandlord
as its attorney-in-fact to execute such instrument in Subtenant's
name, place and stead, it being agreed that such power is one
coupled with an interest. Subtenant agrees that it will from time
to time upon request by Sublandlord execute and deliver to such
persons as Sublandlord shall request a statement in recordable form
certifying that this Sublease is unmodified and in full force and
effect (or if there have been modifications, that the same is in
full force and effect as so modified), stating the dates to which
rent and other charges payable under this Sublease have been paid,
stating that Sublandlord is not in default hereunder (or if
Subtenant alleges a default stating the nature of such alleged
default) and further stating such other matters as Sublandlord
shall reasonably require. Should any existing or prospective
mortgagee require a modification or modifications of this Sublease,
which modification or modifications will not cause an increased
cost or expense to Subtenant or in any other way materially change
the rights and obligations of Subtenant hereunder, Subtenant agrees
that this Sublease may be so modified and agrees to execute
whatever documents are required therefore and deliver the same to
Sublandlord within ten (10) days following the request
therefore.
26.
PROHIBITION TO
RECORD SUBLEASE AGREEMENT: The parties agree that this Sublease
Agreement will not be converted to public instrument and will not
take any action to record this Sublease Agreement in the Registry
of the Property. The Original Lease, however, will be recorded in
the Registry of Property.
27.
SALE OF THE
BUILDING or ORIGINAL LEASE: Landlord covenants and agrees (i) to
notify Subtenant in writing of its intention to sell the Building
or the Subleased Premises; and (ii) to make the purchaser in any
sale of the Building or the Subleased Premises expressly aware of
this Sublease; Sublandlord covenants and agrees (i) to notify
Subtenant in writing of its intention to sell its leasehold rights
to the Subleased Premises; and (ii) to make the purchaser in any
sale of the Sublandlord’s right, title and interests in and
to the Original Lease or the Sublease expressly aware of this
Sublease; Landlord and Sublandlord, as the case may be, shall be
completely released of all further obligations under this Lease
accruing from and after the date of such sale.
28.
NOTICE: Any notice
required or permitted under this Sublease shall be deemed
sufficiently given or served if sent by United States certified
mail, return receipt requested, addressed as follows:
If to
Sublandlord to: Pharma-Bio Serv PR, Inc.
____________________________
____________________________
____________________________
If to
Subtenant to: Global Pharma LLC
____________________________
____________________________
____________________________
Sublandlord and
Subtenant shall each have the right from time to time to change the
place notice is to be given under this paragraph by written notice
thereof to the other party. The first (1st) day following receipt
of such notice shall be the start date for all time periods stated
herein.
H-8
29.
QUIET AND PEACEFUL
ENJOYMENT: Each of Sublandlord and Subtenant warrant that it has
full right, authority, and power to execute and perform this
Sublease. Further, the Sublandlord covenants and warrants that the
Subtenant will have quiet and peaceable possession and enjoyment of
the Subleased Premises for its permitted use (as defined in
Section 13 hereof)
to the full term of this Sublease without hindrance or molestation
by Sublandlord, its other tenants, visitors, agents or employees.
Concurrently, Subtenant warrants and agrees that Subtenant will not
hinder or lessen the quiet and peaceable possession and enjoyment
of any other tenant within the adjacent premises from their
permitted use.
30.
WAIVER: No waiver
of any default of Sublandlord or Subtenant hereunder shall be
implied from any omission to take any action on account of such
default if such default persists or is repeated, and no express
waiver shall affect any default other than the default specified in
the express waiver and that only for the time and to the extent
therein stated. One or more waivers by Sublandlord or Subtenant
shall not be construed as a waiver of a subsequent breach of the
same covenant, term or condition.
31.
FORCE MAJEURE:
Except for monetary obligations, whenever
a day is specified in this Sublease on which, or a period of
time is specified in which, either party is required to do or
complete any act, matter or thing, the time for the doing or
completion shall be reasonably extended because of, civil
commotion, war, warlike operations, sabotage, governmental
regulations or control, fire or other casualty, abnormally severe
weather or other acts of God, or other causes beyond such
party’s reasonable control (financial inability excepted),
and shall not be considered an event of default or breach of this
Sublease by the party in question, but only to the extent and for
the time occasioned by such event.
32.
HEADINGS: The
headings used in this Sublease are for convenience of the parties
only and shall not be considered in interpreting the meaning of any
provision of this Sublease.
33.
SUCCESSORS AND
ASSIGNS: The provisions of this Sublease shall extend to and be
binding upon Sublandlord and Subtenant and their respective heirs,
legal representatives, successors and assigns. This provision shall
not operate to permit any transfer, assignment, mortgage,
encumbrance, lien, charge, or subletting contrary to the provisions
of this Sublease.
34.
CONSENT:
Sublandlord shall not unreasonably withhold or delay its consent
with respect to any matter for which Sublandlord's consent is
required or desirable under this Sublease.
35.
COMPLIANCE WITH
LAW: Subtenant shall comply with all laws, orders, ordinances and
other public requirements now or hereafter pertaining to
Subtenant's use of the Subleased Premises. Sublandlord shall comply
with all laws, orders, ordinances and other public requirements now
or hereafter affecting the Subleased Premises.
36.
FINAL AGREEMENT:
This Sublease terminates and supersedes all prior understandings or
agreements on the subject matter hereof. This Sublease may be
modified only by a further writing that is duly executed by both
parties. Submission of this instrument for examination shall not
constitute a reservation of or option for the Subleased Premises or
in any manner bind Sublandlord and no lease or obligation of
Sublandlord shall arise until this instrument is signed and
delivered by Sublandlord and Subtenant; provided, however, the
execution and delivery by Subtenant of this Sublease to Sublandlord
or the agent of Sublandlord's beneficiary, if any, shall constitute
and irrevocable offer by Subtenant to lease the Subleased Premises
on the terms and conditions herein contained.
37.
GOVERNING LAW: This
Sublease shall be construed and enforced in accordance with the
Laws of the Commonwealth of Puerto Rico.
38.
SEVERABILITY:
Wherever possible, each provision of this Sublease shall be
interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Sublease shall be
prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity,
without invalidating the remainder of such provision or the
remaining provisions of this Sublease.
39.
ORIGINAL LEASE.
Sublandlord and Subtenant agree that at all times this Sublease is
and shall be subject and subordinate to all of the terms,
covenants, conditions, and provisions of the Original Lease.
Subtenant hereby acknowledges that it has received a copy of the
Original Lease and has examined and approved same. All of the
terms, covenants, conditions, and provisions of the Original Lease
are incorporated herein by reference, and shall, as between
Sublandlord and Subtenant, constitute the terms, covenants,
conditions, and provisions of this Sublease, except to the extent
that they are inapplicable to, inconsistent with, or modified by
the provisions of this Sublease. If Subtenant receives any notice
or demand from the Landlord under the Original Lease, Subtenant
shall promptly deliver a copy thereof to Sublandlord. All defined
terms in this Sublease shall have the same meaning as in the
Original Lease, except if otherwise noted. Subtenant shall not do
or permit to be done any act or thing which will constitute a
breach or violation of any of the terms, covenants, conditions, or
provisions of the Original Lease.
H-9
40.
NO ASSIGNMENT AND
SUBLETTING. Subtenant shall have no rights whatsoever to assign
this Sublease or sublet all or any portion of the Subleased
Premises, without the prior written consent of Sublandlord, which
shall not be unreasonably withheld or delayed; provided, that
Subtenant shall have the right to transfer this Sublease (i) to any
affiliate, parent company or subsidiary of Subtenant, or (ii) as
part of a sale of its business, stock and/or substantially all of
its assets to any Person (in Landlord’s reasonable judgment):
(A) with a similar or stronger financial condition; (B) that is
committed to continue a similar business operation at the Subleased
Premises; and (C) with similar recognized and/or reputable
experience in the same industry as Subtenant (the “Authorized
Lease Transfer”). Any other attempted assignment or sublease
by Subtenant shall be void. Notwithstanding any assignment or
subletting including any Authorized Lease Transfer, Subtenant shall
at all times remain fully responsible and liable for the payment of
the rent and for compliance with all of Subtenant's other
obligations under this Sublease (regardless of whether
Sublandlord's approval has been obtained for any such assignments
or sublettings).
41.
ESTOPPEL
CERTIFICATE. Subtenant agrees, from
time to time, within ten (10) Business Days after request of
Sublandlord, to execute and deliver to Sublandlord, or
Sublandlord's designee, any reasonable estoppel certificate
requested by Sublandlord, stating that this Sublease is in full
force and effect, the date to which rent has been paid, that
Sublandlord is not in default hereunder (or specifying in detail
the nature of Sublandlord's default), the termination date of this
Sublease and such other matters pertaining to this Sublease as may
be requested by Sublandlord.
42.
BROKERAGE.
Sublandlord and Subtenant each represent and warrant one to the
other that neither of them has employed any broker in connection
with the negotiations of the terms of this Sublease or the
execution hereof. Sublandlord and Subtenant hereby agree to
indemnify and to hold each other harmless against any loss,
expense, or liability (including, without limitation, reasonable
attorneys' fees and costs) with respect to any claims for
commissions or brokerage fees arising from or out of any breach of
the foregoing representation and warranty.
43.
DIRECT LEASE.
Subtenant is the obligor under a certain Promissory Note of even
date herewith in favor of Scienza Labs, Inc. If, during the
Sublease Term as may be extended, Subtenant satisfies all of its
obligations under such Promissory Note, then this Sublease shall
continue as a direct lease between Subtenant and Landlord (as
Sublandlord) pursuant to the terms of this Sublease, and Sublessee
agrees to attorn to and recognize
Landlord as the Sublandlord under this Sublease as of such
date.
44.
COUNTERPARTS. This
Sublease may be executed in multiple counterparts, and by the
different parties hereto in separate counterparts, each of which
when so executed and delivered shall be deemed to be one and the
same instrument with the same signature as if all parties to this
Sublease had signed the same signature page. An executed facsimile
or e-mail copy shall be an acceptable form of acceptance of this
Sublease, and shall be considered an original for all
purposes.
45.
LANDLORD CONSENT
AND ESTOPPEL: The Landlord hereby acknowledges and agrees to
execute a Landlord Consent and Estoppel in similar form to the
attached Appendix 2 hereto,
in order to confirm the validity and effectiveness of the Original
Lease.
(Signatures
on next page)
H-10
IN
WITNESS WHEREOF, the parties have executed this Sublease as of the
day and year first above written.
SUBLANDLORD:
PHARMA-BIO SERV PR
INC.
By:
Name:
Title:
SUBTENANT:
ROMARK
GLOBAL PHARMA, LLC
By:
Name:
Title:
CONSENT AND JOINDER OF LANDLORD
Landlord hereby
joins the foregoing Sublease by and between PHARMA-BIO SERV PR INC.
and ROMARK GLOBAL PHARMA, LLC to evidence its consent to such
Sublease and the provisions thereof (the “Sublease
Agreement”). Furthermore, Landlord hereby acknowledges and
agrees to be bound by the provisions of this Sublease Agreement, to
the extent they impose terms, covenants and conditions unto
Landlord for the benefit of Subtenant.
LANDLORD:
PLAZA
PROFESSIONAL CENTER, INC.
By:
Name:
Title:
H-11